<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Biomol Ther (Seoul)</journal-id>
<journal-id journal-id-type="iso-abbrev">Biomol Ther (Seoul)</journal-id>
<journal-id journal-id-type="publisher-id">Biomol Ther (Seoul)</journal-id>
<journal-id journal-id-type="publisher-id">ksp</journal-id>
<journal-title-group>
<journal-title>Biomolecules &amp; Therapeutics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1976-9148</issn>
<issn pub-type="epub">2005-4483</issn>
<publisher>
<publisher-name>The Korean Society of Applied Pharmacology</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27133257</article-id>
<article-id pub-id-type="pmc">4859786</article-id>
<article-id pub-id-type="doi">10.4062/biomolther.2016.061</article-id>
<article-id pub-id-type="publisher-id">bt-24-207</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Clinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Ki Chan</given-names>
</name>
<xref ref-type="aff" rid="af1-bt-24-207">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="af2-bt-24-207">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gonzales</surname>
<given-names>Edson Luck</given-names>
</name>
<xref ref-type="aff" rid="af2-bt-24-207">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="af3-bt-24-207">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lázaro</surname>
<given-names>María T.</given-names>
</name>
<xref ref-type="aff" rid="af4-bt-24-207">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Choi</surname>
<given-names>Chang Soon</given-names>
</name>
<xref ref-type="aff" rid="af2-bt-24-207">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="af3-bt-24-207">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bahn</surname>
<given-names>Geon Ho</given-names>
</name>
<xref ref-type="aff" rid="af5-bt-24-207">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yoo</surname>
<given-names>Hee Jeong</given-names>
</name>
<xref ref-type="aff" rid="af6-bt-24-207">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shin</surname>
<given-names>Chan Young</given-names>
</name>
<xref ref-type="aff" rid="af2-bt-24-207">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="af3-bt-24-207">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c1-bt-24-207">
<sup>*</sup>
</xref>
</contrib>
</contrib-group>
<aff id="af1-bt-24-207"><label>1</label>Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX 75390, 
<country>USA</country></aff>
<aff id="af2-bt-24-207"><label>2</label>Center for Neuroscience Research, SMART Institute of Advanced Biomedical Sciences, Konkuk University, Seoul 05029</aff>
<aff id="af3-bt-24-207"><label>3</label>School of Medicine, Konkuk University, Seoul 05029, 
<country>Republic of Korea</country></aff>
<aff id="af4-bt-24-207"><label>4</label>Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, 
<country>USA</country></aff>
<aff id="af5-bt-24-207"><label>5</label>Department of Neuropsychiatry, School of Medicine, Kyung Hee University, Seoul 02447</aff>
<aff id="af6-bt-24-207"><label>6</label>Department of Neuropsychiatry, Seoul National University Bungdang Hospital, Seongnam 13620, 
<country>Republic of Korea</country></aff>
<author-notes>
<corresp id="c1-bt-24-207"><label>*</label>Corresponding Author: E-mail: <email>chanyshin@kku.ac.kr</email>, Tel: +82-2-2030-7834, Fax: +82-2-2049-7899</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>01</day>
<month>5</month>
<year>2016</year>
</pub-date>
<volume>24</volume>
<issue>3</issue>
<fpage>207</fpage>
<lpage>243</lpage>
<history>
<date date-type="received">
<day>15</day>
<month>3</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>4</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright ©2016, The Korean Society of Applied Pharmacology</copyright-statement>
<copyright-year>2016</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
<license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licens-es/by-nc/4.0/">http://creativecommons.org/licens-es/by-nc/4.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p>Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by social and communication impairments, as well as repetitive and restrictive behaviors. The phenotypic heterogeneity of ASD has made it overwhelmingly difficult to determine the exact etiology and pathophysiology underlying the core symptoms, which are often accompanied by comorbidities such as hyperactivity, seizures, and sensorimotor abnormalities. To our benefit, the advent of animal models has allowed us to assess and test diverse risk factors of ASD, both genetic and environmental, and measure their contribution to the manifestation of autistic symptoms. At a broader scale, rodent models have helped consolidate molecular pathways and unify the neurophysiological mechanisms underlying each one of the various etiologies. This approach will potentially enable the stratification of ASD into clinical, molecular, and neurophenotypic subgroups, further proving their translational utility. It is henceforth paramount to establish a common ground of mechanistic theories from complementing results in preclinical research. In this review, we cluster the ASD animal models into lesion and genetic models and further classify them based on the corresponding environmental, epigenetic and genetic factors. Finally, we summarize the symptoms and neuropathological highlights for each model and make critical comparisons that elucidate their clinical and neurobiological relevance.</p>
</abstract>
<kwd-group>
<kwd>Autism spectrum disorders</kwd>
<kwd>Animal models</kwd>
<kwd>Genetic factors</kwd>
<kwd>Environmental factors</kwd>
<kwd>Clinical relevance</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>INTRODUCTION</title>
<p>Autism spectrum disorder (ASD) is a prototypical pervasive developmental disorder resulting from abnormal brain development. ASD constitutes two main behavioral symptoms including impairment in social interactions and communication, and restricted, repetitive behaviors, diagnosed at an early age in development (<xref ref-type="bibr" rid="b7-bt-24-207">American Psychiatric Association, 2013</xref>). The disorder is often accompanied by sensory processing abnormalities (<xref ref-type="bibr" rid="b268-bt-24-207">Rogers <italic>et al</italic>., 2003</xref>), sleep problems (<xref ref-type="bibr" rid="b286-bt-24-207">Schreck <italic>et al</italic>., 2004</xref>), anxiety and depression (<xref ref-type="bibr" rid="b306-bt-24-207">Strang <italic>et al</italic>., 2012</xref>), hyperactivity (<xref ref-type="bibr" rid="b5-bt-24-207">Aman and Langworthy, 2000</xref>), aggression or self-injurious behaviors (<xref ref-type="bibr" rid="b295-bt-24-207">Singh <italic>et al</italic>., 2006</xref>), seizures (<xref ref-type="bibr" rid="b330-bt-24-207">Volkmar and Nelson, 1990</xref>) and eating or digestive problems (<xref ref-type="bibr" rid="b212-bt-24-207">Martins <italic>et al</italic>., 2008</xref>), among others. ASD is incredibly heterogeneous and is commonly comorbid with other psychiatric and neurodevelopmental disorders or syndromes (<xref ref-type="bibr" rid="b193-bt-24-207">Leyfer <italic>et al</italic>., 2006</xref>). As one may expect, this condition causes great hardship to affected families, as it may lead to social, occupational and other functional afflictions (<xref ref-type="bibr" rid="b7-bt-24-207">American Psychiatric Association, 2013</xref>).</p>
<p>Research over the last several decades has identified various risk factors leading to ASD, which can be classified into genetic abnormalities, epigenetic alterations and environmental insults (<xref ref-type="bibr" rid="b115-bt-24-207">Gepner and Feron, 2009</xref>). Genetic risk factors take the form of monogenic mutations, single nucleotide polymorphism (SNP), and copy number variants (CNVs). Not surprisingly, many of the implicated genes have been associated with modulation of brain development and cortical organization, synapse formation and function, and neurotransmission. On the other hand, environmental insults implicated in ASD comprise prenatal exposure to viral infections or chemicals, including rubella (<xref ref-type="bibr" rid="b67-bt-24-207">Chess <italic>et al</italic>., 1978</xref>), cytomegalovirus (<xref ref-type="bibr" rid="b350-bt-24-207">Yamashita <italic>et al</italic>., 2003</xref>), thimerosal (<xref ref-type="bibr" rid="b29-bt-24-207">Bernard <italic>et al</italic>., 2002</xref>), thalidomide (<xref ref-type="bibr" rid="b308-bt-24-207">Stromland <italic>et al</italic>., 2002</xref>) and alcohol (<xref ref-type="bibr" rid="b13-bt-24-207">Aronson <italic>et al</italic>., 1997</xref>). Accordingly, it has been shown that both genetic and environmental factors associated with the disorder can directly induce epigenetic disruptions, as is the case of mutations in MeCP2 gene (<xref ref-type="bibr" rid="b8-bt-24-207">Amir <italic>et al</italic>., 1999</xref>) and abnormal methylation of the imprinted region of the UBE3A gene (<xref ref-type="bibr" rid="b163-bt-24-207">Jiang <italic>et al</italic>., 2004</xref>). Likewise, prenatal valproate (VPA) exposure (<xref ref-type="bibr" rid="b71-bt-24-207">Christianson <italic>et al</italic>., 1994</xref>) is thought to mechanistically affect the epigenome at critical developmental stages and lead to ASD. More recently, the effect of increased maternal and paternal age have been linked to ASD risk, mainly by increasing the proportion of copy number variants and de novo mutations in their offspring (<xref ref-type="bibr" rid="b191-bt-24-207">Lee and McGrath, 2015</xref>).</p>
<p>Based on the identified risk factors and possible etiology of ASD, animal models were created to mimic and understand the pathological mechanisms underlying the behavioral abnormalities of this disorder. Two main types of animal models, the lesion and genetic models thus became apparent. The lesion models include prenatal infection (neonatal Borna disease virus), neonatal amygdala lesion, and prenatal VPA exposure. Thalidomide exposure, which showed different effects between primates and rodents, may not be an appropriate animal model of ASD (<xref ref-type="bibr" rid="b174-bt-24-207">Kemper and Bauman, 1993</xref>). Genetic models consist of knockout mice of various isolated genes that are thought to be involved in the pathology of both syndromic and non-syndromic ASD such as <italic>FMR1</italic> (Fragile X syndrome), <italic>NF1</italic> (Neurofibromatosis type 1), <italic>TSC1</italic> (Tuberous sclerosis), <italic>DHCR7</italic> (Smith-Lemli-Opitz syndrome), <italic>MeCP2</italic> (Rett syndrome), <italic>SHANK2</italic>, <italic>CNTNAP2</italic>, Eukaryotic translation initiation factor 4E (eIF4E), transgenic mouse targeting Oxytocin, Vasopressin, Reelin, Dishevelled-1, Sert (serotonin transporter), Maoa (monoamine oxidase A), HOXA1, PTEN and Neuroligins.</p>
<p>Although the number of animal models for ASD is rapidly expanding and will continuously increase in upcoming years, systemic efforts to concisely assess their clinical relevance and neurobiological significance are still scarce. In this review, we will tackle the two main classes of ASD animal models, lesion and genetic models, in order to dissect them into specific sub-groups to find out whether the studies of these models have neurobiological relevance to the clinical setting (<xref ref-type="table" rid="t1-bt-24-207">Table 1</xref>).</p>
</sec>
<sec>
<title>LESION MODELS</title>
<sec>
<title>Anatomical lesion models</title>
<p>Anatomical lesion models have long been used to isolate brain regions involved in the pathologic pathways of a number of neurological disorders. In the case of autism, however, brain damage induced by a gross chemical or electrolytic lesion of specific regions have not been able to even remotely replicate human ASD. The complexity of human development and the heterogeneity that is found in ASD phenotypes could perhaps be two of the main reasons that make the recapitulation of ASD much difficult in this type of postnatal lesion animal models. Moreover, the impairments found in ASD are not likely to be rooted only from a single neural circuit or brain region.</p>
<sec>
<title>Amygdala:</title>
<p>Early life dysfunction and alterations in the amygdala have long been linked to autistic behaviors (<xref ref-type="bibr" rid="b17-bt-24-207">Bachevalier, 1994</xref>). Indeed, autistic children have been found to have enlarged amygdala and decreased neuronal cell size within this region, despite increased cell density brain-wide (<xref ref-type="bibr" rid="b173-bt-24-207">Kemper and Bauman, 1998</xref>). Interestingly, changes in amygdala volume throughout development was directly correlated with initiating communicative eye contact in autistic children (<xref ref-type="bibr" rid="b20-bt-24-207">Barnea-Goraly <italic>et al</italic>., 2014</xref>). In addition, other studies found that ASD patients tend to avoid eye contact on facial gaze tasks and showed increased amygdala activity during gaze manipulation along with an increase in subjective threat ratings (<xref ref-type="bibr" rid="b319-bt-24-207">Tottenham <italic>et al</italic>., 2014</xref>).</p>
<p>Most established animal models used to assess the contribution of amygdala to autistic behaviors have utilized rats that have undergone direct amygdala lesions or indirect impairment using other etiologic factors. Initial studies from amygdala-lesioned rats (at postnatal day 7) which were subjected to juvenile isolation prior to testing, showed that these animals developed a tendency for stereotyped walking (<xref ref-type="bibr" rid="b347-bt-24-207">Wolterink <italic>et al</italic>., 2001</xref>), decreased social play and exploration (<xref ref-type="bibr" rid="b347-bt-24-207">Wolterink <italic>et al</italic>., 2001</xref>), impaired social interaction, and decreased spatial learning and memory in the spontaneous alternation task (<xref ref-type="bibr" rid="b91-bt-24-207">Diergaarde <italic>et al</italic>., 2005</xref>). However, similar lesions to the amygdala of macaque monkeys failed to affect their social behaviors, and mostly impaired their fear learning and anxiety behaviors (<xref ref-type="bibr" rid="b6-bt-24-207">Amaral <italic>et al</italic>., 2003</xref>). These discrepancies are not surprising, as data from humans with ASD show similar inconsistencies.</p>
<p>Accordingly, it seems that ASD-related alterations in amygdala size vary across developmental time-points; some studies have shown that this region is enlarged in children with ASD, whereas it has been found to be smaller in size in adolescents or young adults with the disorder, compared to controls (<xref ref-type="bibr" rid="b287-bt-24-207">Schumann <italic>et al</italic>., 2004</xref>). These findings suggest that the involvement of amygdala in ASD is rather complex, making it harder to model both with targeted lesions and in animals. Yet, even if the hallmark social behavior deficits associated with ASD are inconclusive with regards to the amygdala, it is still possible that fear and anxiety phenotypes in ASD are still linked to functional deficits in this brain region (<xref ref-type="bibr" rid="b6-bt-24-207">Amaral <italic>et al</italic>., 2003</xref>). Recently, however, another clinical study failed to find a relationship between ASD and amygdala dysfunction, using visual tasks as a measure of impaired social attention (<xref ref-type="bibr" rid="b191-bt-24-207">Lee and McGrath, 2015</xref>). Thus, further study is needed to clarify and consolidate the results regarding the involvement of amygdala in ASD pathology and to encourage its validity in the modeling of the disorder.</p>
</sec>
<sec>
<title>Cerebellum:</title>
<p>Anatomical abnormalities of the cerebellum have been widely observed in human autistic patients (<xref ref-type="bibr" rid="b22-bt-24-207">Bauman and Kemper, 1985</xref>). Reported abnormalities include hypoplasia of cerebellar vermal lobules VI and VII (<xref ref-type="bibr" rid="b80-bt-24-207">Courchesne <italic>et al</italic>., 1994</xref>), which were negatively correlated to increased repetitive behaviors and decreased exploratory behavior in autistic children (<xref ref-type="bibr" rid="b251-bt-24-207">Pierce and Courchesne, 2001</xref>), results which have been somewhat controversial. Loss of Purkinje cells in the cerebellar vermis and cortex was also reported in human autistic subjects (<xref ref-type="bibr" rid="b3-bt-24-207">Allen and Courchesne, 2003</xref>). A comprehensive review had been published explaining the pathological involvement of the cerebellum in the development of autism (<xref ref-type="bibr" rid="b101-bt-24-207">Fatemi <italic>et al</italic>., 2012</xref>). The review highlighted that in some autistic patients, there are cerebellar abnormalities covering anatomical defects, inflammation, oxidative stress, abnormal neurotransmitters and protein levels, and cerebellum-related motor and cognitive impairments. Moreover, the pathological onset of cerebellar defects in autism is at an early age, which affects the development later in life. Lastly, various risk factors involving genetics, environment, or their combination can affect the development of the cerebral circuitry found in autism (<xref ref-type="bibr" rid="b101-bt-24-207">Fatemi <italic>et al</italic>., 2012</xref>).</p>
<p>In rats, lesions in the midline of the cerebellum cause visuomotor defects in the Morris water maze test, despite any spatial memory defects in the spontaneous alternation test (<xref ref-type="bibr" rid="b164-bt-24-207">Joyal <italic>et al</italic>., 1996</xref>). Moreover, early postnatal cerebellum lesions have been shown to increase spontaneous motor activity and decrease anxiety-like behavior in rodents (<xref ref-type="bibr" rid="b39-bt-24-207">Bobee <italic>et al</italic>., 2000</xref>). Using the lurcher mutation model, which provides a reasonable mouse model of cerebellar defects (<xref ref-type="bibr" rid="b209-bt-24-207">Martin <italic>et al</italic>., 2004</xref>), it was shown that the loss of Purkinje cells in mice induced significantly increased repetitive behaviors (<xref ref-type="bibr" rid="b210-bt-24-207">Martin <italic>et al</italic>., 2010</xref>). As a whole, these cerebellum lesion studies in rodents confirm a potential role of this structure in producing some of the motor, repetitive and exploratory behavioral deficits or anxiety-like behaviors, observed in autism (<xref ref-type="bibr" rid="b251-bt-24-207">Pierce and Courchesne, 2001</xref>). This is also consistent with the fact that cerebellar injury at birth is a risk factor for ASD in children (<xref ref-type="bibr" rid="b337-bt-24-207">Wang <italic>et al</italic>., 2014</xref>). Indeed, cerebellar damage animal models could be an important tool for isolating the role of the cerebellum in specific autistic symptoms.</p>
</sec>
<sec>
<title>Medial prefrontal cortex (mPFC):</title>
<p>Studies have shown that brain overgrowth in the mPFC and dorsolateral PFC is generally pronounced in autistic patients (<xref ref-type="bibr" rid="b53-bt-24-207">Carper and Courchesne, 2005</xref>; <xref ref-type="bibr" rid="b138-bt-24-207">Hazlett <italic>et al</italic>., 2005</xref>). Aside from PFC overgrowth, early PFC damage in humans has also been shown to impair social interaction and cognition (<xref ref-type="bibr" rid="b98-bt-24-207">Eslinger <italic>et al</italic>., 2004</xref>). In rats, neonatal mPFC lesions decrease social play, conditioned place-preference associated with social contacts, and social grooming (<xref ref-type="bibr" rid="b284-bt-24-207">Schneider and Koch, 2005</xref>). Interestingly, similar lesions in adult rats do not seem to affect social interactions as much (<xref ref-type="bibr" rid="b284-bt-24-207">Schneider and Koch, 2005</xref>), suggesting that these deficits arise early in development. As morphological changes in mPFC have been linked to ASD, the exact neurobiological pathway pertaining to social deficits should be further studied. When doing so, nonetheless, it is important to be aware of the fact that alterations in mPFC function are not unique to ASD, as they also overlap with other neurological conditions.</p>
</sec>
</sec>
<sec>
<title>Maternal infection</title>
<p>Maternal immune activation (MIA) is a proposed risk factor for abnormal fetal brain development leading to neurodevelopmental disorders such as ASD (<xref ref-type="bibr" rid="b214-bt-24-207">Mazina <italic>et al</italic>., 2015</xref>). It has been shown that MIA during pregnancy in rodents leads to a dysregulated immune system in offspring and also results in autism-related phenotypes that persist well into adulthood (<xref ref-type="bibr" rid="b245-bt-24-207">Patterson, 2011</xref>). In more detailed molecular studies, interleukin-6 (IL-6) has been suggested to play a mechanistic role in the transcriptional and behavioral abnormalities of MIA in offspring (<xref ref-type="bibr" rid="b299-bt-24-207">Smith <italic>et al</italic>., 2007</xref>). This could parallel some reports from human ASD cases, where mothers of affected individuals display elevated IL-6 levels, as is observed in depression and schizophrenia (<xref ref-type="bibr" rid="b85-bt-24-207">Daniels <italic>et al</italic>., 2008</xref>). This overlap with other neuropsychiatric disorders is also to be taken into consideration when using animal models of MIA. Yet, the fact that IL-6 has consistently been found to be increased in ASD brains (<xref ref-type="bibr" rid="b26-bt-24-207">Benvenuto <italic>et al</italic>., 2009</xref>) and plasma (<xref ref-type="bibr" rid="b14-bt-24-207">Ashwood <italic>et al</italic>., 2011</xref>), makes it a very worthy line of study. Furthermore, recent progress in animal models of MIA have shown promising results, yet further studies will be needed to connect immune dysregulation with ASD pathophysiology (<xref ref-type="bibr" rid="b146-bt-24-207">Hsiao <italic>et al</italic>., 2012</xref>). Below, we briefly describe the three most commonly used MIA models of ASD.</p>
<p>Prenatal BDV (Borna Disease Virus) infection was the first virus-induced animal model of ASD (<xref ref-type="bibr" rid="b252-bt-24-207">Pletnikov <italic>et al</italic>., 2002</xref>). BDV, a transmissible, progressive and lethal virus that causes encephalomyelitis in horses and sheep, is associated with neurologic impairments and behavioral disorders in humans (<xref ref-type="bibr" rid="b263-bt-24-207">Richt <italic>et al</italic>., 1997</xref>). Prenatally BDV-infected rats, which have been commonly used to investigate pathogenic mechanisms (<xref ref-type="bibr" rid="b311-bt-24-207">Taieb <italic>et al</italic>., 2001</xref>), show increased stereotypy (<xref ref-type="bibr" rid="b144-bt-24-207">Hornig <italic>et al</italic>., 1999</xref>), decreased social play (<xref ref-type="bibr" rid="b252-bt-24-207">Pletnikov <italic>et al</italic>., 2002</xref>) and impaired social interactions (<xref ref-type="bibr" rid="b253-bt-24-207">Pletnikov <italic>et al</italic>., 1999</xref>), which are clearly ASD-related phenotypes. These BDV-infected rats also display abnormalities in postnatal hippocampus and cerebellum development (<xref ref-type="bibr" rid="b311-bt-24-207">Taieb <italic>et al</italic>., 2001</xref>). Although BDV infection shows behavioral changes relevant to autism in offspring of affected animals, its implication and reflection to human condition is still elusive and needs to be studied further for clinical comparison, as no study directly related BDV exposure with autism in humans.</p>
<p>Lipopolysaccharide (LPS) is another immune activator found in the outer membrane of gram-negative bacteria that acts as an endotoxin. It is a highly immunogenic antigen that carries the ability to induce antibody responses <italic>in vivo</italic> (<xref ref-type="bibr" rid="b297-bt-24-207">Skidmore <italic>et al</italic>., 1975</xref>). Although there has been no direct association between LPS and autism, peripheral blood mononuclear cells (PBMCs) of ASD patients seem to produce more TNF-α, IL-1β and IL-6 after LPS exposure, compared to controls (<xref ref-type="bibr" rid="b167-bt-24-207">Jyonouchi <italic>et al</italic>., 2005</xref>). Interestingly, prenatally LPS-exposed mice display increased anxiety (<xref ref-type="bibr" rid="b336-bt-24-207">Wang <italic>et al</italic>., 2010</xref>), decreased social interactions (<xref ref-type="bibr" rid="b137-bt-24-207">Hava <italic>et al</italic>., 2006</xref>) and impaired learning and memory (<xref ref-type="bibr" rid="b123-bt-24-207">Golan <italic>et al</italic>., 2005</xref>). In rats, gestational LPS exposure significantly decreases pre-pulse inhibition in male offspring (<xref ref-type="bibr" rid="b269-bt-24-207">Romero <italic>et al</italic>., 2007</xref>). Other studies have found that LPS-exposed animals show increased cell density, increased excitability of pyramidal neurons and postsynaptic glutamatergic responses to NMDA-induced synaptic plasticity (<xref ref-type="bibr" rid="b244-bt-24-207">Patterson, 2009</xref>). These findings from both rat and mouse studies indeed support the possibility that LPS-induced MIA can cause ASD phenotypes in offspring. More importantly, further research should be done in order to determine whether, postmortem autistic brains from individuals with a history of prenatal MIA or infection display some of the anatomical deficits observed in rodents.</p>
<p>Poly I:C is a double-stranded RNA that mimics viral infection and can induce MIA. Offspring of rats that have been injected with Poly I:C during pregnancy display autism-related phenotypes, including increased anxiety, stereotypic-repetitive behaviors (<xref ref-type="bibr" rid="b244-bt-24-207">Patterson, 2009</xref>; <xref ref-type="bibr" rid="b219-bt-24-207">Meyer <italic>et al</italic>., 2011</xref>), decreased social interaction and communication, impaired social preference and decreased sensorimotor coordination (<xref ref-type="bibr" rid="b230-bt-24-207">Naviaux <italic>et al</italic>., 2013</xref>) and impaired prepulse inhibition (<xref ref-type="bibr" rid="b244-bt-24-207">Patterson, 2009</xref>; <xref ref-type="bibr" rid="b219-bt-24-207">Meyer <italic>et al</italic>., 2011</xref>). In rat and mice brains exposed to poly I:C has been found a spatially localized deficit in Purkinje cells at the lobule VII of the cerebellum, along with heterotrophic morphology and delayed migration of these cells in lobules VI and VII (<xref ref-type="bibr" rid="b230-bt-24-207">Naviaux <italic>et al</italic>., 2013</xref>). In addition, synaptosome abnormalities were also observed, both at structural and chemical levels, including PSD malformation, downregulation of purinergic receptors and reduced phosphorylation of ERK1/2 and CAMKII (<xref ref-type="bibr" rid="b230-bt-24-207">Naviaux <italic>et al</italic>., 2013</xref>). However, poly I:C induction in rodents have also been used to model schizophrenia (<xref ref-type="bibr" rid="b185-bt-24-207">Kumamaru <italic>et al</italic>., 2014</xref>), so careful interpretation of results should be noted.</p>
<p>Overall, MIA animal models of autism could be a great tool not only in predicting the cause but also in identifying the pathophysiologic pathways involved in the disorder. This is supported by the fact that clinical epidemiologic studies can be the only practical and ethical option to identify disease-causing factors in humans. Although the type of microbial pathogens or immune activators may differ in humans to those used in animal models, the autistic effects of maternal MIA in animal models may somehow explain some pathologic mechanisms involved in human ASD. For more details on this topic, please see the works of Patterson (<xref ref-type="bibr" rid="b245-bt-24-207">Patterson, 2011</xref>).</p>
</sec>
<sec>
<title>Prenatal valproate (VPA) exposure</title>
<p>Valproic acid (VPA) is a commonly used pharmaceutical that relieves seizures, migraine headaches and manic episodes related to bipolar disorder. However, several studies have shown that gestational VPA treatment for a life-threatening epilepsy may cause numerous defects in children, including neural tube defects (<xref ref-type="bibr" rid="b239-bt-24-207">Ornoy, 2009</xref>), intellectual impairments (<xref ref-type="bibr" rid="b224-bt-24-207">Moore <italic>et al</italic>., 2000</xref>) and cognitive-behavioral impairments (<xref ref-type="bibr" rid="b224-bt-24-207">Moore <italic>et al</italic>., 2000</xref>), many related to the core symptoms of autism. Moreover, prenatal VPA exposure has often been associated with ASD (<xref ref-type="bibr" rid="b71-bt-24-207">Christianson <italic>et al</italic>., 1994</xref>). The VPA animal models of ASD have thus been widely used due to their strong etiological and clinical relevance. Here, we mention notable progress and studies utilizing this model.</p>
<p>To investigate the possible effects of VPA on human embryos and explain its effect on brain development, rats and mice models have been widely used, although treatment dosage and injection timings vary among labs (<xref ref-type="bibr" rid="b171-bt-24-207">Kataoka <italic>et al</italic>., 2013</xref>; <xref ref-type="bibr" rid="b176-bt-24-207">Kim <italic>et al</italic>., 2014a</xref>). Indeed, prenatal VPA exposure to rodents does induce neural tube defects, abnormal brain mass at birth and behavioral impairments in the offspring (<xref ref-type="bibr" rid="b171-bt-24-207">Kataoka <italic>et al</italic>., 2013</xref>; <xref ref-type="bibr" rid="b176-bt-24-207">Kim <italic>et al</italic>., 2014a</xref>). Similar to autistic symptoms in human patients, both rats and mice that have been subjected to prenatal VPA exposure show increased stereotypic repetitive behaviors (<xref ref-type="bibr" rid="b285-bt-24-207">Schneider <italic>et al</italic>., 2008</xref>), impaired social interactions (<xref ref-type="bibr" rid="b178-bt-24-207">Kim <italic>et al</italic>., 2011</xref>), and decreased social preference for social novelty (<xref ref-type="bibr" rid="b178-bt-24-207">Kim <italic>et al</italic>., 2011</xref>)</p>
<p>The VPA-exposed animal models also showed some common accompanying phenotypes of ASD such as increased anxiety, impaired reversal learning and fear memory processing, abnormal nesting behaviors (<xref ref-type="bibr" rid="b285-bt-24-207">Schneider <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="b244-bt-24-207">Patterson, 2009</xref>), and decreased prepulse inhibition (<xref ref-type="bibr" rid="b285-bt-24-207">Schneider <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="b244-bt-24-207">Patterson, 2009</xref>). In addition, our group and others have recently reported that prenatal VPA exposure at embryonic day 12 (E12) in rats recapitulates autism-related phenotypes, including deficits in social interactions (<xref ref-type="bibr" rid="b178-bt-24-207">Kim <italic>et al</italic>., 2011</xref>) and increased seizure susceptibility, as is observed in 1/3 of ASD patients (<xref ref-type="bibr" rid="b301-bt-24-207">Spence and Schneider, 2009</xref>). Interestingly, these deficits were only observed in male offspring, which is quite striking given that male preponderance is a common feature of neurodevelopmental disorders such as ASD and attention-deficit hyperactivity disorder (ADHD) (<xref ref-type="bibr" rid="b271-bt-24-207">Rutter <italic>et al</italic>., 2003</xref>).</p>
<p>Physiologically, the brains of VPA-exposed rats display hyper-connectivity and hyper-plasticity in the mPFC region (<xref ref-type="bibr" rid="b265-bt-24-207">Rinaldi <italic>et al</italic>., 2008</xref>), along with an increased NMDA/AMPA ratio (<xref ref-type="bibr" rid="b264-bt-24-207">Rinaldi <italic>et al</italic>., 2007</xref>). These animals also show dysregulated LTP and decreased NMDAR-mediated currents in adult mPFC, but not in early postnatal life and adolescence (<xref ref-type="bibr" rid="b208-bt-24-207">Martin and Manzoni, 2014</xref>). These results demonstrate that synaptic abnormalities in the VPA animal model persist well into adulthood and suggest that an aberrant developmental switch in synaptic function of mPFC could underlie some of the ASD-related pathophysiological mechanisms. In other studies, VPA-exposed rats display abnormal neuronal migration (<xref ref-type="bibr" rid="b186-bt-24-207">Kuwagata <italic>et al</italic>., 2009</xref>) aberrant GABA<sub>A</sub> receptor subunit expression and alterations in benzodiazepines binding, as has been observed in ASD patients (<xref ref-type="bibr" rid="b235-bt-24-207">Oblak <italic>et al</italic>., 2011</xref>). Moreover, VPA exposure in rats reduced the expression of glutamate decarboxylase, which catalyzes the decarboxylation of glutamate to GABA and CO<sub>2</sub> in young neurons suggesting excitatory/inhibitory imbalance (<xref ref-type="bibr" rid="b110-bt-24-207">Fukuchi <italic>et al</italic>., 2009</xref>). In naïve rats, GABA currents are excitatory in early development and undergo an inhibitory switch at birth, presumably through neuromodulation by oxytocin. Such shift is not observed (or is delayed) in both the VPA and fragile X models of autism, resulting in neuronal hyperexcitability and increased glutamatergic neurotransmission (<xref ref-type="bibr" rid="b325-bt-24-207">Tyzio <italic>et al</italic>., 2014</xref>). These studies showed that lowering the intracellular chloride concentration by treating the dam with bumetanide produced long-term normalization of electrophysiological properties and behaviors in VPA offspring (<xref ref-type="bibr" rid="b325-bt-24-207">Tyzio <italic>et al</italic>., 2014</xref>).</p>
<p><italic>In vitro</italic> studies have provided additional evidence supporting the profound effects of early developmental exposure to VPA. First, cultured cells that have been treated with VPA show altered neural progenitor cell properties (<xref ref-type="bibr" rid="b165-bt-24-207">Jung <italic>et al</italic>., 2008</xref>) and prolonged neurogenesis (<xref ref-type="bibr" rid="b165-bt-24-207">Jung <italic>et al</italic>., 2008</xref>). In addition, VPA-exposed premature neurons and N1E-115 cell lines show enhanced expression of PSD-95 (<xref ref-type="bibr" rid="b175-bt-24-207">Kim and Thayer, 2009</xref>) and increased neurite outgrowth (<xref ref-type="bibr" rid="b351-bt-24-207">Yamauchi <italic>et al</italic>., 2008</xref>), respectively. Finally, studies have demonstrated that VPA treatment <italic>in vitro</italic> can increase the tissue plasminogen activator (tPA) and decrease plasminogen activator inhibitor-1 (PAI-1) activity in astrocytes but not in neurons (<xref ref-type="bibr" rid="b70-bt-24-207">Cho <italic>et al</italic>., 2013</xref>). This led to the increased neurite outgrowth via JNK signaling, which could thus be related to the altered neural development in ASD.</p>
<p>A lot of progress has also been made in terms of the molecular mechanisms underlying the VPA animal model of ASD. For example, we found that the histone deacetylase inhibitor (HDACi) function of VPA prevented the apoptosis of neural progenitor cells (NPC). Mechanistically, VPA reduced the expression level of IκBα and activated the NF-κB signaling pathway, leading to increased expression of the anti-apoptotic protein Bcl-XL (<xref ref-type="bibr" rid="b121-bt-24-207">Go <italic>et al</italic>., 2012</xref>). In a follow-up investigation, VPA exposure at E12 enhanced Wnt1 signaling, which activated the GSK-3β/β catenin pathway and lead to increased neurogenesis in the embryonic brain (<xref ref-type="bibr" rid="b121-bt-24-207">Go <italic>et al</italic>., 2012</xref>). These processes shed light onto potential molecular pathways that could explain prolonged NPC proliferation and neuron overproduction in ASD.</p>
<p>In general, these studies showed that prenatal VPA exposure in rats has profound effects on neurotransmission and leads to excitatory/inhibitory imbalance, reminiscent to the human ASD condition (<xref ref-type="bibr" rid="b179-bt-24-207">Kim <italic>et al</italic>., 2014c</xref>). We further discovered that Pax6, a transcription factor that modulates glutamatergic neuronal differentiation, was transiently increased after VPA exposure. This led to the increased sequential expression of additional transcription factors involved in the regulation of glutamatergic differentiation, including Ngn2, Tbr2 and NeuroD1. Ultimately, this series of events directed to the increased glutamatergic neurons in mature brains, marked by increased PSD-95, α-CaMKII, vGluT1 and synaptophysin expression. Conversely, there we found a slight decrease in GABAergic marker Mash1 early in development, followed by a decrease in GAD and Reelin, (<xref ref-type="bibr" rid="b179-bt-24-207">Kim <italic>et al</italic>., 2014c</xref>), further highlighting the excitatory/inhibitory ratio shift. This imbalance was concurrent with abnormally elevated kinetic profiles of the glutamatergic NMDA, AMPA and mGluR5 pathways in the PFC of VPA-exposed young rats, through the attenuation of MeCP2 expression (<xref ref-type="bibr" rid="b177-bt-24-207">Kim <italic>et al</italic>., 2014b</xref>), suggesting increased excitatory signaling. Intriguingly, Walcott and colleagues found that the increased neuronal excitability in young VPA-exposed rats was gradually corrected to normal levels during the adolescent period, suggesting a delay in neuronal circuit maturation, which prompts further investigation (<xref ref-type="bibr" rid="b334-bt-24-207">Walcott <italic>et al</italic>., 2011</xref>).</p>
<p>As can be seen, the VPA model of autism has provided useful insights on potential mechanisms leading to ASD. Consequently, it has been also useful in the search for potential therapeutics for ASD. Our group, for example, used the VPA model to screen for drug treatments targeting known dysregulated pathways and found that NMDA receptor antagonists like MK801 and memantine, as well as the acetylcholinesterase inhibitor donepezil, normalized the social defects in the VPA-exposed animals (<xref ref-type="bibr" rid="b176-bt-24-207">Kim <italic>et al</italic>., 2014a</xref>), in addition to bumetanide proposed by Tyzio <italic>et al</italic> as a therapeutic candidate (<xref ref-type="bibr" rid="b325-bt-24-207">Tyzio <italic>et al</italic>., 2014</xref>). Overall, these studies show a great potential for using the VPA animal model of ASD in the mechanistic and therapeutic treatment exploration of ASD.</p>
</sec>
<sec>
<title>BTBR T+Itpr3tf/J</title>
<p>The BTBR T+Itpr3tf/J (BTBR) mice are inbred strain mice used as an animal model of ASD, due to its natural traits that resemble ASD-phenotypes. This mouse line is derived from Black and Tan BRachyury inbred strain (BTBR), which carry mutations in <italic>a<sup>t</sup></italic> (nonagouti; black and tan), <italic>Itpr3<sup>tf</sup></italic> (inositol 1,4,5- triphosphate receptor 3; tufted), and <italic>T</italic> (brachyury). Anatomically, BTBR mice exhibit the absence of the corpus callosum and a severe reduction of the hippocampal commis-sure (<xref ref-type="bibr" rid="b333-bt-24-207">Wahlsten <italic>et al</italic>., 2003</xref>), as well as high circulating levels of corticosteroid, progesterone, and its 3α,5α-THP metabolite (<xref ref-type="bibr" rid="b109-bt-24-207">Frye and Llaneza, 2010</xref>). These mice also show altered brain connective tissue, reduced heparan sulfate levels (<xref ref-type="bibr" rid="b35-bt-24-207">Blanchard <italic>et al</italic>., 2012</xref>), and reduced adult hippocampal neurogenesis (<xref ref-type="bibr" rid="b305-bt-24-207">Stephenson <italic>et al</italic>., 2011</xref>). BTBR mice show decreased social behaviors (<xref ref-type="bibr" rid="b41-bt-24-207">Bolivar <italic>et al</italic>., 2007</xref>), defects in ultrasonic vocalizations, (<xref ref-type="bibr" rid="b345-bt-24-207">Wohr <italic>et al</italic>., 2011a</xref>), increased stereotyped repetitive behaviors (<xref ref-type="bibr" rid="b9-bt-24-207">Amodeo <italic>et al</italic>., 2012</xref>) and repetitive self-grooming (<xref ref-type="bibr" rid="b216-bt-24-207">McFarlane <italic>et al</italic>., 2008</xref>). Interestingly, these impairments are alleviated by acute administration of either the mGluR5 antagonist MPEP (<xref ref-type="bibr" rid="b292-bt-24-207">Silverman <italic>et al</italic>., 2010</xref>) or the AChE inhibitor, donepezil (<xref ref-type="bibr" rid="b170-bt-24-207">Karvat and Kimchi, 2014</xref>). Moreover, the SERT blocker fluoxetine enhanced the social interactions in BTBR mice (<xref ref-type="bibr" rid="b59-bt-24-207">Chadman, 2011</xref>). Indeed, the autism-related phenotypes in this inbred mouse strain could be used as good models for finding therapeutic candidates for broader or idiopathic etiologies and pathophysiologies of ASD.</p>
</sec>
</sec>
<sec>
<title>GENETIC MODELS</title>
<sec>
<title>Brain-derived neurotrophic factor (BDNF)</title>
<p>BDNF is a secretory protein and a member of the neurotrophic factor family (<xref ref-type="bibr" rid="b34-bt-24-207">Binder and Scharfman, 2004</xref>), which is widely expressed in the brain and periphery (<xref ref-type="bibr" rid="b227-bt-24-207">Murer <italic>et al</italic>., 2001</xref>). <italic>BDNF</italic> has been proposed as a candidate gene for ASD susceptibility (<xref ref-type="bibr" rid="b241-bt-24-207">Pardo and Eberhart, 2007</xref>) and plays a key role in the growth and differentiation of new neurons and synapses, as well as in the survival of existing neurons (<xref ref-type="bibr" rid="b148-bt-24-207">Huang and Reichardt, 2001</xref>). Children with ASD were reported to possess higher BDNF levels in the blood, compared with typically-developing individuals (<xref ref-type="bibr" rid="b48-bt-24-207">Bryn <italic>et al</italic>., 2015</xref>). Furthermore, autistic adults have been reported to have increased BDNF levels in the basal forebrain (<xref ref-type="bibr" rid="b249-bt-24-207">Perry <italic>et al</italic>., 2001</xref>). These findings, therefore, suggest that over-expression of BDNF at various developmental time points could be associated with ASD and may be an underlying mechanism of brain overgrowth in autistic patients (<xref ref-type="bibr" rid="b322-bt-24-207">Tsai, 2005</xref>). However, the role of BDNF in ASD etiology remains inconclusive, as recent work demonstrates completely opposite results, finding decreased serum BDNF levels in ASD patients (<xref ref-type="bibr" rid="b314-bt-24-207">Taurines <italic>et al</italic>., 2014</xref>). These contradicting outcomes make BDNF a variable and perhaps unreliable biomarker for ASD; yet, it is clear that optimal levels of BDNF are essential for brain development and maintenance of normal brain function.</p>
<p>BDNF function has been extensively studied in mice, mainly through the use of conditional knockouts and mutants. Initial studies in these transgenics found somewhat robust behavioral phenotypes, although they were not initially attributed to autism (<xref ref-type="bibr" rid="b204-bt-24-207">MacQueen <italic>et al</italic>., 2001</xref>). One of such phenotypes can be observed in the conditional <italic>BDNF</italic> knockout mouse, which displays increased locomotor activity in males and depression-like behaviors in <italic>BDNF</italic><sup>+/−</sup> females (<xref ref-type="bibr" rid="b223-bt-24-207">Monteggia <italic>et al</italic>., 2007</xref>). Other studies found aggressive behaviors in this model (<xref ref-type="bibr" rid="b63-bt-24-207">Chan <italic>et al</italic>., 2006</xref>). The exact mechanism behind these deficits remains elusive, yet some studies suggest that they may be related to alterations in serotonergic signaling (<xref ref-type="bibr" rid="b87-bt-24-207">Daws <italic>et al</italic>., 2007</xref>) and 5-HT<sub>2A</sub> receptor function (<xref ref-type="bibr" rid="b63-bt-24-207">Chan <italic>et al</italic>., 2006</xref>).</p>
<p>To this date, only a few researchers have used the BDNF overexpression model (BDNF-tg) to investigate its possible role in ASD pathology. This could mainly be due to the fact that these mice do not display any deficits in social behavior, diminishing its face validity (<xref ref-type="bibr" rid="b340-bt-24-207">Weidner <italic>et al</italic>., 2014</xref>). Still, the BDNF overexpression model does recapitulate some ASD-related phenotypes, including high seizure susceptibility in both males and females and other sex-specific phenotypes. For example, male BDNF-tg mice have deficits in marble burying, and display anxiety and depressive-like behaviors (<xref ref-type="bibr" rid="b340-bt-24-207">Weidner <italic>et al</italic>., 2014</xref>). Female transgenics, on the other hand, display higher self-grooming, higher anxiety scores but no depression-like behaviors (<xref ref-type="bibr" rid="b240-bt-24-207">Papaleo <italic>et al</italic>., 2011</xref>).</p>
<p>Although BDNF overexpression in animals may not well represent a monogenic ASD model, they can still be useful for studying the multifactorial aspects leading to ASD and its comorbidities, such as epilepsy (<xref ref-type="bibr" rid="b340-bt-24-207">Weidner <italic>et al</italic>., 2014</xref>). It is also possible that neural substrates such neurotrophins and nerve growth factors, which are connected with BDNF dysregulation, may be cooperatively involved in the ASD pathophysiology.</p>
</sec>
<sec>
<title>7-dehydrocholesterol reductase (DHCR7)</title>
<p>DHCR7 is a ubiquitously expressed catalytic enzyme that converts 7-dehydrocholesterol to cholesterol. Defects in DHCR7 function are the main cause of Smith-Lemli-Optiz syndrome (SLOS) (<xref ref-type="bibr" rid="b155-bt-24-207">Irons <italic>et al</italic>., 1993</xref>), which is often comorbid with autism (50%) (<xref ref-type="bibr" rid="b318-bt-24-207">Tierney <italic>et al</italic>., 2000</xref>). SLOS patients have abnormal behavioral phenotypes including increased hyperactivity, irritability, aggression, insomnia, self-injurious behavior, repetitive and ritualistic behaviors, and impaired communication (<xref ref-type="bibr" rid="b318-bt-24-207">Tierney <italic>et al</italic>., 2000</xref>). Interestingly, low cholesterol levels have been observed in children with idiopathic autism (<xref ref-type="bibr" rid="b317-bt-24-207">Tierney <italic>et al</italic>., 2006</xref>).</p>
<p>Similar to <italic>BDNF</italic> homozygous knockouts, <italic>DHCR7</italic> null (−/−) mice have high lethality rates at birth (<xref ref-type="bibr" rid="b107-bt-24-207">Fitzky <italic>et al</italic>., 2001</xref>); therefore, <italic>DHCR7</italic><sup>+/−</sup> or <italic>DHCR7</italic> mutant mice are used as animal models. <italic>DHCR7</italic><sup>+/−</sup> mice show low exploratory activity both in the social preference and open field tests (<xref ref-type="bibr" rid="b226-bt-24-207">Moy <italic>et al</italic>., 2009</xref>). DHCR7 mutant mice display increased ventricular size (<xref ref-type="bibr" rid="b77-bt-24-207">Correa-Cerro <italic>et al</italic>., 2006</xref>) and abnormalities in the hippocampus and serotonergic neurons (<xref ref-type="bibr" rid="b331-bt-24-207">Waage-Baudet <italic>et al</italic>., 2003</xref>). Additionally, the Dhcr7-heterozygous mice show increased response to treatment with a 5-HT2A agonist, as marked by frequent head-twitch, further suggesting the involvement of the serotonergic system in the phenotypes observed in the model (<xref ref-type="bibr" rid="b182-bt-24-207">Korade <italic>et al</italic>., 2013</xref>). These data further demonstrate the impact of cholesterol dysregulation on behavior and provide further insights onto a potential ASD mechanism that is often overlooked, as in the case of SLOS patients.</p>
</sec>
<sec>
<title>Engrailed-2 (EN2)</title>
<p>EN2 is a homeodomain-containing protein that regulates pattern formation during brain development (<xref ref-type="bibr" rid="b359-bt-24-207">Zec <italic>et al</italic>., 1997</xref>). Although not consistently observed (<xref ref-type="bibr" rid="b361-bt-24-207">Zhong <italic>et al</italic>., 2003</xref>), it has been suggested that genetic variants of EN2 are associated with ASD (<xref ref-type="bibr" rid="b25-bt-24-207">Benayed <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="b47-bt-24-207">Brune <italic>et al</italic>., 2008</xref>), <italic>EN2</italic><sup>−/−</sup> mice were introduced as a potential model of ASD in 2006, and were shown to have behavioral deficits in social play, aggression, spatial memory and motor coordination (<xref ref-type="bibr" rid="b65-bt-24-207">Cheh <italic>et al</italic>., 2006</xref>). Furthermore <italic>EN2</italic><sup>−/−</sup> mice display decreased cerebellar size and abnormal foliation patterns, similar to patients with ASD (<xref ref-type="bibr" rid="b183-bt-24-207">Kuemerle <italic>et al</italic>., 2007</xref>). In addition, these studies found that major cell types of the olivocerebellar circuit, e.g. Purkinje, were reduced up to 30–40% (<xref ref-type="bibr" rid="b184-bt-24-207">Kuemerle <italic>et al</italic>., 1997</xref>). This places the <italic>EN2</italic><sup>−/−</sup> mouse in parallel to the cerebellar lesion model for ASD, as described above. Thus, even though <italic>EN2</italic><sup>−/−</sup> mice do not fully recapitulate all of the structural abnormalities and behavioral phenotypes in ASD, it can somehow provide quality pathophysiologic insights (<xref ref-type="bibr" rid="b183-bt-24-207">Kuemerle <italic>et al</italic>., 2007</xref>).</p>
</sec>
<sec>
<title>Fragile X mental retardation 1 (FMR1)</title>
<p>The <italic>FMR1</italic> gene encodes for fragile X mental retardation protein (FMRP) (<xref ref-type="bibr" rid="b328-bt-24-207">Verheij <italic>et al</italic>., 1993</xref>). FMRP is an RNA-binding protein that is commonly expressed in brain, testes, and ovaries. FMRP takes part in local protein synthesis regulation in dendrites, as well as mRNA transport from nucleus to the cytoplasm (<xref ref-type="bibr" rid="b111-bt-24-207">Garber <italic>et al</italic>., 2008</xref>). In addition, FMRP plays an essential role in synapse development (<xref ref-type="bibr" rid="b341-bt-24-207">Weiler <italic>et al</italic>., 1997</xref>), which is vital for proper neurotransmission, learning and memory, and synaptic plasticity. Mutations in <italic>FMR1</italic> take the form of expanded CGG trinucleotide repeats (55–230) in the 5′ gene untranslated region (5′UTR); this halts the production of FMRP and leads to a developmental condition called Fragile X Syndrome (FXS). FXS is characterized by intellectual disabilities, developmental delays, congenital malformations, seizures and autistic-like symptoms (<xref ref-type="bibr" rid="b111-bt-24-207">Garber <italic>et al</italic>., 2008</xref>). Indeed, 10–30% of FXS patients were also diagnosed with autism (<xref ref-type="bibr" rid="b136-bt-24-207">Hatton <italic>et al</italic>., 2006</xref>).</p>
<p><italic>FMR1</italic> knockout mice have widely been used to investigate the behavioral abnormalities and pathophysiological mechanisms underlying FXS. Interestingly, a number of studies have shown that <italic>FMR1</italic> knockout mice display comorbidities with autistic behaviors including decreased social interaction, increased repetitive behaviors, anxiety, hyperactivity (<xref ref-type="bibr" rid="b30-bt-24-207">Bernardet and Crusio, 2006</xref>), increased seizure susceptibility (<xref ref-type="bibr" rid="b290-bt-24-207">Silva and Ehninger, 2009</xref>), decreased spatial learning ability, and impaired object recognition (<xref ref-type="bibr" rid="b46-bt-24-207">Brennan <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="b221-bt-24-207">Mineur <italic>et al</italic>., 2006</xref>). Nonetheless, some of these results are inconclusive, as McNaughton <italic>et al</italic>. and Spencer <italic>et al</italic>. reported that these mice show increased social approach and anxiety (<xref ref-type="bibr" rid="b302-bt-24-207">Spencer <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="b217-bt-24-207">McNaughton <italic>et al</italic>., 2008</xref>), whereas Liu and Smith, and Mineur <italic>et al</italic>. reported decreased social approach and anxiety in <italic>FMR1</italic> knockout animals (<xref ref-type="bibr" rid="b221-bt-24-207">Mineur <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="b198-bt-24-207">Liu and Smith, 2009</xref>). These inconclusive findings might be due to lab-specific technical differences and conditions.</p>
<p>Physiologically, <italic>FMR1</italic> knockout mice display increased dendritic spine length (<xref ref-type="bibr" rid="b156-bt-24-207">Irwin <italic>et al</italic>., 2000</xref>), decreased mGluR5 expression (<xref ref-type="bibr" rid="b23-bt-24-207">Bear <italic>et al</italic>., 2004</xref>) and increased mGluR-dependent LTD (<xref ref-type="bibr" rid="b232-bt-24-207">Nosyreva and Huber, 2006</xref>), decreased LTP (<xref ref-type="bibr" rid="b360-bt-24-207">Zhang <italic>et al</italic>., 2009</xref>), and an imbalance between excitation and inhibition (<xref ref-type="bibr" rid="b290-bt-24-207">Silva and Ehninger, 2009</xref>). Furthermore, recent studies have demonstrated the involvement of abnormal GABAergic neurotransmission and development in the generation of autistic-related behaviors in FRX mice. For instance, it has been found that the developmental switch in GABA polarity is delayed in these mice (i.e. from depolarizing to hyperpolarizing) and that this might be due to dysregulated intracellular chloride levels, which surely contributes to abnormal brain development and can be implicated in autism pathophysiology (<xref ref-type="bibr" rid="b325-bt-24-207">Tyzio <italic>et al</italic>., 2014</xref>).</p>
<p>Some reports have also suggested a dysfunctional endocannabinoid system (ECS) in FXS as a disordered mechanism. The ECS plays a critical role in the regulation of synaptic plasticity, cognition, pain, seizure susceptibility and anxiety (<xref ref-type="bibr" rid="b169-bt-24-207">Kano <italic>et al</italic>., 2009</xref>). On the other hand, FMRP modulates mGluR5-mediated signal transduction in glutamatergic synapses, which controls the LTD type of synaptic plasticity. Interestingly, 2-arachidonoyl-sn-glycerol (2-AG), a retrograde endocannabinoid transmitter, mediates mGluR5-dependent LTD in excitatory synapses, in the ventral striatum and PFC (<xref ref-type="bibr" rid="b166-bt-24-207">Jung <italic>et al</italic>., 2012</xref>). The FMRP null mice exhibit increased activity of diacylglycerol lipase (DAGL), a limiting enzyme in 2-AG biosynthesis, which disrupts the GABAergic synaptic sensitivity to endocannabinoid mobilization (<xref ref-type="bibr" rid="b203-bt-24-207">Maccarrone <italic>et al</italic>., 2010</xref>). Ultimately, this produces enhanced activation of cannabinoid receptors (CB1R and CB2R), which increases synaptic strength and excitation as a result of mGluR5-mediated 2-AG release (<xref ref-type="bibr" rid="b203-bt-24-207">Maccarrone <italic>et al</italic>., 2010</xref>). Remarkably, modulating or blocking CB1 and CB2 receptors signaling normalizes 2-AG dysregulation and rescues the cognitive and behavioral abnormalities in FMRP null mice (<xref ref-type="bibr" rid="b49-bt-24-207">Busquets-Garcia <italic>et al</italic>., 2013</xref>). These studies show how targeting the ECS and mGluR5 pathways can be of great therapeutic value, which certainly warrant further investigation. Overall, and based on these behavioral and neurological findings, <italic>FMR1</italic> knockout animal models provide useful insights on ASD pathology and the involvement of the <italic>FMR1</italic> gene or FMRP in the neurobiology of autism.</p>
</sec>
<sec>
<title>GABA receptor subunit beta-3 (GABRB3)</title>
<p>The <italic>GABRB3</italic> gene encodes for a major subunit of the ligand-gated GABA receptor. The gene itself is located within the 15q11-13 chromosome region. It has long been known that maternal deletion of 15q11-13, which also contains <italic>UBE3A</italic>, causes Angelman syndrome, which is highly comorbid with ASD (<xref ref-type="bibr" rid="b229-bt-24-207">Nakao <italic>et al</italic>., 1994</xref>). Interestingly, down-regulation of <italic>UBE3A</italic> and <italic>GABRB3</italic> result in autism-related phenotypes in mice, similar to those caused by <italic>MECP2</italic> mutations in Rett syndrome (described below) (<xref ref-type="bibr" rid="b274-bt-24-207">Samaco <italic>et al</italic>., 2005</xref>). The involvement of GABRB3 in modulating inhibitory neurotransmission is further supported by a number of clinical studies, which associate <italic>GABRB3</italic> polymorphisms with ASD (<xref ref-type="bibr" rid="b51-bt-24-207">Buxbaum <italic>et al</italic>., 2002</xref>). Moreover, individuals with autism often display disruptions in GABAergic biomarkers (<xref ref-type="bibr" rid="b36-bt-24-207">Blatt, 2005</xref>), including reduced expression of GABAergic receptors (<xref ref-type="bibr" rid="b37-bt-24-207">Blatt <italic>et al</italic>., 2001</xref>) and decreased expression of GAD, the enzyme that catalyzes synthesis of GABA (<xref ref-type="bibr" rid="b102-bt-24-207">Fatemi <italic>et al</italic>., 2002</xref>)</p>
<p><italic>GABRB3</italic> knockout (−/−) mice display many phenotypes associated with ASD. These include increased neonatal mortality, seizure susceptibility (<xref ref-type="bibr" rid="b143-bt-24-207">Homanics <italic>et al</italic>., 1997</xref>), hyperactivity, stereotyped/circling behavior (<xref ref-type="bibr" rid="b89-bt-24-207">DeLorey <italic>et al</italic>., 2008</xref>), deficits in learning and memory (<xref ref-type="bibr" rid="b88-bt-24-207">DeLorey <italic>et al</italic>., 1998</xref>), and impaired social interactions, nesting ability and exploratory behaviors (<xref ref-type="bibr" rid="b89-bt-24-207">DeLorey <italic>et al</italic>., 2008</xref>). Furthermore, GABA<sub>A</sub> receptors in <italic>GABRB3</italic> null mice show a 50% reduction in GABA binding capacity, both in newborns and adults (<xref ref-type="bibr" rid="b296-bt-24-207">Sinkkonen <italic>et al</italic>., 2003</xref>). Thus, this model has provided useful insights onto another pathological mechanism underlying Angelman syndrome or potentially ASD. Yet, additional human genetic studies must be done in order to further elucidate the role of GABRB3 in ASD (<xref ref-type="bibr" rid="b315-bt-24-207">Tavassoli <italic>et al</italic>., 2012</xref>; <xref ref-type="bibr" rid="b338-bt-24-207">Warrier <italic>et al</italic>., 2013</xref>).</p>
</sec>
<sec>
<title>Methyl CpG binding protein 2 (MeCP2)</title>
<p>MeCP2 acts mainly as a transcriptional repressor by binding to methyl groups in CpG islands of DNA (<xref ref-type="bibr" rid="b354-bt-24-207">Yasui <italic>et al</italic>., 2007</xref>), although its role in activating gene transcription has also been observed (<xref ref-type="bibr" rid="b60-bt-24-207">Chahrour <italic>et al</italic>., 2008</xref>). In mammals, regulation of genetic transcription by Mecp2 has been shown to be crucial for the modulation of chromatin at critical developmental time points. Human mutations in <italic>MeCP2</italic> cause Rett syndrome, a progressive X-linked neurodevelopmental disorder that causes mental retardation and a number of developmental deficits in females (<xref ref-type="bibr" rid="b262-bt-24-207">Rett, 1966</xref>); it is thought that homozygous mutations in males result in lethality <italic>in utero</italic> (<xref ref-type="bibr" rid="b262-bt-24-207">Rett, 1966</xref>). Historically, Rett syndrome had been initially categorized as a subtype of autism, yet more recent DSM-V criteria separate it from ASD (<xref ref-type="bibr" rid="b7-bt-24-207">American Psychiatric Association, 2013</xref>).</p>
<p><italic>MeCP2</italic> knockout mice show increased anxiety (<xref ref-type="bibr" rid="b61-bt-24-207">Chahrour and Zoghbi, 2007</xref>), decreased motor coordination (<xref ref-type="bibr" rid="b133-bt-24-207">Guy <italic>et al</italic>., 2001</xref>), impaired social interactions, impaired long-term social memory, decreased nest-building ability, and impaired learning and memory (<xref ref-type="bibr" rid="b225-bt-24-207">Moretti <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="b61-bt-24-207">Chahrour and Zoghbi, 2007</xref>). It has also been shown that neurons of <italic>MeCP2</italic>-null mice have increased gene transcription, likely mediated through enhanced histone acetylation (<xref ref-type="bibr" rid="b132-bt-24-207">Guy <italic>et al</italic>., 2011</xref>). This is also accompanied by neurotoxicity due to excessive glutamate release from microglia (<xref ref-type="bibr" rid="b205-bt-24-207">Maezawa and Jin, 2010</xref>). Moreover, <italic>MeCP2</italic>-null astrocytes are unable to support normal dendritic morphology in wild-type hippocampal neurons (<xref ref-type="bibr" rid="b19-bt-24-207">Ballas <italic>et al</italic>., 2009</xref>). In addition, <italic>MeCP2</italic>-null neurons have abnormal dendritic and axonal development (<xref ref-type="bibr" rid="b189-bt-24-207">Larimore <italic>et al</italic>., 2009</xref>), and <italic>MeCP2</italic>-deficient GABAergic neurons show reduced inhibitory quantal size and decreased expression of GAD (<xref ref-type="bibr" rid="b64-bt-24-207">Chao <italic>et al</italic>., 2010</xref>). These findings from the <italic>MeCP2</italic> knockout model converge with the VPA animal model, which also shows a decreased <italic>MeCP2</italic> expression in a male-specific manner, leading to increased glutamatergic neurotransmission (<xref ref-type="bibr" rid="b177-bt-24-207">Kim <italic>et al</italic>., 2014b</xref>). Collectively, this highlights the potential pathophysiological role of epigenetic dysregulation on genetic determinants of ASD.</p>
</sec>
<sec>
<title>Monoamine oxidase A (MAOA)</title>
<p><italic>MAOA</italic> and its neighboring gene are regulators of the mitochondrial enzyme MAO, responsible for the oxidative deamination of monoamine neurotransmitters such as dopamine and norepinephrine. Mutations in <italic>MAOA</italic> cause Brunner syndrome and have been linked to antisocial behaviors, low IQ, impulsiveness and violent behaviors (<xref ref-type="bibr" rid="b150-bt-24-207">Hunter, 2010</xref>). In addition, the alleles regulating the levels of <italic>MAOA</italic> have been correlated with autism in humans (<xref ref-type="bibr" rid="b75-bt-24-207">Cohen <italic>et al</italic>., 2003</xref>), which is mainly driven my maternally inherited mutations in male off-spring (<xref ref-type="bibr" rid="b74-bt-24-207">Cohen <italic>et al</italic>., 2011</xref>). Moreover, clinical studies have found that variations in the number of MAOA-upstream variable number of tandem repeats (uVNTR) are associated with ASD hyperserotonemia (<xref ref-type="bibr" rid="b145-bt-24-207">Hranilovic <italic>et al</italic>., 2008</xref>) and cortical enlargement (<xref ref-type="bibr" rid="b86-bt-24-207">Davis <italic>et al</italic>., 2008</xref>).</p>
<p>Similar to the human phenotype, <italic>MAOA</italic>-deficient mice display aggressive behaviors (<xref ref-type="bibr" rid="b58-bt-24-207">Cases <italic>et al</italic>., 1995</xref>), increased fear, aberrant eye-blink conditioning (<xref ref-type="bibr" rid="b294-bt-24-207">Singh <italic>et al</italic>., 2013</xref>) and hyper-responsiveness to acoustic stimuli (<xref ref-type="bibr" rid="b257-bt-24-207">Popova <italic>et al</italic>., 2000</xref>). In accordance with ASD, this animal model has social and communication impairments, repetitive behaviors, behavioral rigidity and motor abnormalities (<xref ref-type="bibr" rid="b44-bt-24-207">Bortolato <italic>et al</italic>., 2013</xref>). These mice also display increased hippocampal LTP and NMDAR expression, thinning of the corpus callosum, increased dendritic arborizations in pyramidal neurons of the PFC, and disrupted microarchitecture of the cerebellum (<xref ref-type="bibr" rid="b294-bt-24-207">Singh <italic>et al</italic>., 2013</xref>). As expected, these mice also show increased brain serotonin, dopamine and norepinephrine levels (<xref ref-type="bibr" rid="b44-bt-24-207">Bortolato <italic>et al</italic>., 2013</xref>; <xref ref-type="bibr" rid="b294-bt-24-207">Singh <italic>et al</italic>., 2013</xref>), which might be directly related to the manifestation of anxiety and aggressive behaviors in <italic>MAOA</italic>-deficient mice, albeit these phenotypes have not been well characterized in humans (<xref ref-type="bibr" rid="b75-bt-24-207">Cohen <italic>et al</italic>., 2003</xref>). This remarkable recapitulation of the core deficits of ASD symptoms, as well as the clinically similar neuropathologic phenotypes in <italic>MAOA</italic>-deficient mice, makes them a plausible model wherein potential therapeutic agents could be tested, especially with monoamines as the main target.</p>
</sec>
<sec>
<title>Neurofibromin 1 (NF1)</title>
<p><italic>NF1</italic>, also called neurofibromatosis-related protein, is a gene that functions as a tumor suppressor in the nervous system and plays a role in controlling the Ras signaling pathway (<xref ref-type="bibr" rid="b73-bt-24-207">Cichowski and Jacks, 2001</xref>). <italic>NF1</italic> is part of the NMDA receptor complex (<xref ref-type="bibr" rid="b151-bt-24-207">Husi <italic>et al</italic>., 2000</xref>), which is suggested to underlie mental retardation and learning deficits in humans (<xref ref-type="bibr" rid="b151-bt-24-207">Husi <italic>et al</italic>., 2000</xref>). In accordance with its proposed function, mutations in <italic>NF1</italic> result in a life-shortening condition known as Neurofibromatosis (<xref ref-type="bibr" rid="b260-bt-24-207">Rasmussen and Friedman, 2000</xref>), an autosomal dominant disorder characterized by cognitive and language deficits, poor motor skills and peripheral nerve tumors (<xref ref-type="bibr" rid="b291-bt-24-207">Silva <italic>et al</italic>., 1997</xref>).</p>
<p>Interestingly, <italic>NF1</italic> heterozygous (+/−) mice show deficits in spatial learning in the Morris water maze (<xref ref-type="bibr" rid="b78-bt-24-207">Costa <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="b291-bt-24-207">Silva <italic>et al</italic>., 1997</xref>), delayed acquisition of motor skills and impaired fear conditioning (<xref ref-type="bibr" rid="b79-bt-24-207">Costa <italic>et al</italic>., 2001</xref>). In addition, cortical neurons and astrocytes of <italic>NF1</italic> mutant mice fail to form cortical barrels in somatosensory cortex (<xref ref-type="bibr" rid="b202-bt-24-207">Lush <italic>et al</italic>., 2008</xref>). In human studies, however, <italic>NF1</italic> polymorphisms and overexpression of the gene, not deficiency, have been associated with autism (<xref ref-type="bibr" rid="b215-bt-24-207">Mbarek <italic>et al</italic>., 1999</xref>; <xref ref-type="bibr" rid="b213-bt-24-207">Marui <italic>et al</italic>., 2004</xref>) Thus, further study of <italic>NF1</italic> polymorphisms in animal models, as opposed to knock-outs or knock-downs, should be conducted in the future.</p>
</sec>
<sec>
<title>Neuroligin (NLGN) family</title>
<p>The <italic>NLGN</italic> family of genes encode for neuroligin proteins, which are cell adhesion molecules required for synaptic function (<xref ref-type="bibr" rid="b309-bt-24-207">Sudhof, 2008</xref>). NLGN is found in the postsynaptic membrane and mediates synapse transmission between neurons (<xref ref-type="bibr" rid="b159-bt-24-207">Jamain <italic>et al</italic>., 2008</xref>). Mutations of <italic>NLGN3</italic> and <italic>NLGN4</italic> are associated with X-linked intellectual disability, seizures, and autism (<xref ref-type="bibr" rid="b158-bt-24-207">Jamain <italic>et al</italic>., 2003</xref>) In addition, an in-depth molecular genetic analysis of the <italic>NLGN</italic> family found an association between non-functional polymorphisms and ASD in the Finnish population. This study concluded that neuroligin mutations may cause autism only in rare cases and that variations in neuroligin alleles are not a major risk factor for autism (<xref ref-type="bibr" rid="b357-bt-24-207">Ylisaukko-oja <italic>et al</italic>., 2005</xref>). Nonetheless, the role of several neuroligin subunits and their association with ASD have been studied in mice.</p>
<sec>
<title>NLGN1:</title>
<p><italic>NLGN1</italic> encodes for a group of neuronal membrane-bound proteins which are involved in CNS synapse development. <italic>NLGN1</italic> knockout mice display impaired spatial memory and repetitive/stereotyped grooming (<xref ref-type="bibr" rid="b38-bt-24-207">Blundell <italic>et al</italic>., 2010</xref>). The latter is thought to be related to reduced NMDA/AMPA ratios in cortico-striatal synapses (<xref ref-type="bibr" rid="b38-bt-24-207">Blundell <italic>et al</italic>., 2010</xref>). More studies are needed in order to provide a clinical link between the autism-related phenotypes found in <italic>NLGN1</italic> knockout mice.</p>
</sec>
<sec>
<title>NLGN3:</title>
<p>Arg451Cys (R451C) mutation of <italic>NLGN3</italic> has been associated with autism in humans (<xref ref-type="bibr" rid="b76-bt-24-207">Comoletti <italic>et al</italic>., 2004</xref>). <italic>NLGN3</italic> mutant mice carrying the R451C mutation have been long used as a model of ASD. These mice have impaired social interactions and enhanced spatial learning, as well as enhanced synaptic inhibition in the somatosensory cortex (<xref ref-type="bibr" rid="b99-bt-24-207">Etherton <italic>et al</italic>., 2011</xref>). However, the Etherton <italic>et al</italic>. study also showed an increased excitatory transmission within the hippocampal region of NLGN3 (R451C) mutant mice, but not in NLGN3 KO mice. This study concluded that NLGN3 is differentially involved in modulation of excitatory and inhibitory synaptic neurotransmission in a brain region-specific manner (<xref ref-type="bibr" rid="b99-bt-24-207">Etherton <italic>et al</italic>., 2011</xref>). <italic>NLGN3</italic> mutant mice also showed deficits in ultrasonic vocalizations, impaired preference for social novelty (<xref ref-type="bibr" rid="b159-bt-24-207">Jamain <italic>et al</italic>., 2008</xref>) and altered olfactory function (<xref ref-type="bibr" rid="b259-bt-24-207">Radyushkin <italic>et al</italic>., 2009</xref>). However, there were no changes in time spent engaged in social interaction, pre-pulse inhibition and seizure propensity in <italic>NLGN3</italic> mutant mice, as compared with their wild-type controls (<xref ref-type="bibr" rid="b259-bt-24-207">Radyushkin <italic>et al</italic>., 2009</xref>). Thus, the <italic>NLGN3</italic> mutant mice may only partly model autistic features and not the global ASD condition.</p>
</sec>
<sec>
<title>NLGN4:</title>
<p>Mutations in <italic>NLGN4</italic> have been associated with X-linked mental retardation, autism (<xref ref-type="bibr" rid="b158-bt-24-207">Jamain <italic>et al</italic>., 2003</xref>), and other neurodevelopmental conditions comorbid with ASD, although it has been suggested that the contribution of NLGN4 mutations to ASD is very small (<xref ref-type="bibr" rid="b113-bt-24-207">Gauthier <italic>et al</italic>., 2005</xref>). Yet, <italic>NLGN4</italic> deficient mice, display impairments in social interactions and social memory (<xref ref-type="bibr" rid="b159-bt-24-207">Jamain <italic>et al</italic>., 2008</xref>), along with reduced brain volume (<xref ref-type="bibr" rid="b159-bt-24-207">Jamain <italic>et al</italic>., 2008</xref>). However, these mice did not display deficits in repetitive behaviors, exploratory activity, anxiety, and learning and memory (<xref ref-type="bibr" rid="b159-bt-24-207">Jamain <italic>et al</italic>., 2008</xref>). This shows that, although NLGN4 and the rest of the NLGN subunits may not consistently represent a very strong cause for ASD, they may still contribute to the complex, connecting pathways of ASD pathophysiology.</p>
</sec>
</sec>
<sec>
<title>Neurexin 1 (NRXN1)</title>
<p>NRXN1 is a pre-synaptic membrane cell adhesion molecule and a receptor which mediates the synaptic interaction between neurons (<xref ref-type="bibr" rid="b195-bt-24-207">Li <italic>et al</italic>., 2006</xref>), mainly through interactions with neuroligins. Phenotypes of individuals with <italic>NRXN1</italic> deletion vary, and include mental retardation, language delay, schizophrenia (<xref ref-type="bibr" rid="b316-bt-24-207">The International Schizophrenia Consortium, 2008</xref>; <xref ref-type="bibr" rid="b335-bt-24-207">Walsh <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="b231-bt-24-207">Need <italic>et al</italic>., 2009</xref>), nicotine dependence (<xref ref-type="bibr" rid="b234-bt-24-207">Nussbaum <italic>et al</italic>., 2008</xref>) and ASD (<xref ref-type="bibr" rid="b69-bt-24-207">Ching <italic>et al</italic>., 2010</xref>). Behavioral testing of <italic>NRXN1</italic>α deficient mice have shown deficits in pre-pulse inhibition and nesting ability, along with increased grooming activity, and enhanced motor learning on the rota-rod test (<xref ref-type="bibr" rid="b100-bt-24-207">Etherton <italic>et al</italic>., 2009</xref>), despite the absence of obvious social defects (<xref ref-type="bibr" rid="b100-bt-24-207">Etherton <italic>et al</italic>., 2009</xref>). Physiologically, these mice also display alterations in excitatory synaptic transmission. As a whole, the neurexin-1 model is somewhat complex in terms of using it for the study of ASD, as many of the observed phenotypes overlap or could be associated with other disorders.</p>
</sec>
<sec>
<title>Oxytocin (OXT), oxytocin receptor (OXTR), and MAGEL2</title>
<p><italic>Oxt</italic> encodes the protein precursor of oxytocin and neurophysin 1. Oxytocin is a neuromodulating hormone produced by the posterior pituitary gland. It stimulates uterine muscle contraction during childbirth and stimulates lactation. Moreover, it is known to participate in various cognitive, adaptive, cardiovascular, excretory and complex sexual functions. Recent studies have also found that oxytocin has a key role in social recognition and social interactions (<xref ref-type="bibr" rid="b130-bt-24-207">Guastella <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="b278-bt-24-207">Savaskan <italic>et al</italic>., 2008</xref>). Such findings have produced an increasing interest in the study of oxytocin and its involvement in ASD (<xref ref-type="bibr" rid="b127-bt-24-207">Gregory <italic>et al</italic>., 2009</xref>). Research in humans have found that oxytocin plasma levels are reduced in autistic children (<xref ref-type="bibr" rid="b154-bt-24-207">Insel, 2010</xref>) and that intranasal administration of the hormone to autistic patients enhances their social interactions (<xref ref-type="bibr" rid="b10-bt-24-207">Andari <italic>et al</italic>., 2010</xref>), reduces repetitive behaviors (<xref ref-type="bibr" rid="b141-bt-24-207">Hollander <italic>et al</italic>., 2003</xref>) and improves emotional recognition (<xref ref-type="bibr" rid="b129-bt-24-207">Guastella <italic>et al</italic>., 2010</xref>). Moreover, in VPA prenatal exposure and FXS animal models of autism, prenatal oxytocin treatment can rescue autistic-like behaviors in offspring, which further demonstrates the pathophysiologic involvement and therapeutic potential of this hormone in ASD (<xref ref-type="bibr" rid="b325-bt-24-207">Tyzio <italic>et al</italic>., 2014</xref>).</p>
<p>In mice, <italic>Oxt</italic> deficiency induces impairments in social recognition (<xref ref-type="bibr" rid="b104-bt-24-207">Ferguson <italic>et al</italic>., 2001</xref>) and decreased social odor memory in females (<xref ref-type="bibr" rid="b172-bt-24-207">Kavaliers <italic>et al</italic>., 2003</xref>), despite normal social approach and decreased aggression (<xref ref-type="bibr" rid="b104-bt-24-207">Ferguson <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="b344-bt-24-207">Winslow and Insel, 2002</xref>). Interestingly, oxytocin administration directly into the amygdala region has been shown to enhance social recognition in <italic>Oxt</italic> knockout mice (<xref ref-type="bibr" rid="b344-bt-24-207">Winslow and Insel, 2002</xref>), similar to what is observed when oxytocin is administered to autistic individuals (<xref ref-type="bibr" rid="b10-bt-24-207">Andari <italic>et al</italic>., 2010</xref>).</p>
<p>In recent studies, common polymorphisms in the oxytocin receptor gene (<italic>Oxtr</italic>) have also revealed an association with ASD (<xref ref-type="bibr" rid="b157-bt-24-207">Jacob <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="b127-bt-24-207">Gregory <italic>et al</italic>., 2009</xref>). Moreover, a number of <italic>Oxtr</italic> SNPs were associated with autism in various ethnic populations, encouraging further exploration to define its role in ASD (<xref ref-type="bibr" rid="b349-bt-24-207">Wu <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="b157-bt-24-207">Jacob <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="b197-bt-24-207">Liu <italic>et al</italic>., 2010</xref>). However, a study discouraged the association of common <italic>Oxtr</italic> variation with autism in mixed Caucasian populations (<xref ref-type="bibr" rid="b313-bt-24-207">Tansey <italic>et al</italic>., 2010</xref>) but later meta-analysis studies with one of the largest population ever investigated for <italic>Oxtr</italic> polymorphisms, showed positive correlations with autism (<xref ref-type="bibr" rid="b199-bt-24-207">LoParo and Waldman, 2015</xref>). Additional studies further support these later findings by finding a positive correlation between <italic>Oxtr</italic> polymorphisms and social recognition skills, thus suggesting <italic>Oxtr</italic> SNPs as predictors of social impairments in both typically developing individuals and in children with ASD (<xref ref-type="bibr" rid="b242-bt-24-207">Parker <italic>et al</italic>., 2014</xref>).</p>
<p>Accordingly, conditional Oxtr knockout mice, display deficits in social memory and defective ultrasonic vocalizations (<xref ref-type="bibr" rid="b192-bt-24-207">Lee <italic>et al</italic>., 2008</xref>), but are devoid of stereotyped/repetitive behavior phenotypes (<xref ref-type="bibr" rid="b254-bt-24-207">Pobbe <italic>et al</italic>., 2012</xref>). In addition, <italic>Oxtr</italic>-null mice display increased aggression and high seizure susceptibility (<xref ref-type="bibr" rid="b272-bt-24-207">Sala <italic>et al</italic>., 2011</xref>). These mice also have a decreased ratio of GABAergic presynapses to the total number of presynapses in hippocampal neurons (<xref ref-type="bibr" rid="b272-bt-24-207">Sala <italic>et al</italic>., 2011</xref>), suggesting that alterations in the oxytocin system or aberrant oxytocin receptor function can have profound effects in the overall excitatory/inhibitory balance in the brain.</p>
<p>Additional evidence supporting the role of oxytocin in ASD comes from studies using the Magel2 mouse model. <italic>MAGEL2</italic> is a paternally imprinted gene that has been recently identified as an autism risk gene and has been associated with Prader-Willi Syndrome (PWS) (<xref ref-type="bibr" rid="b40-bt-24-207">Boccaccio <italic>et al</italic>., 1999</xref>; <xref ref-type="bibr" rid="b280-bt-24-207">Schaaf <italic>et al</italic>., 2013</xref>). PWS results from large deletions in chromosome 15q11-q13 and is characterized by intellectual disabilities, repetitive behaviors, and hyperphagia-induced obesity. Interestingly, individuals with PWS have high comorbidity with ASD (&gt;30%) (<xref ref-type="bibr" rid="b95-bt-24-207">Dykens <italic>et al</italic>., 2011</xref>). In congruence with ASD, the <italic>Magel2</italic>-deficient mice showed abnormalities in social recognition and interaction, as well as learning difficulties in adults (<xref ref-type="bibr" rid="b220-bt-24-207">Meziane <italic>et al</italic>., 2015</xref>). More importantly, at birth, these mice have reduced production of oxytocin in the hypothalamus, which causes decreased suckling behavior and leads to a 50% mortality rate (<xref ref-type="bibr" rid="b281-bt-24-207">Schaller <italic>et al</italic>., 2010</xref>). Interestingly, a single postnatal injection or a one-week-long administration of oxytocin after birth improved suckling, prevented mortality as well as the development of behavioral impairments in adulthood (<xref ref-type="bibr" rid="b281-bt-24-207">Schaller <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="b220-bt-24-207">Meziane <italic>et al</italic>., 2015</xref>), suggesting a mechanistic link between oxytocin and Magel2. Thus, additional studies exploring the relationship between Magel2 and oxytocin will be beneficial for supporting the potential of oxytocin as a therapeutic treatment for ASD.</p>
</sec>
<sec>
<title>Phosphatase and tensin homolog (PTEN)</title>
<p>PTEN is a tumor suppressor protein involved in cell cycle arrest and apoptosis through negative regulation of the AKT/PKB signaling pathway (<xref ref-type="bibr" rid="b72-bt-24-207">Chu and Tarnawski, 2004</xref>). A number of genetic variants in <italic>PTEN</italic> have been observed in ASD patients with macrocephalic phenotypes (<xref ref-type="bibr" rid="b50-bt-24-207">Butler <italic>et al</italic>., 2005</xref>), which stimulated the study of a <italic>PTEN</italic> transgenic mouse model. Given that <italic>PTEN</italic>-null mice die during embryogenesis (<xref ref-type="bibr" rid="b90-bt-24-207">Di Cristofano <italic>et al</italic>., 1998</xref>), conditional knockout mice are used to investigate the role of <italic>PTEN</italic> in development and autism pathogenesis. <italic>PTEN</italic> mutant mice display abnormal social interactions, hyperactivity, excessive responses to external stimuli and decreased prepulse inhibition (<xref ref-type="bibr" rid="b236-bt-24-207">Ogawa <italic>et al</italic>., 2007</xref>); they also develop macrocephaly and neuronal hypertrophy in the CNS, similar to human patients (<xref ref-type="bibr" rid="b187-bt-24-207">Kwon <italic>et al</italic>., 2006</xref>). A recent study suggested that PTEN deficiency <italic>in vivo</italic> increases the net excitatory drive onto granule neurons, enlarges the neuronal size, and increases the density of dendritic spines (<xref ref-type="bibr" rid="b201-bt-24-207">Luikart <italic>et al</italic>., 2011</xref>). Further studies have shown that deletion of PTEN leads to increased cell proliferation (<xref ref-type="bibr" rid="b126-bt-24-207">Gregorian <italic>et al</italic>., 2009</xref>; <xref ref-type="bibr" rid="b43-bt-24-207">Bonaguidi <italic>et al</italic>., 2011</xref>). These findings all agree with the role of PTEN as a regulator of neural stem cell proliferation and lineage specification (<xref ref-type="bibr" rid="b362-bt-24-207">Zhou and Parada, 2012</xref>). Lastly, PTEN may also interact and synergize with other signaling pathways, such as the PI3K/AKT and TSC/mTORC1 pathway, that contribute to the complex pathogenesis of the global ASD condition (<xref ref-type="bibr" rid="b362-bt-24-207">Zhou and Parada, 2012</xref>).</p>
</sec>
<sec>
<title>Reelin (RELN)</title>
<p>Reelin is a secreted extracellular matrix (ECM) protein that is important for ECM development and plays an essential role in the migration and proper positioning of cortical neurons (<xref ref-type="bibr" rid="b83-bt-24-207">D’Arcangelo, 2005</xref>). In adult brains, Reelin is actively involved in synaptic regulation, formation of dendrites and modulation of cognitive function (<xref ref-type="bibr" rid="b267-bt-24-207">Rogers <italic>et al</italic>., 2011</xref>). In the hippocampus, Reelin accumulation is essential for NMDA subunit receptor maturation and NR2B surface mobility, which ultimately leads to mature excitatory synapses (<xref ref-type="bibr" rid="b128-bt-24-207">Groc <italic>et al</italic>., 2007</xref>). In addition to NMDA receptor regulation in cortical neurons, Reelin mediates tyrosine phosphorylation and increases calcium influx, which is physiologically involved in learning and memory (<xref ref-type="bibr" rid="b66-bt-24-207">Chen <italic>et al</italic>., 2005</xref>). Down-regulation of Reelin in cortical GABAergic interneurons has been frequently observed in schizophrenia, bipolar disorders and autism (<xref ref-type="bibr" rid="b237-bt-24-207">Ognibene <italic>et al</italic>., 2007</xref>). Furthermore, mutations in 7q22-23, consisting of longer triplet repeats in the 5′UTR of <italic>RELN</italic> gene locus, have been observed in autistic patients (<xref ref-type="bibr" rid="b118-bt-24-207">Gillberg, 1998</xref>; <xref ref-type="bibr" rid="b352-bt-24-207">Yan <italic>et al</italic>., 2000</xref>).</p>
<p>Mice used to model the effects of <italic>RELN</italic> mutations, known as <italic>Reeler</italic> (rl/rl) mice, display cortical disorganization in various brain regions, including cortex, cerebellum, hippocampus, subcortical regions, and spinal cord (<xref ref-type="bibr" rid="b211-bt-24-207">Martin, 1981</xref>; <xref ref-type="bibr" rid="b122-bt-24-207">Goffinet, 1983</xref>; <xref ref-type="bibr" rid="b355-bt-24-207">Yip <italic>et al</italic>., 2000</xref>; <xref ref-type="bibr" rid="b83-bt-24-207">D’Arcangelo, 2005</xref>). Decreased density of striatal GABAergic interneurons were also found (<xref ref-type="bibr" rid="b207-bt-24-207">Marrone <italic>et al</italic>., 2006</xref>). Behaviorally, Reeler mice showed increased seizure susceptibility (<xref ref-type="bibr" rid="b243-bt-24-207">Patrylo <italic>et al</italic>., 2006</xref>) and decreased ultrasonic vocalizations (<xref ref-type="bibr" rid="b237-bt-24-207">Ognibene <italic>et al</italic>., 2007</xref>).</p>
<p>In previous reports, heterozygous <italic>Reeler</italic> mutant (+/rl) mice had shown indistinguishable features in anatomy (<xref ref-type="bibr" rid="b303-bt-24-207">Stanfield and Cowan, 1979</xref>) and behavior (<xref ref-type="bibr" rid="b228-bt-24-207">Muroga <italic>et al</italic>., 1982</xref>) from normal (+/+) mice. However, later studies reported that +/rl mice displayed abnormalities in anatomical (<xref ref-type="bibr" rid="b298-bt-24-207">Smalheiser <italic>et al</italic>., 2000</xref>; <xref ref-type="bibr" rid="b196-bt-24-207">Liu <italic>et al</italic>., 2001</xref>) and behavioral (<xref ref-type="bibr" rid="b323-bt-24-207">Tueting <italic>et al</italic>., 1999</xref>) phenotypes, resembling those of human schizophrenia patients. <italic>Reeler</italic> mutant mice also showed deficits in pre-pulse inhibition and decreased exploration in the elevated plus maze test (<xref ref-type="bibr" rid="b323-bt-24-207">Tueting <italic>et al</italic>., 1999</xref>). Other studies, such as those of Salinger <italic>et al</italic>., reported that +/rl mice have normal social aggressive behaviors (<xref ref-type="bibr" rid="b273-bt-24-207">Salinger <italic>et al</italic>., 2003</xref>), whereas Podhoma <italic>et al</italic> found no behavioral abnormalities in the model (<xref ref-type="bibr" rid="b255-bt-24-207">Podhorna and Didriksen, 2004</xref>). Recently, Iafrati and colleagues developed the juvenile reelin-haploinsufficient heterozygous reeler mice (HRM), which exhibited a reduction in dendritic spine density and abnormal LTP in the prefrontal cortex, as well as deficits in fear memory formation (<xref ref-type="bibr" rid="b153-bt-24-207">Iafrati <italic>et al</italic>., 2014</xref>). Overall, studies in Reeler mice have resulted in conflicting and inconsistent findings of behavioral phenotypes. Whether +/rl mice are suitable as animal models for schizophrenia and/or autism requires further investigation.</p>
</sec>
<sec>
<title>Serotonin transporter (SERT, <italic>SLC6A4</italic>)</title>
<p>The serotonin transporter (5-HTT, SERT) removes serotonin from the synaptic cleft back into the presynaptic terminal and has a general role in the termination and recycling of serotonin during neurotransmission. Hyperserotonemia is one of the most consistent findings in ASD patients (<xref ref-type="bibr" rid="b145-bt-24-207">Hranilovic <italic>et al</italic>., 2008</xref>). However, there is conflicting evidence regarding the involvement of SERT in ASD, especially from a genetics standpoint. Only one study found a significant association between SERT polymorphism (<italic>SLC6A4</italic> variants) and autism hyperserotonemia, which failed to replicate in other studies (<xref ref-type="bibr" rid="b31-bt-24-207">Betancur <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="b147-bt-24-207">Huang and Santangelo, 2008</xref>). It is also difficult to determine whether hyperserotonemia in autism is related to serotonin activity and re-uptake (<xref ref-type="bibr" rid="b258-bt-24-207">Prasad <italic>et al</italic>., 2009</xref>).</p>
<p>In preclinical studies, the <italic>5-HTT</italic> knockout mice showed decreased exploratory behavior, increased anxiety-like behaviors (<xref ref-type="bibr" rid="b142-bt-24-207">Holmes <italic>et al</italic>., 2003</xref>), elevated sensitivity to stress (<xref ref-type="bibr" rid="b160-bt-24-207">Jiang <italic>et al</italic>., 2009</xref>) and reduced social interactions (<xref ref-type="bibr" rid="b168-bt-24-207">Kalueff <italic>et al</italic>., 2007</xref>). In the brains of <italic>5-HTT</italic> knockout mice, altered cortical thickness and cell density (<xref ref-type="bibr" rid="b4-bt-24-207">Altamura <italic>et al</italic>., 2007</xref>) as well as altered hypothalamic-pituitary-adrenal (HPA) axis signaling (<xref ref-type="bibr" rid="b160-bt-24-207">Jiang <italic>et al</italic>., 2009</xref>) were observed. Genetic variations in the SERT gene, including Gly56Ala, Ile425Leu, Ile425Val, Phe-465Leu, Leu550Val, and Lys605Asn, enhance the serotonin re-uptake activity of SERT proteins (<xref ref-type="bibr" rid="b258-bt-24-207">Prasad <italic>et al</italic>., 2009</xref>). Currently, no strong association between SERT polymorphisms and ASD has been found, despite the consistent occurrence of hyperserotonemia in autism; thus, the involvement of SERT variation is yet to be established. As a result, further research is needed both at the clinical and animal model level. It is important nonetheless, to acknowledge the fact that SERT animal models may not be uniquely reflecting autism-related phenotypes, as there may be some association between the gene and other disorders, such as obsessive-compulsive disorder (<xref ref-type="bibr" rid="b327-bt-24-207">Veenstra-Vanderweele <italic>et al</italic>., 2009</xref>). Thus, careful interpretation of results when using this animal model is needed.</p>
</sec>
<sec>
<title>SH3 and multiple ankyrin repeat domains protein (SHANK)</title>
<p>SHANKs are postsynaptic scaffold proteins that interact with neurotransmitter receptors, ion channels, and other membrane proteins. SHANKs play a key role in synapse formation and dendritic spine maturation during brain development. Shank genes have long been implicated in ASD and Shank dysregulation supports the synaptic dysfunction hypothesis in ASD pathophysiology (<xref ref-type="bibr" rid="b161-bt-24-207">Jiang and Ehlers, 2013</xref>). Nevertheless, the molecular diversity of <italic>SHANK</italic> genes and their heterogeneity in both the human and mouse genome poses a great challenge in using <italic>Shank</italic> mutant models, as described below.</p>
<sec>
<title>SHANK1:</title>
<p>Hung and colleagues reported that <italic>SHANK1</italic><sup>−/−</sup> mice showed increased anxiety-like behavior, impaired contextual fear memory and enhanced spatial learning (<xref ref-type="bibr" rid="b149-bt-24-207">Hung <italic>et al</italic>., 2008</xref>). Another study also reported reduced ultrasonic vocalizations and decreased scent marking behaviors in <italic>SHANK1</italic><sup>−/−</sup> mice (<xref ref-type="bibr" rid="b346-bt-24-207">Wohr <italic>et al</italic>., 2011b</xref>). However, Silverman and colleagues observed that although null mutant mice showed some degree of motor disability and anxiety, they did not display other autism-related deficits, especially in terms of reciprocal social interactions (<xref ref-type="bibr" rid="b293-bt-24-207">Silverman <italic>et al</italic>., 2011</xref>). This study, therefore, raised the notion that <italic>SHANK1</italic><sup>−/−</sup> mice may not be appropriate for modeling autism-related social deficits, but could be useful in understanding alterations in motor function. Further neurobiological studies showed that <italic>SHANK1</italic><sup>−/−</sup> mice displayed alterations in the composition of postsynaptic density proteins, reduced size of dendritic spines and weaker basal synaptic transmission (<xref ref-type="bibr" rid="b149-bt-24-207">Hung <italic>et al</italic>., 2008</xref>). The involvement of <italic>SHANK1</italic> gene in autism etiology has not been ruled out since a previous study found a male-heritable <italic>SHANK1</italic> microdeletion in ASD patients (<xref ref-type="bibr" rid="b277-bt-24-207">Sato <italic>et al</italic>., 2012</xref>).</p>
</sec>
<sec>
<title>SHANK2:</title>
<p>Mutations in the <italic>SHANK2</italic> gene have been reported in ASD patients (<xref ref-type="bibr" rid="b27-bt-24-207">Berkel <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="b190-bt-24-207">Leblond <italic>et al</italic>., 2012</xref>). Furthermore, heritable <italic>SHANK2</italic> variants, particularly T1127M and R462X, are known to affect spine volume and result in smaller SHANK2 cluster sizes (<xref ref-type="bibr" rid="b28-bt-24-207">Berkel <italic>et al</italic>., 2012</xref>). Rodent overexpression of the R462X variant results in a more severe phenotype of defective dendritic branching and decreased postsynaptic clustering (<xref ref-type="bibr" rid="b28-bt-24-207">Berkel <italic>et al</italic>., 2012</xref>). In animal models, <italic>ProSAP1/Shank2</italic><sup>−/−</sup> mutant mice displayed fewer dendritic spines and lower basal synaptic transmission along with increased NMDA-mediated excitatory currents (<xref ref-type="bibr" rid="b283-bt-24-207">Schmeisser <italic>et al</italic>., 2012</xref>). These mutant mice display autism-related behavioral phenotypes, including repetitive grooming, hyperactivity, and impaired vocal and social behaviors (<xref ref-type="bibr" rid="b283-bt-24-207">Schmeisser <italic>et al</italic>., 2012</xref>). Won <italic>et al</italic>. confirmed and further found that <italic>Shank2</italic><sup>−/−</sup> mutant mice exhibited decreased social interactions, impaired ultrasonic vocalizations, and repetitive jumping behavior. However, in contrast to the previous study, these mutant mice showed decreased NMDA receptor function (<xref ref-type="bibr" rid="b348-bt-24-207">Won <italic>et al</italic>., 2012</xref>). Based on these mechanistic findings, Won <italic>et al</italic>.’s study also tested therapeutic candidates for ASD and found that D-cycloserine (a partial agonist of NMDA receptor) normalized the function of NMDAR and enhanced social interactions in <italic>Shank2</italic><sup>−/−</sup> mutant mice (<xref ref-type="bibr" rid="b348-bt-24-207">Won <italic>et al</italic>., 2012</xref>). It is likely that the opposing NMDA function findings in these studies are related to the fact that they use different exon mutation sites in each model, which could result in slightly different protein disruptions. Yet, and as a whole, these results provide useful insights in the importance of maintaining a normal range of NMDA function in the brain, as both over- and under- regulation of NMDA transmission could result in abnormal behavioral phenotypes.</p>
</sec>
<sec>
<title>SHANK3:</title>
<p>Mutations in <italic>SHANK3</italic>, such as those observed in microdeletions of 22q13, have been implicated in ASD etiology. Recent studies reported that <italic>SHANK3</italic> genes are lost or rearranged in ASD patients and are associated with developmental delays, dysmorphic features and autistic behaviors (<xref ref-type="bibr" rid="b206-bt-24-207">Manning <italic>et al</italic>., 2004</xref>). Moreover, heterozygous mutations of SHANK3 may cause ASD in a gene-dosage-dependent manner (<xref ref-type="bibr" rid="b94-bt-24-207">Durand <italic>et al</italic>., 2007</xref>). <italic>SHANK3</italic> mutant mice have been recently proposed as a model of ASD and have provided great insights on the pathological mechanisms that could underlie the disorder. For example, <italic>SHANK3B</italic><sup>−/−</sup> mice display repetitive grooming and deficits in social interactions, along with corticostriatal circuit alterations and striatal synaptic defects (<xref ref-type="bibr" rid="b246-bt-24-207">Peca <italic>et al</italic>., 2011</xref>). In another study, these mice showed deficits in glutamatergic synaptic transmission and hippocampal LTP, yet only displayed mild social deficits in juvenile but not adult age (<xref ref-type="bibr" rid="b353-bt-24-207">Yang <italic>et al</italic>., 2012</xref>). In addition, increased self-grooming, decreased ultrasonic vocalizations, and decreased reversal learning were observed only in some cohorts, suggesting variable phenotypic severity in SHANK3 mutant mice (<xref ref-type="bibr" rid="b353-bt-24-207">Yang <italic>et al</italic>., 2012</xref>). Yet another investigation revealed decreased excitatory postsynaptic currents (EPSCs) in pyramidal neurons of the hippocampal CA1 region, highlighting a reduced basal neurotransmission in these animals in an AMPAR-mediated manner (<xref ref-type="bibr" rid="b45-bt-24-207">Bozdagi <italic>et al</italic>., 2010</xref>). The GluR1-immunoreactive puncta of the stratum radiatum was also quantitatively reduced, along with impaired LTP but not LTD (<xref ref-type="bibr" rid="b45-bt-24-207">Bozdagi <italic>et al</italic>., 2010</xref>). Behaviorally, these mice displayed reduced social sniffing and ultrasonic vocalizations in the presence of a female mouse (<xref ref-type="bibr" rid="b45-bt-24-207">Bozdagi <italic>et al</italic>., 2010</xref>).</p>
<p>Although the Shank3 mouse model data is very compelling, human studies still suggest that not all genetic mutations and alterations in <italic>SHANK3</italic> directly lead to ASD, thus careful interpretations should be given. This was suggested by a clinical study, where a child with autism showed a rare genetic variant in Shank3, consisting of a 1-bp insertion in exon 11; although this mutation was of high penetrance, it was not attributed a strong etiological relationship to the ASD phenotype (<xref ref-type="bibr" rid="b180-bt-24-207">Kolevzon <italic>et al</italic>., 2011</xref>). Lastly, it is important to note that the phenotypic consequences of Shank3 dysfunction can be rather complex and require careful interpretation since similar mutations can be associated to both ASD and schizophrenia (<xref ref-type="bibr" rid="b114-bt-24-207">Gauthier <italic>et al</italic>., 2010</xref>).</p>
</sec>
</sec>
<sec>
<title>Tuberous sclerosis complex protein (TSC) 1 or 2</title>
<p>Mutations of <italic>TSC1</italic> or <italic>TSC2</italic> cause the Tuberous sclerosis complex (TSC) disorder. <italic>TSC1</italic> encodes hamartin and <italic>TSC2</italic> encodes tuberin. TSC1/TSC2 act as tumor growth suppressors and are involved in cell proliferation and differentiation. TSC patients have a high prevalence of autism, ranging from 20 to 60% (<xref ref-type="bibr" rid="b42-bt-24-207">Bolton <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="b82-bt-24-207">Curatolo <italic>et al</italic>., 2004</xref>). TSC1/TSC2 mutations are associated with neurological deficits including cognitive dysfunction, epilepsy, and autism (<xref ref-type="bibr" rid="b92-bt-24-207">DiMario, 2004</xref>; <xref ref-type="bibr" rid="b124-bt-24-207">Goorden <italic>et al</italic>., 2007</xref>).</p>
<p>Mutant mice that lack TSC1 in astrocytes showed significant brain pathologies and seizure vulnerability (<xref ref-type="bibr" rid="b326-bt-24-207">Uhlmann <italic>et al</italic>., 2002</xref>). Furthermore, neuronal loss of TSC1 induced cortical hyperexcitability and seizure susceptibility in mice (<xref ref-type="bibr" rid="b218-bt-24-207">Meikle <italic>et al</italic>., 2007</xref>). Sparse deletion of <italic>TSC1</italic> in CA1 hippocampal neurons led to enhanced AMPAR and NMDAR-mediated EPSCs, as well as an increase in spontaneous EPSC frequency, and absent mGluR-LTD in the hippocampus (<xref ref-type="bibr" rid="b21-bt-24-207">Bateup <italic>et al</italic>., 2011</xref>). <italic>TSC1</italic> conditional knockout in neural progenitor cells resulted in increased brain size and elevated mToRC1 signaling, as well as decreased mToRC2 signaling in mice (Carson <italic>et al</italic>., 2011). More importantly, hetero- or homozygous loss of TSC in mice induced abnormal social interactions, repetitive behaviors, and impaired vocalizations, coupled with decreased Purkinje neurons (<xref ref-type="bibr" rid="b321-bt-24-207">Tsai <italic>et al</italic>., 2012</xref>). Overall, these studies suggest that conditional or complete <italic>TSC1</italic> deficiency leads to an elevation in glutamatergic or excitatory synaptic activity, and once again implies dysregulation of mToR signaling in the pathophysiology of ASD.</p>
<p>Interestingly, <italic>TSC2</italic><sup>w/−</sup> mice showed no significant brain pathology (<xref ref-type="bibr" rid="b238-bt-24-207">Onda <italic>et al</italic>., 2002</xref>), yet a recent study suggested that heterozygous TSC (+/−) mutant mice with maternal immune activation by poly I:C leads to impaired social interactions in offspring (<xref ref-type="bibr" rid="b96-bt-24-207">Ehninger <italic>et al</italic>., 2012</xref>). In other studies, TSC<sup>+/−</sup> mice displayed alterations in ultrasonic vocalizations (<xref ref-type="bibr" rid="b358-bt-24-207">Young <italic>et al</italic>., 2010</xref>) while mice expressing a dominant negative form of tuberin showed impaired social interactions (<xref ref-type="bibr" rid="b68-bt-24-207">Chevere-Torres <italic>et al</italic>., 2012</xref>). Moreover, selective deletion of <italic>TSC2</italic> in Purkinje cells increased Purkinje cell size and induced ER oxidative stress, which eventually led to cellular apoptosis in these neurons (<xref ref-type="bibr" rid="b261-bt-24-207">Reith <italic>et al</italic>., 2011</xref>). Interestingly, such phenotypes were rescued by treatment with the mToRC1 inhibitor rapamycin (<xref ref-type="bibr" rid="b261-bt-24-207">Reith <italic>et al</italic>., 2011</xref>). Concurrent with these studies, Tsc2<sup>+/−</sup> mice exhibit mToR-dependent upregulation of GluN2C-containing NMDARs, and display seizure symptoms early in life (<xref ref-type="bibr" rid="b200-bt-24-207">Lozovaya <italic>et al</italic>., 2014</xref>) and deficient mGluR-LTD in the hippocampus (<xref ref-type="bibr" rid="b15-bt-24-207">Auerbach <italic>et al</italic>., 2011</xref>). More recently, Tang <italic>et al</italic>. showed that Tsc2<sup>+/−</sup> mice have impaired social behaviors, in which their brain exhibit upregulated mToR activity and abnormal post-natal dendritic pruning mediated by inactivation of normal autophagy (<xref ref-type="bibr" rid="b312-bt-24-207">Tang <italic>et al</italic>., 2014</xref>).</p>
<p>Although there is a considerable prevalence of ASD in TSC, and mouse models show compelling evidence supporting the role of TSC1/TSC2 in autism etiology, the exact neurobiological mechanism by which this occurs is still poorly understood (<xref ref-type="bibr" rid="b233-bt-24-207">Numis <italic>et al</italic>., 2011</xref>). Some would suggest persistent seizures or epilepsy in early development as the main driver of autistic behavioral phenotypes in TSC (<xref ref-type="bibr" rid="b82-bt-24-207">Curatolo <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="b233-bt-24-207">Numis <italic>et al</italic>., 2011</xref>). Yet, it is worthy of noting that gene-environment interactions (e.g. maternal immune activation) could play a major role in precipitating the development autism symptomatology and could provide novel implications for ASD pathophysiology and etiology (<xref ref-type="bibr" rid="b96-bt-24-207">Ehninger <italic>et al</italic>., 2012</xref>). In this way, animal models of TSC could help uncover unknown biological pathways associated with ASD, especially in terms of how early disruptions in brain activity (e.g. seizures), genes, and environmental factors lead to the disorder.</p>
</sec>
<sec>
<title>Ubiquitin-protein ligase E3A (UBE3A)</title>
<p><italic>UBE3A</italic> gene encodes the E6AP ubiquitin-protein ligase (E6AP) protein, which mediates ubiquitin-dependent protein degradation. As mentioned above, mutations of <italic>UBE3A</italic> and <italic>GABRB3</italic>, both located in chromosome 15q11-13, cause Angelman syndrome (AS) (<xref ref-type="bibr" rid="b332-bt-24-207">Wagstaff <italic>et al</italic>., 1991</xref>). <italic>UBE3A</italic> regulates excitatory synapse development by ubiquitin-dependent degradation of Arc, a synaptic protein that promotes AMPA receptor internalization (<xref ref-type="bibr" rid="b125-bt-24-207">Greer <italic>et al</italic>., 2010</xref>). Interestingly, preclinical studies have found that increased gene dosage of <italic>UBE3A</italic> leads to reduced glutamate synaptic transmission in mice and result in autism-related behaviors (<xref ref-type="bibr" rid="b300-bt-24-207">Smith <italic>et al</italic>., 2011</xref>). Furthermore, maternal deletion of <italic>UBE3A</italic> increases the emission of ultrasonic vocalizations (<xref ref-type="bibr" rid="b162-bt-24-207">Jiang <italic>et al</italic>., 2010</xref>) and seizure susceptibility in offspring mice (<xref ref-type="bibr" rid="b222-bt-24-207">Miura <italic>et al</italic>., 2002</xref>). On the other hand, <italic>UBE3A</italic> knockout in mice leads to Arc accumulation in neurons, which weakens synaptic function through the excessive internalization of AMPA receptors (<xref ref-type="bibr" rid="b125-bt-24-207">Greer <italic>et al</italic>., 2010</xref>). These findings could mean that UBE3A mutations, more specifically implicated in AS, may also have a specific role in ASD etiology. This is supported by a clinical study in Italian patients with autism, which found a potential role of UBE3A in ASD pathogenesis (<xref ref-type="bibr" rid="b131-bt-24-207">Guffanti <italic>et al</italic>., 2011</xref>). Another clinical study highlighted the phenotypic overlap between AS and ASD, as autistic phenotypes were observed in some children with AS (<xref ref-type="bibr" rid="b250-bt-24-207">Peters <italic>et al</italic>., 2004</xref>). Indeed, the UBE3A mouse models present good candidates for studying ASD pathogenesis, as the gene seems to partake in complex signaling pathways that exacerbate autism symptomatology in syndromes such as AS.</p>
</sec>
<sec>
<title>Arginine Vasopressin (AVP) and its receptor (AVPR1A)</title>
<p>AVP is a pituitary hormone that mainly functions as an antidiuretic by stimulating water reabsorption in the collecting ducts of nephrons. It also plays a contributive role in peripheral vasoconstriction, smooth muscle contraction during parturition and lactation, cognition, tolerance, adaptation, cardiovascular regulation and complex sexual and maternal behaviors; indeed, it functions very similarly to oxytocin. The AVP receptor, AVPR1A, belongs to the G-protein coupled receptor family (along with V2R and OXT receptors) and works by activating the phosphatidylinositol-calcium second messenger system. When activated, AVPR1A leads to cell proliferation and contraction, glycogenolysis, the release of coagulation factors and platelet aggregation. Interestingly, the <italic>AVPR1A</italic> gene has been associated with ASD (<xref ref-type="bibr" rid="b339-bt-24-207">Wassink <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="b356-bt-24-207">Yirmiya <italic>et al</italic>., 2006</xref>).</p>
<p>With regards to ASD, the study of the Brattleboro rat could reveal useful insights on the effect of AVP alterations in producing autism-related phenotypes. The Brattleboro rat is an inbred strain that does not synthesize vasopressin due to a homozygous frameshift mutation in the AVP gene (<xref ref-type="bibr" rid="b282-bt-24-207">Schmale <italic>et al</italic>., 1989</xref>). This rat strain was found to have decreased social recognition (<xref ref-type="bibr" rid="b97-bt-24-207">Engelmann and Landgraf, 1994</xref>) and no cardiovascular response to social isolation (<xref ref-type="bibr" rid="b112-bt-24-207">Gardiner and Bennett, 1983</xref>). Similarly, vasopressin receptor 1a (<italic>V1aR</italic>) knockout mice also show defects in social recognition, social interactions, anxiety (<xref ref-type="bibr" rid="b32-bt-24-207">Bielsky <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="b154-bt-24-207">Insel, 2010</xref>), social aggression, social motivation, social memory (<xref ref-type="bibr" rid="b342-bt-24-207">Wersinger <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="b52-bt-24-207">Caldwell <italic>et al</italic>., 2008</xref>), and ultrasonic vocalizations (<xref ref-type="bibr" rid="b279-bt-24-207">Scattoni <italic>et al</italic>., 2008</xref>). Interestingly, studies in humans have found a significant association between autism and heritable genetic defects in <italic>AVPR1a</italic> (<xref ref-type="bibr" rid="b339-bt-24-207">Wassink <italic>et al</italic>., 2004</xref>), including transmission disequilibrium within the <italic>AVR</italic> intronic microsatellite region (<xref ref-type="bibr" rid="b356-bt-24-207">Yirmiya <italic>et al</italic>., 2006</xref>). These findings, together with the known role of <italic>AVPR1a</italic> in social skill formation, suggest a link between vasopressin dysregulation and development of autism, thus warranting the use of AVP mouse models for the elucidation of ASD-related mechanistic insights.</p>
</sec>
<sec>
<title>Contactin-associated protein-like 2 (CNTNAP2)</title>
<p>The <italic>CNTNAP2</italic> gene encodes contactin associated protein-like 2 (Caspr2) protein, which is part of the neurexin family and, therefore, plays a key role in cell adhesion. During the early nervous system development, Caspr2 mediates neuronglia interactions and helps in localizing potassium channels in developing axons (<xref ref-type="bibr" rid="b256-bt-24-207">Poliak <italic>et al</italic>., 1999</xref>). The transcription factor forkhead box protein P2 (FOXP2), involved in speech and language development, regulates and directly binds to CNTNAP2 (<xref ref-type="bibr" rid="b106-bt-24-207">Fisher and Scharff, 2009</xref>). Recessive-truncating mutations in CNTNAP2 cause Cortical Dysplasia Focal Epilepsy (CDFE) syndrome, which is highly comorbid with ASD (70%) (<xref ref-type="bibr" rid="b307-bt-24-207">Strauss <italic>et al</italic>., 2006</xref>). Additionally, many other mutations within the CNTNAP2 gene have been identified in a number of ASD patients (<xref ref-type="bibr" rid="b2-bt-24-207">Alarcón <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="b11-bt-24-207">Arking <italic>et al</italic>., 2008</xref>).</p>
<p>Interestingly, <italic>Cntnap2</italic><sup>−/−</sup> mice exhibit the three core symptoms of ASD, including decreased social interactions, reduced vocalizations, and repetitive behaviors, as well as hyperactivity and epileptic seizures (<xref ref-type="bibr" rid="b247-bt-24-207">Peñagarikano <italic>et al</italic>., 2011</xref>). Moreover, these knockout mice show abnormal neuronal migration and decreased neuronal synchrony, concurrent with a reduction in the total number of GABAergic interneurons (<xref ref-type="bibr" rid="b247-bt-24-207">Peñagarikano <italic>et al</italic>., 2011</xref>). This study found that risperidone treatment rescued the repetitive behaviors of these mice. More recently, the same group found that the oxytocin system is defective in these mice and that both acute and chronic administration of the hormone rescued the social behavioral phenotypes (<xref ref-type="bibr" rid="b248-bt-24-207">Peñagarikano <italic>et al</italic>., 2015</xref>). In other recent studies, <italic>Cntnap2</italic><sup>−/−</sup> mice display impairments in auditory processing, and their hippocampus show reduction of evoked IPSC in the perisomatic part of the CA1 region while the excitatory inputs were barely affected (<xref ref-type="bibr" rid="b320-bt-24-207">Truong <italic>et al</italic>., 2015</xref>). These findings further elucidate the roles of <italic>Cntnap2</italic> gene in language development and synaptic function which are commonly affected in ASD.</p>
<p>In the Australian population common genetic variants in the <italic>CNTNAP2</italic> gene were found, one of which was carried by a boy with autism and speech delays, confirming the gene’s involvement in language development and ASD (<xref ref-type="bibr" rid="b343-bt-24-207">Whitehouse <italic>et al</italic>., 2011</xref>). Another study found that polymorphisms in <italic>CNTNAP2</italic> were correlated with autism and impaired frontal lobe connectivity (<xref ref-type="bibr" rid="b288-bt-24-207">Scott-Van Zeeland <italic>et al</italic>., 2010</xref>). In a population study of Chinese families with autism, a number <italic>CNTNAP2</italic> SNPs were identified and significantly correlated with increased ASD risk (<xref ref-type="bibr" rid="b194-bt-24-207">Li <italic>et al</italic>., 2010</xref>). However, not all <italic>CNTNAP2</italic> variants are necessarily implicated in ASD, which may limit and complicate the use of knockout mice (<xref ref-type="bibr" rid="b275-bt-24-207">Sampath <italic>et al</italic>., 2013</xref>). Nevertheless, the known and important roles of CNTNAP2 in brain and language development may help in elucidating the pathophysiologic mechanisms of ASD in a subset of patients.</p>
</sec>
<sec>
<title>Eukaryotic translation initiation factor 4E (eIF4E)</title>
<p>The <italic>eIF4E</italic> gene is found in the chromosome 4q locus and encodes a component of the eukaryotic translation initiation factor 4F complex. The encoded protein recognizes the 7-methylguanosine cap structure found at the 5′ end of mRNA. eIF4E acts as a downstream effector in the mToR, PTEN and FMRP pathways and functions as a promoter of translational initiation of target mRNAs such as neuroligins, by recruiting ribosomes to mRNA. Patients with ASD have been found to carry variants within the eIF4E gene promoter and mToR-mediated eIF4A hyperactivation has been observed in autistic FXS patients (<xref ref-type="bibr" rid="b310-bt-24-207">Szatmari <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="b140-bt-24-207">Hoeffer <italic>et al</italic>., 2013</xref>).</p>
<p>In mice with direct eIF4E overexpression, or indirect over-expression through knockout of eIF4E repressor 4E-BP2 (eukaryotic translation initiation factor 4E-binding protein 2), impaired social interactions, communication deficits, and repetitive behaviors were observed (<xref ref-type="bibr" rid="b120-bt-24-207">Gkogkas <italic>et al</italic>., 2013</xref>; <xref ref-type="bibr" rid="b276-bt-24-207">Santini <italic>et al</italic>., 2013</xref>). In line with these autistic behaviors, these mice also display synaptic abnormalities in the mPFC, striatum and hippocampus, including increased excitatory to inhibitory ratios and an increase in eIF4E-dependent neuroligins expression (<xref ref-type="bibr" rid="b120-bt-24-207">Gkogkas <italic>et al</italic>., 2013</xref>). These alterations were partly due to an increase in cap-dependent translation (<xref ref-type="bibr" rid="b276-bt-24-207">Santini <italic>et al</italic>., 2013</xref>), which could be a promising pathophysiological target with implications for therapeutic treatment of ASD. The clear causal relationship between a known genetic defect and direct neurobehavioral abnormalities validates the use of the eIF4E animal model and makes it of high clinical relevance. In addition, eIF4E’s causal relationship to synaptic development and plasticity in mice supports the involvement of excitation/inhibition imbalance in ASD.</p>
</sec>
</sec>
<sec sec-type="discussion">
<title>DISCUSSION</title>
<sec>
<title>Frequency of use and general applicability of ASD animal models</title>
<p>A number of ASD animal models have been established, proposed and utilized to investigate the pathways of abnormal development leading to ASD. Notably, prenatal VPA exposure and monogenetic defects in <italic>FMR1</italic>, <italic>MeCP2</italic>, <italic>NLGNs</italic>, and <italic>Oxt</italic> have been most substantially studied. Moreover, the maternal immune activation (MIA) model and the prenatal VPA exposure model have both consistently recapitulated general autistic symptoms and phenotypes. Particularly, VPA exposure produced various autistic symptoms and phenotypes in rodents, such as macrocephaly, seizure susceptibility, GABAergic defects, and male-specificity. In the genetic models, knockout of <italic>FMR1</italic> or <italic>GABRB3</italic> leads to impaired social interactions, repetitive behaviors, increased excitatory neurotransmission, and seizure susceptibility. However, only a handful of studies on the neurobiological defects of <italic>GABRB3</italic> knockout mice has been reported. These genetic models were inspired by studies that showed a strong association between the genes and ASD. Recently, <italic>SHANK3</italic> mutant mice have emerged as a compelling model of ASD, and most studies have focused in understanding the underlying synaptic abnormalities. Indeed, animal models have played an essential role in the molecular and neurobiological exploration of various autism etiologies and have led to the testing and discovery of many therapeutic candidates. These studies highlight the incredible utility of animal models, despite the clear evolutionary separation and evident differences in brain structure, function, and complexity.</p>
</sec>
<sec>
<title>Imbalance between excitation and inhibition in ASD animal models</title>
<p>The brain of ASD patients show specific and notable features that include increased prevalence of macrocephaly (<xref ref-type="bibr" rid="b105-bt-24-207">Fidler <italic>et al</italic>., 2000</xref>; <xref ref-type="bibr" rid="b135-bt-24-207">Hardan <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="b119-bt-24-207">Gillberg and de Souza, 2002</xref>), reduced GABAergic signaling (<xref ref-type="bibr" rid="b37-bt-24-207">Blatt <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="b235-bt-24-207">Oblak <italic>et al</italic>., 2011</xref>) and increased glutamatergic signaling (<xref ref-type="bibr" rid="b289-bt-24-207">Shinohe <italic>et al</italic>., 2006</xref>). Moreover, it has also been reported that ASD patients have abnormalities in cortical minicolumn organization (<xref ref-type="bibr" rid="b56-bt-24-207">Casanova <italic>et al</italic>., 2002</xref>) and synaptic development (<xref ref-type="bibr" rid="b117-bt-24-207">Geschwind and Levitt, 2007</xref>; <xref ref-type="bibr" rid="b152-bt-24-207">Hutsler and Zhang, 2010</xref>). In addition, some of the most prominent anatomical features of autistic brains include increased number of neurons (<xref ref-type="bibr" rid="b57-bt-24-207">Casanova <italic>et al</italic>., 2006</xref>), reduced number of Purkinje cells in the cerebellum (<xref ref-type="bibr" rid="b270-bt-24-207">Rout and Dhossche, 2008</xref>) and reduced GABAergic neurons and markers (<xref ref-type="bibr" rid="b103-bt-24-207">Fatemi <italic>et al</italic>., 2009</xref>). These features are reminiscent of imbalanced excitation and inhibition in the autistic brain, which has been recently proposed as a major cause of ASD symptomatology. Along these lines, a number of studies have suggested that an increase in the ratio of excitatory versus inhibitory neurotransmission is consistent across various autism etiologies (<xref ref-type="bibr" rid="b84-bt-24-207">Dani <italic>et al</italic>., 2005</xref>). For example, the expression of GABA<sub>A</sub> receptor subunits (<xref ref-type="bibr" rid="b274-bt-24-207">Samaco <italic>et al</italic>., 2005</xref>) and GAD proteins (<xref ref-type="bibr" rid="b102-bt-24-207">Fatemi <italic>et al</italic>., 2002</xref>) are decreased in the brain of autistic patients. Disrupted inhibitory architecture in the brain of ASD patients were also reported (<xref ref-type="bibr" rid="b55-bt-24-207">Casanova <italic>et al</italic>., 2003</xref>).</p>
<p>Converging evidence supporting the role of imbalanced excitatory/inhibitory neurotransmission in ASD has also been found in a number of animal models. For example, prenatal VPA exposed-rats have increased excitation and hyperconnectivity in the brain, as well as NMDA receptor over-expression (<xref ref-type="bibr" rid="b264-bt-24-207">Rinaldi <italic>et al</italic>., 2007</xref>, <xref ref-type="bibr" rid="b265-bt-24-207">2008</xref>). Moreover, the prenatal LPS-exposed models show pyramidal neuron hyperexcitability, increased postsynaptic glutamatergic activity, and reduced NMDA-induced synaptic plasticity (<xref ref-type="bibr" rid="b188-bt-24-207">Lante <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="b244-bt-24-207">Patterson, 2009</xref>). In addition, reduction of mGluR5 expression in the brain of <italic>FMR1</italic> knockout mice was also associated with an increased excitatory/inhibitory ratio (<xref ref-type="bibr" rid="b290-bt-24-207">Silva and Ehninger, 2009</xref>). <italic>MeCP2</italic> knockout mice, on the other hand, showed defects in GABAergic neuron function, as demonstrated by reduced inhibitory quantal size and decreased GAD expression (<xref ref-type="bibr" rid="b64-bt-24-207">Chao <italic>et al</italic>., 2010</xref>). In addition, these mice display excessive glutamate release by microglia (<xref ref-type="bibr" rid="b205-bt-24-207">Maezawa and Jin, 2010</xref>). Interestingly, in the VPA prenatal exposure animal model, MeCP2 expression was attenuated and glutamatergic transmission was increased, reflected by the upregulation of NMDA, AMPA and mGlu receptors and postsynaptic proteins (<xref ref-type="bibr" rid="b177-bt-24-207">Kim <italic>et al</italic>., 2014b</xref>). In the <italic>Oxtr</italic>-null mice, a decreased ratio of GABAergic synapse versus the total presynapse was observed (<xref ref-type="bibr" rid="b272-bt-24-207">Sala <italic>et al</italic>., 2011</xref>), while, in <italic>PTEN</italic> mutant mice, the net excitatory drive was increased (<xref ref-type="bibr" rid="b201-bt-24-207">Luikart <italic>et al</italic>., 2011</xref>). In <italic>Reeler</italic> mice, decreased density of striatal GABAergic interneurons was shown (<xref ref-type="bibr" rid="b207-bt-24-207">Marrone <italic>et al</italic>., 2006</xref>). More recently, eIF4E’s causal role in synaptic development and plasticity has provided additional evidence supporting the E/I imbalance hypothesis of ASD pathogenesis (<xref ref-type="bibr" rid="b276-bt-24-207">Santini <italic>et al</italic>., 2013</xref>). Both human and animal studies have demonstrated that the overall anatomical sites and neuro-transmission phenotypes related to ASD, especially in terms of E/I imbalance, could vary depending on the etiologic factors involved. Many of the studies included in this review suggest either “too much excitation” or “too little inhibition” and vice versa, as the culprits for the altered E/I ratios in the animal models, which mostly result in common, although not identical, behavioral phenotypes. By carefully comparing the data obtained from the various animal models of ASD, we can obtain an idea of how and why the seemingly diverse neurobiological changes caused by each etiologic factor induce similar behavioral phenotypes. Furthermore, the data gathered from all of these models may help us find multiple levels of convergence in terms of signaling pathways, receptor and neurotransmitter systems, and specific neuronal circuits involved in the pathophysiologic mechanisms of ASD.</p>
<p>Alterations in the function of postsynaptic proteins, which mediate synapse formation and maturation, can be also notably related to the defects in excitatory neurotransmission. For example, genetic abnormalities in neuroligins and neurexins result in decreased excitatory activity and altered NMDA/AMPA ratios in multiple animal models (<xref ref-type="bibr" rid="b100-bt-24-207">Etherton <italic>et al</italic>., 2009</xref>; <xref ref-type="bibr" rid="b38-bt-24-207">Blundell <italic>et al</italic>., 2010</xref>). In addition, defects in the SHANK genes also led to impaired NMDA receptor function and mGluR5-dependent synaptic transmission (<xref ref-type="bibr" rid="b329-bt-24-207">Verpelli <italic>et al</italic>., 2011</xref>). This suggests that the study of a subset of these animal models can provide useful information about the specific implications of synaptic dysregulation in the pathophysiology of ASD.</p>
<p>Altogether, our current knowledge from animal models, in combination with clinical findings in ASD, suggests that aberrations in E/I activity are likely involved in the disorder pathogenesis. This leads to the conclusion that optimal levels of excitation and inhibition are essential in the maintenance of proper synaptic function and prevent the precipitation of aberrant behavioral phenotypes (<xref ref-type="fig" rid="f1-bt-24-207">Fig. 1</xref>). As schematically represented in our hot air balloon conceptualization, maintaining the optimal range of neurobehavioral activity requires adequate balance of excitation (as represented by the hot air regulated by the activity of gas burners) and inhibition (as represented by weights regulated by sand bags); alterations in either direction will cause a drift into pathologic neurobehavioral phenotypes. One important aspect of this model is the role that synaptic activity modulators have in the overall E/I state, as they become key determinants of whether or not autistic behaviors arise, in a way that might involve the meta-plastic regulation of LTP and LTD (<xref ref-type="bibr" rid="b1-bt-24-207">Abraham, 2008</xref>; <xref ref-type="bibr" rid="b324-bt-24-207">Turrigiano, 2012</xref>). For examples, the innate properties of neural circuits, as well as the homeostatic maintenance of intracellular calcium concentration and the expression level of other neuromodulators, may differentially determine the final behavioral outcome. These, together with an interplay between genetic and/or environmental factors, will ultimately regulate and determine synapse quantity and structure (<xref ref-type="fig" rid="f2-bt-24-207">Fig. 2</xref> as represented by persons grabbing the safety line of the hot air balloon). This model also predicts that stimuli affecting the long-term activity and expression of synaptic modulators may result in long-term hyper- or hypo-sensitivity, and is analogous to how gene <italic>x</italic> gene or gene <italic>x</italic> environmental interactions contribute to specific phenotypes (see below).</p>
</sec>
<sec>
<title>Opposing neurotransmission profiles with similar behavior symptoms in animal models</title>
<p>As can be appreciated from the numerous studies described above, most of them found similar behavioral phenotypes in their models, yet somewhat opposing neurotransmission profiles. One good example is the <italic>Shank2</italic><sup>−/−</sup> mutant mice, where <xref ref-type="bibr" rid="b283-bt-24-207">Schmeisser <italic>et al</italic>. (2012)</xref> found heightened NMDAR excitatory currents in the model, whereas <xref ref-type="bibr" rid="b248-bt-24-207">Won <italic>et al</italic>. (2012)</xref> discovered a decreased NMDA receptor function. Nevertheless, both studies found repetitive grooming, hyperactivity, impaired vocalizations and social behaviors in <italic>Shank2</italic><sup>−/−</sup> mutant mice. A similar phenomenon was also observed in models showing abnormalities in the serotonergic system. For example, rats exposed to prenatal VPA displayed low serotonin levels in the hippocampus at postnatal day 50 (<xref ref-type="bibr" rid="b93-bt-24-207">Dufour-Rainfray <italic>et al</italic>., 2010</xref>) as well as the abnormal migration of 5-HT<sup>+</sup> neurons (<xref ref-type="bibr" rid="b186-bt-24-207">Kuwagata <italic>et al</italic>., 2009</xref>). <italic>BDNF</italic><sup>−/+</sup> and <italic>DHCR7</italic> mutant mice further showed serotonergic transmission defects (<xref ref-type="bibr" rid="b266-bt-24-207">Rios <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="b87-bt-24-207">Daws <italic>et al</italic>., 2007</xref>). On the other hand, <italic>MAOA</italic> deficient mice displayed elevated levels of serotonin and other monoamines in the brain (<xref ref-type="bibr" rid="b44-bt-24-207">Bortolato <italic>et al</italic>., 2013</xref>; <xref ref-type="bibr" rid="b294-bt-24-207">Singh <italic>et al</italic>., 2013</xref>). Interestingly, all of these models express similar aggressive and social deficit behaviors (although varied in locomotor activity), despite the opposing serotonin phenotypes. As such, this demonstrates an obvious variability across the various animal models, where opposing neurophysiological phenotypes can overlap with common behavioral symptoms. These conflicting results can perhaps be resolved by employing a more careful comparison of the various animal models and the clinical presentation within each corresponding etiological subgroup, be it at the molecular, behavioral, and physiological level. Nonetheless, this might be a challenging task given the heterogeneity of ASD. This, therefore, calls for a more individualized approach in the treatment of ASD patients. This approach will also be beneficial for future patient stratification and subgroup classification, which may aid in devising a group or patient-specific treatment based on specific autistic features and range in the spectrum.</p>
</sec>
<sec>
<title>Interactions between environment and genetics</title>
<p>Although a number of genetic models have been reported for ASD, most, if not all of them, only share a part of the core symptoms of the disorder. Moreover, single gene knockout models usually correspond to specific syndromes that can be distinguished from ASD. Thus, although ASD-like symptoms occur in a number of single-gene disorders such as tuberous sclerosis, Angelman syndrome, phenylketonuria, Joubert syndrome, Mőbius syndrome and fragile X syndrome, more than 90% of ASD cases are not related to any of these (<xref ref-type="bibr" rid="b116-bt-24-207">Geschwind, 2011</xref>). Indeed, the etiological heterogeneity of ASD further hinders the identification of causative genes (<xref ref-type="bibr" rid="b33-bt-24-207">Bill and Geschwind, 2009</xref>). Twin studies showed that ASD is highly heritable, with monozygotic twins showing 60–90% concordance and dizygotic twins showing &lt;5% concordance (<xref ref-type="bibr" rid="b304-bt-24-207">Steffenburg <italic>et al</italic>., 1989</xref>; <xref ref-type="bibr" rid="b18-bt-24-207">Bailey <italic>et al</italic>., 1995</xref>). However, recent studies have shown that monozygotic twins do not always display complete heritability (100% concordance) and attribute this in part to environmental factors, which could either aggravate or even protect against ASD (<xref ref-type="bibr" rid="b81-bt-24-207">Croen <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="b134-bt-24-207">Hallmayer <italic>et al</italic>., 2011</xref>). Moreover, it was suggested that at least 40% of ASD cases are likely spawned by environmental causes (<xref ref-type="bibr" rid="b139-bt-24-207">Hertz-Picciotto <italic>et al</italic>., 2006</xref>). Based on these reports, the role of the environment should not be ignored as it might have a substantial impact in the development of ASD (<xref ref-type="bibr" rid="b33-bt-24-207">Bill and Geschwind, 2009</xref>). In addition, the prevalence of ASD has remarkably increased over the years, (<xref ref-type="bibr" rid="b139-bt-24-207">Hertz-Picciotto <italic>et al</italic>., 2006</xref>) from 4–5 per 10,000 births in 1990s (<xref ref-type="bibr" rid="b108-bt-24-207">Fombonne, 1999</xref>) to 4–6 per 1000 births in early 2000s (<xref ref-type="bibr" rid="b62-bt-24-207">Chakrabarti and Fombonne, 2005</xref>) and to 14.7 per 1000 children (US) in 2010 (<xref ref-type="bibr" rid="b16-bt-24-207">Autism and Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators, 2014</xref>). It is thought that, perhaps, environmental factors could be contributing to the rise in ASD prevalence over time. One good example that used animal models to explore this hypothesis was the work of Ehninger <italic>et al</italic>., as described above, which demonstrated that MIA (through poly I:C treatment) in TSC mutant mice potentiated the social impairments in the offspring (<xref ref-type="bibr" rid="b96-bt-24-207">Ehninger <italic>et al</italic>., 2012</xref>). Indeed, this experimental design provides new insights to potentially harmonize the involvement of genetics and environment in the development of ASD. Along with the increasing awareness about the co-contributions of environmental and genetic factors in the development and rise of ASD diagnoses (<xref ref-type="bibr" rid="b12-bt-24-207">Arndt <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="b24-bt-24-207">Bello, 2007</xref>; <xref ref-type="bibr" rid="b181-bt-24-207">Kolevzon <italic>et al</italic>., 2007</xref>), other animal models suitable for the study of gene-environmental interactions (G×E) in ASD are eagerly anticipated. In this regard, our group is now actively investigating the effects of combined environmental (VPA exposure) and genetic mutations in animal brain development and autism-related phenotypes.</p>
</sec>
</sec>
<sec>
<title>CONCLUSION AND FUTURE DIRECTION</title>
<p>While the prevalence of ASD has increased over the years, the number of proposed etiologic factors including genetic, epigenetic and environmental factors has also grown. Moreover, theories about the pathophysiologic mechanisms and pathways underlying the disorder have greatly diversified. As much as it is beneficial and essential to dig deeper into the neurobiological events underlying the phenotypes in ASD, animal studies require careful interpretation, especially due to the increasing evidence of ASD comorbidity and phenotype overlap with other disorders. Animal models provide an important role in completing the puzzle of how each etiologic factor contributes to ASD pathophysiology. It is evident that every specific etiologic condition being modeled in ASD holds a uniquely different set of behavioral and neurobiological phenotypes. This nonetheless, will likely foment the development of therapeutic strategies targeted towards the specific symptoms and neuronal abnormalities observed. Scientists and medical practitioners should, therefore, collaborate and create a database or open resource for mining the possible environmental or genetic causes that can be assessed in every autistic family and individual, in combination with potential case-specific therapeutic treatments. From there, more applicable and effective therapies could be given to autistic patients with a clearly identified etiology. Patient- and etiology-specific approaches may be the ultimate solution to treat the complex and heterogeneous disorder that is ASD.</p>
</sec>
<sec sec-type="supplementary-material">
<title></title>
<supplementary-material content-type="local-data" id="SD1">
<media id="d36e3842" mime-subtype="pdf" mimetype="image" orientation="portrait" position="anchor" xlink:href="BT-24-207_suppl.pdf"></media>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>The authors declare no conflict of interests. This work was supported by the Korean Health Technology R&amp;D Project, Ministry of Health &amp; Welfare, Republic of Korea (No. A120029), and Mid-career Researcher Program (2014R1A2A2A01003079) through the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST), and supported by NSF-GRFP DGE-1144087 and UCLA Pre-doctoral Training Program in Neurogenetics (NIMH-T32).</p>
</ack>
<ref-list>
<title>REFERENCES</title>
<ref id="b1-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abraham</surname>
<given-names>WC</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Metaplasticity: tuning synapses and networks for plasticity</article-title>
<source/>Nat Rev Neurosci
          <volume>9</volume>
<fpage>387</fpage>
<pub-id pub-id-type="doi">10.1038/nrn2356</pub-id>
<pub-id pub-id-type="pmid">18401345</pub-id>
</element-citation>
</ref>
<ref id="b2-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alarcón</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Abrahams</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Duvall</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Perederiy</surname>
<given-names>JV</given-names>
</name>
<name>
<surname>Bomar</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Sebat</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wigler</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Ledbetter</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Cantor</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Linkage, Association, and Gene-Expression Analyses Identify CNTNAP2 as an Autism-Susceptibility Gene</article-title>
<source/>Am J Hum Genet
          <volume>82</volume>
<fpage>150</fpage>
<lpage>159</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2007.09.005</pub-id>
<!--<pub-id pub-id-type="pmcid">2253955</pub-id>-->
<pub-id pub-id-type="pmid">18179893</pub-id>
</element-citation>
</ref>
<ref id="b3-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Courchesne</surname>
<given-names>E</given-names>
</name>
</person-group>
<year>2003</year>
<article-title>Differential effects of developmental cerebellar abnormality on cognitive and motor functions in the cerebellum: an fMRI study of autism</article-title>
<source/>Am. J. Psychiatry
          <volume>160</volume>
<fpage>262</fpage>
<lpage>273</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.160.2.262</pub-id>
<pub-id pub-id-type="pmid">12562572</pub-id>
</element-citation>
</ref>
<ref id="b4-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Altamura</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dell’Acqua</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Moessner</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Lesch</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Persico</surname>
<given-names>AM</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>Altered neocortical cell density and layer thickness in serotonin transporter knockout mice: a quantitation study</article-title>
<source/>Cereb. Cortex
          <volume>17</volume>
<fpage>1394</fpage>
<lpage>1401</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/bhl051</pub-id>
<pub-id pub-id-type="pmid">16905592</pub-id>
</element-citation>
</ref>
<ref id="b5-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aman</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Langworthy</surname>
<given-names>KS</given-names>
</name>
</person-group>
<year>2000</year>
<article-title>Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders</article-title>
<source/>J Autism Dev Disord
          <volume>30</volume>
<fpage>451</fpage>
<lpage>459</lpage>
<pub-id pub-id-type="doi">10.1023/A:1005559725475</pub-id>
<pub-id pub-id-type="pmid">11098883</pub-id>
</element-citation>
</ref>
<ref id="b6-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amaral</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bauman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schumann</surname>
<given-names>CM</given-names>
</name>
</person-group>
<year>2003</year>
<article-title>The amygdala and autism: implications from non-human primate studies</article-title>
<source/>Genes Brain Behav
          <volume>2</volume>
<fpage>295</fpage>
<lpage>302</lpage>
<pub-id pub-id-type="doi">10.1034/j.1601-183X.2003.00043.x</pub-id>
<pub-id pub-id-type="pmid">14606694</pub-id>
</element-citation>
</ref>
<ref id="b7-bt-24-207">
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>American Psychiatric Association</collab>
</person-group>
<year>2013</year>
<source/>Diagnostic and Statistical Manual of Mental Disorders
          <edition>Fifth Edition</edition>
<publisher-name>American Psychiatric Publishing</publisher-name>
</element-citation>
</ref>
<ref id="b8-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amir</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Van den Veyver</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>CQ</given-names>
</name>
<name>
<surname>Francke</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<year>1999</year>
<article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</article-title>
<source/>Nat Genet
          <volume>23</volume>
<fpage>185</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="doi">10.1038/13810</pub-id>
<pub-id pub-id-type="pmid">10508514</pub-id>
</element-citation>
</ref>
<ref id="b9-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amodeo</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Sweeney</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Ragozzino</surname>
<given-names>ME</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Differences in BTBR T+ tf/J and C57BL/6J mice on probabilistic reversal learning and stereotyped behaviors</article-title>
<source/>Behav Brain Res
          <volume>227</volume>
<fpage>64</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2011.10.032</pub-id>
<!--<pub-id pub-id-type="pmcid">3273330</pub-id>-->
<pub-id pub-id-type="pmid">22056750</pub-id>
</element-citation>
</ref>
<ref id="b10-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andari</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Duhamel</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Zalla</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Herbrecht</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Leboyer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sirigu</surname>
<given-names>A</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Promoting social behavior with oxytocin in high-functioning autism spectrum disorders</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>107</volume>
<fpage>4389</fpage>
<lpage>4394</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0910249107</pub-id>
<!--<pub-id pub-id-type="pmcid">2840168</pub-id>-->
<pub-id pub-id-type="pmid">20160081</pub-id>
</element-citation>
</ref>
<ref id="b11-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arking</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Cutler</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Brune</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Teslovich</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>West</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rea</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Guy</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Chakravarti</surname>
<given-names>A</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism</article-title>
<source/>Am J Hum Genet
          <volume>82</volume>
<fpage>160</fpage>
<lpage>164</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2007.09.015</pub-id>
<!--<pub-id pub-id-type="pmcid">2253968</pub-id>-->
<pub-id pub-id-type="pmid">18179894</pub-id>
</element-citation>
</ref>
<ref id="b12-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arndt</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Stodgell</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Rodier</surname>
<given-names>PM</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>The teratology of autism</article-title>
<source/>Int J Dev Neurosci
          <volume>23</volume>
<fpage>189</fpage>
<lpage>199</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijdevneu.2004.11.001</pub-id>
<pub-id pub-id-type="pmid">15749245</pub-id>
</element-citation>
</ref>
<ref id="b13-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aronson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hagberg</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>C</given-names>
</name>
</person-group>
<year>1997</year>
<article-title>Attention deficits and autistic spectrum problems in children exposed to alcohol during gestation: a follow-up study</article-title>
<source/>Dev Med Child Neurol
          <volume>39</volume>
<fpage>583</fpage>
<lpage>587</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-8749.1997.tb07493.x</pub-id>
<pub-id pub-id-type="pmid">9344050</pub-id>
</element-citation>
</ref>
<ref id="b14-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashwood</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Krakowiak</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hertz-Picciotto</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pessah</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Van de Water</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome</article-title>
<source/>Brain Behav Immun
          <volume>25</volume>
<fpage>40</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2010.08.003</pub-id>
<pub-id pub-id-type="pmid">20705131</pub-id>
</element-citation>
</ref>
<ref id="b15-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Auerbach</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Osterweil</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Bear</surname>
<given-names>MF</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Mutations causing syndromic autism define an axis of synaptic pathophysiology</article-title>
<source/>Nature
          <volume>480</volume>
<fpage>63</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="doi">10.1038/nature10658</pub-id>
<!--<pub-id pub-id-type="pmcid">3228874</pub-id>-->
<pub-id pub-id-type="pmid">22113615</pub-id>
</element-citation>
</ref>
<ref id="b16-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Autism and Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators</collab>
</person-group>
<year>2014</year>
<article-title>Prevalence of autism spectrum disorder among children aged 8 years-autism and developmental disabilities monitoring network, 11 sites, United States, 2010</article-title>
<source/>MMWR Surveill Summ
          <volume>63</volume>
<fpage>1</fpage>
<lpage>21</lpage>
</element-citation>
</ref>
<ref id="b17-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bachevalier</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>1994</year>
<article-title>Medial temporal lobe structures and autism: a review of clinical and experimental findings</article-title>
<source/>Neuropsychologia
          <volume>32</volume>
<fpage>627</fpage>
<lpage>648</lpage>
<pub-id pub-id-type="doi">10.1016/0028-3932(94)90025-6</pub-id>
<pub-id pub-id-type="pmid">8084420</pub-id>
</element-citation>
</ref>
<ref id="b18-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bailey</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Le Couteur</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gottesman</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bolton</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Simonoff</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Yuzda</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rutter</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>1995</year>
<article-title>Autism as a strongly genetic disorder: evidence from a British twin study</article-title>
<source/>Psychol Med
          <volume>25</volume>
<fpage>63</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1017/S0033291700028099</pub-id>
<pub-id pub-id-type="pmid">7792363</pub-id>
</element-citation>
</ref>
<ref id="b19-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ballas</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lioy</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Grunseich</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mandel</surname>
<given-names>G</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology</article-title>
<source/>Nat Neurosci
          <volume>12</volume>
<fpage>311</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="doi">10.1038/nn.2275</pub-id>
<!--<pub-id pub-id-type="pmcid">3134296</pub-id>-->
<pub-id pub-id-type="pmid">19234456</pub-id>
</element-citation>
</ref>
<ref id="b20-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnea-Goraly</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Frazier</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Piacenza</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Minshew</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Keshavan</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Reiss</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Hardan</surname>
<given-names>AY</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>A preliminary longitudinal volumetric MRI study of amygdala and hippocampal volumes in autism</article-title>
<source/>Prog. Neuro-Psychopharmacol. Biol. Psychiatry
          <volume>48</volume>
<fpage>124</fpage>
<lpage>128</lpage>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2013.09.010</pub-id>
</element-citation>
</ref>
<ref id="b21-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bateup</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Takasaki</surname>
<given-names>KT</given-names>
</name>
<name>
<surname>Saulnier</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Denefrio</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Sabatini</surname>
<given-names>BL</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Loss of Tsc1 in vivo impairs hippocampal mGluRLTD and increases excitatory synaptic function</article-title>
<source/>J Neurosci
          <volume>31</volume>
<fpage>8862</fpage>
<lpage>8869</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1617-11.2011</pub-id>
<!--<pub-id pub-id-type="pmcid">3133739</pub-id>-->
<pub-id pub-id-type="pmid">21677170</pub-id>
</element-citation>
</ref>
<ref id="b22-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bauman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kemper</surname>
<given-names>TL</given-names>
</name>
</person-group>
<year>1985</year>
<article-title>Histoanatomic observations of the brain in early infantile autism</article-title>
<source/>Neurology
          <volume>35</volume>
<fpage>866</fpage>
<lpage>874</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.35.6.866</pub-id>
<pub-id pub-id-type="pmid">4000488</pub-id>
</element-citation>
</ref>
<ref id="b23-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bear</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>ST</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>The mGluR theory of fragile X mental retardation</article-title>
<source/>Trends Neurosci
          <volume>27</volume>
<fpage>370</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2004.04.009</pub-id>
<pub-id pub-id-type="pmid">15219735</pub-id>
</element-citation>
</ref>
<ref id="b24-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bello</surname>
<given-names>SC</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>Autism and environmental influences: review and commentary</article-title>
<source/>Rev. Environ. Health
          <volume>22</volume>
<fpage>139</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="doi">10.1515/REVEH.2007.22.2.139</pub-id>
<pub-id pub-id-type="pmid">17894204</pub-id>
</element-citation>
</ref>
<ref id="b25-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benayed</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gharani</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rossman</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Mancuso</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lazar</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kamdar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bruse</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Tischfield</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Zimmerman</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Dicicco-Bloom</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Brzustowicz</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Millonig</surname>
<given-names>JH</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Support for the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disorder susceptibility locus</article-title>
<source/>Am J Hum Genet
          <volume>77</volume>
<fpage>851</fpage>
<lpage>868</lpage>
<pub-id pub-id-type="doi">10.1086/497705</pub-id>
<!--<pub-id pub-id-type="pmcid">1271392</pub-id>-->
<pub-id pub-id-type="pmid">16252243</pub-id>
</element-citation>
</ref>
<ref id="b26-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benvenuto</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Moavero</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Alessandrelli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Manzi</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Curatolo</surname>
<given-names>P</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Syndromic autism: causes and pathogenetic pathways</article-title>
<source/>World J Pediatr
          <volume>5</volume>
<fpage>169</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="doi">10.1007/s12519-009-0033-2</pub-id>
<pub-id pub-id-type="pmid">19693459</pub-id>
</element-citation>
</ref>
<ref id="b27-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berkel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Howe</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Roeth</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Moog</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Endris</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Szatmari</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bonin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Riess</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Engels</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sprengel</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Rappold</surname>
<given-names>GA</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation</article-title>
<source/>Nat Genet
          <volume>42</volume>
<fpage>489</fpage>
<lpage>491</lpage>
<pub-id pub-id-type="doi">10.1038/ng.589</pub-id>
<pub-id pub-id-type="pmid">20473310</pub-id>
</element-citation>
</ref>
<ref id="b28-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berkel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Treviño</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vogt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Obenhaus</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Gass</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Sprengel</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schratt</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rappold</surname>
<given-names>GA</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology</article-title>
<source/>Hum Mol Genet
          <volume>21</volume>
<fpage>344</fpage>
<lpage>357</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddr470</pub-id>
<!--<pub-id pub-id-type="pmcid">3276277</pub-id>-->
<pub-id pub-id-type="pmid">21994763</pub-id>
</element-citation>
</ref>
<ref id="b29-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernard</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Enayati</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Roger</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Binstock</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Redwood</surname>
<given-names>L</given-names>
</name>
</person-group>
<year>2002</year>
<article-title>The role of mercury in the pathogenesis of autism</article-title>
<source/>Mol. Psychiatry
          <volume>7 Suppl</volume>
<issue>2</issue>
<fpage>S42</fpage>
<lpage>S43</lpage>
<pub-id pub-id-type="doi">10.1038/sj.mp.4001177</pub-id>
<pub-id pub-id-type="pmid">12142947</pub-id>
</element-citation>
</ref>
<ref id="b30-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernardet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Crusio</surname>
<given-names>WE</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Fmr1 KO mice as a possible model of autistic features</article-title>
<source/>Sci World J
          <volume>6</volume>
<fpage>1164</fpage>
<lpage>1176</lpage>
<pub-id pub-id-type="doi">10.1100/tsw.2006.220</pub-id>
</element-citation>
</ref>
<ref id="b31-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Betancur</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Corbex</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Spielewoy</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Philippe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Laplanche</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Launay</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mouren-Siméoni</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Hamon</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Giros</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Nosten-Bertrand</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Leboyer</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2002</year>
<article-title>Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder</article-title>
<source/>Mol. Psychiatry
          <volume>7</volume>
<fpage>67</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1038/sj.mp.4000923</pub-id>
<!--<pub-id pub-id-type="pmcid">1896269</pub-id>-->
<pub-id pub-id-type="pmid">11803447</pub-id>
</element-citation>
</ref>
<ref id="b32-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bielsky</surname>
<given-names>IF</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Terwilliger</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>LJ</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>The V1a vasopressin receptor is necessary and sufficient for normal social recognition: a gene replacement study</article-title>
<source/>Neuron
          <volume>47</volume>
<fpage>503</fpage>
<lpage>513</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2005.06.031</pub-id>
<pub-id pub-id-type="pmid">16102534</pub-id>
</element-citation>
</ref>
<ref id="b33-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bill</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Genetic advances in autism: heterogeneity and convergence on shared pathways</article-title>
<source/>Curr Opin Genet Dev
          <volume>19</volume>
<fpage>271</fpage>
<lpage>278</lpage>
<pub-id pub-id-type="doi">10.1016/j.gde.2009.04.004</pub-id>
<!--<pub-id pub-id-type="pmcid">2715429</pub-id>-->
<pub-id pub-id-type="pmid">19477629</pub-id>
</element-citation>
</ref>
<ref id="b34-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Binder</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Scharfman</surname>
<given-names>HE</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>Brain-derived neurotrophic factor</article-title>
<source/>Growth Factors
          <volume>22</volume>
<fpage>123</fpage>
<lpage>131</lpage>
<pub-id pub-id-type="doi">10.1080/08977190410001723308</pub-id>
<!--<pub-id pub-id-type="pmcid">2504526</pub-id>-->
<pub-id pub-id-type="pmid">15518235</pub-id>
</element-citation>
</ref>
<ref id="b35-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blanchard</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Defensor</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Meyza</surname>
<given-names>KZ</given-names>
</name>
<name>
<surname>Pobbe</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Pearson</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Bolivar</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Blanchard</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>BTBR T+tf/J mice: autism-relevant behaviors and reduced fractone-associated heparan sulfate</article-title>
<source/>Neurosci Biobehav Rev
          <volume>36</volume>
<fpage>285</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2011.06.008</pub-id>
<pub-id pub-id-type="pmid">21741402</pub-id>
</element-citation>
</ref>
<ref id="b36-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blatt</surname>
<given-names>GJ</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>GABAergic cerebellar system in autism: a neuropathological and developmental perspective</article-title>
<source/>Int Rev Neurobiol
          <volume>71</volume>
<fpage>167</fpage>
<lpage>178</lpage>
<pub-id pub-id-type="doi">10.1016/S0074-7742(05)71007-2</pub-id>
<pub-id pub-id-type="pmid">16512350</pub-id>
</element-citation>
</ref>
<ref id="b37-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blatt</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Guptill</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Booker</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Kemper</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Bauman</surname>
<given-names>ML</given-names>
</name>
</person-group>
<year>2001</year>
<article-title>Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study</article-title>
<source/>J Autism Dev Disord
          <volume>31</volume>
<fpage>537</fpage>
<lpage>543</lpage>
<pub-id pub-id-type="doi">10.1023/A:1013238809666</pub-id>
<pub-id pub-id-type="pmid">11814263</pub-id>
</element-citation>
</ref>
<ref id="b38-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blundell</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Blaiss</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Etherton</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Espinosa</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Tabuchi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Walz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bolliger</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Sudhof</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>CM</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior</article-title>
<source/>J Neurosci
          <volume>30</volume>
<fpage>2115</fpage>
<lpage>2129</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4517-09.2010</pub-id>
<!--<pub-id pub-id-type="pmcid">2824441</pub-id>-->
<pub-id pub-id-type="pmid">20147539</pub-id>
</element-citation>
</ref>
<ref id="b39-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bobee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mariette</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tremblay-Leveau</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Caston</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>2000</year>
<article-title>Effects of early midline cerebellar lesion on cognitive and emotional functions in the rat</article-title>
<source/>Behav Brain Res
          <volume>112</volume>
<fpage>107</fpage>
<lpage>117</lpage>
<pub-id pub-id-type="doi">10.1016/S0166-4328(00)00166-2</pub-id>
<pub-id pub-id-type="pmid">10862941</pub-id>
</element-citation>
</ref>
<ref id="b40-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boccaccio</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Glatt-Deeley</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Watrin</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Roeckel</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lalande</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Muscatelli</surname>
<given-names>F</given-names>
</name>
</person-group>
<year>1999</year>
<article-title>The human MAGEL2 gene and its mouse homologue are paternally expressed and mapped to the Prader-Willi region</article-title>
<source/>Hum Mol Genet
          <volume>8</volume>
<fpage>2497</fpage>
<lpage>2505</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/8.13.2497</pub-id>
<pub-id pub-id-type="pmid">10556298</pub-id>
</element-citation>
</ref>
<ref id="b41-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolivar</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Phoenix</surname>
<given-names>JL</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>Assessing autism-like behavior in mice: variations in social interactions among inbred strains</article-title>
<source/>Behav Brain Res
          <volume>176</volume>
<fpage>21</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2006.09.007</pub-id>
<pub-id pub-id-type="pmid">17097158</pub-id>
</element-citation>
</ref>
<ref id="b42-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolton</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Higgins</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Griffiths</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Pickles</surname>
<given-names>A</given-names>
</name>
</person-group>
<year>2002</year>
<article-title>Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex</article-title>
<source/>Brain
          <volume>125</volume>
<fpage>1247</fpage>
<lpage>1255</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awf124</pub-id>
<pub-id pub-id-type="pmid">12023313</pub-id>
</element-citation>
</ref>
<ref id="b43-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonaguidi</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Wheeler</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Stadel</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Ming</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>In vivo clonal analysis reveals self-renewing and multipotent adult neural stem cell characteristics</article-title>
<source/>Cell
          <volume>145</volume>
<fpage>1142</fpage>
<lpage>1155</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2011.05.024</pub-id>
<!--<pub-id pub-id-type="pmcid">3124562</pub-id>-->
<pub-id pub-id-type="pmid">21664664</pub-id>
</element-citation>
</ref>
<ref id="b44-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bortolato</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Godar</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Alzghoul</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Darling</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Bini</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wellman</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Shih</surname>
<given-names>JC</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Monoamine oxidase A and A/B knockout mice display autistic-like features</article-title>
<source/>Int J Neuropsychopharmacol
          <volume>16</volume>
<fpage>869</fpage>
<lpage>888</lpage>
<pub-id pub-id-type="doi">10.1017/S1461145712000715</pub-id>
<pub-id pub-id-type="pmid">22850464</pub-id>
</element-citation>
</ref>
<ref id="b45-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bozdagi</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Sakurai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Papapetrou</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Dickstein</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kajiwara</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Scattoni</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Saxena</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Silverman</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Crawley</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Hof</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Buxbaum</surname>
<given-names>JD</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication</article-title>
<source/>Mol. Autism
          <volume>1</volume>
<fpage>15</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-1-15</pub-id>
<!--<pub-id pub-id-type="pmcid">3019144</pub-id>-->
<pub-id pub-id-type="pmid">21167025</pub-id>
</element-citation>
</ref>
<ref id="b46-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brennan</surname>
<given-names>FX</given-names>
</name>
<name>
<surname>Albeck</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Paylor</surname>
<given-names>R</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Fmr1 knockout mice are impaired in a leverpress escape/avoidance task</article-title>
<source/>Genes Brain Behav
          <volume>5</volume>
<fpage>467</fpage>
<lpage>471</lpage>
<pub-id pub-id-type="doi">10.1111/j.1601-183X.2005.00183.x</pub-id>
<pub-id pub-id-type="pmid">16923151</pub-id>
</element-citation>
</ref>
<ref id="b47-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brune</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Korvatska</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Allen-Brady</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>EH</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Dawson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Devlin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Estes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hennelly</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hyman</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Munson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rodier</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Schellenberg</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Stodgell</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Coon</surname>
<given-names>H</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Heterogeneous association between engrailed-2 and autism in the CPEA network</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet
          <volume>147B</volume>
<fpage>187</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30585</pub-id>
<pub-id pub-id-type="pmid">17948868</pub-id>
</element-citation>
</ref>
<ref id="b48-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bryn</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Halvorsen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ueland</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Isaksen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kolkova</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ravn</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Skjeldal</surname>
<given-names>O</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Brain derived neurotrophic factor (BDNF) and autism spectrum disorders (ASD) in childhood</article-title>
<source/>Eur J Paediatr Neurol
          <volume>19</volume>
<fpage>411</fpage>
<lpage>414</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejpn.2015.03.005</pub-id>
<pub-id pub-id-type="pmid">25847750</pub-id>
</element-citation>
</ref>
<ref id="b49-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Busquets-Garcia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gomis-González</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Guegan</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Agustín-Pavón</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pastor</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mato</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pérez-Samartín</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Matute</surname>
<given-names>C</given-names>
</name>
<name>
<surname>de la Torre</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dierssen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Maldonado</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ozaita</surname>
<given-names>A</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Targeting the endocannabinoid system in the treatment of fragile X syndrome</article-title>
<source/>Nat Med
          <volume>19</volume>
<fpage>603</fpage>
<lpage>607</lpage>
<pub-id pub-id-type="doi">10.1038/nm.3127</pub-id>
<pub-id pub-id-type="pmid">23542787</pub-id>
</element-citation>
</ref>
<ref id="b50-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butler</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Dasouki</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>XP</given-names>
</name>
<name>
<surname>Talebizadeh</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>TN</given-names>
</name>
<name>
<surname>Miles</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Stratton</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pilarski</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Eng</surname>
<given-names>C</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations</article-title>
<source/>J Med Genet
          <volume>42</volume>
<fpage>318</fpage>
<lpage>321</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2004.024646</pub-id>
<!--<pub-id pub-id-type="pmcid">1736032</pub-id>-->
<pub-id pub-id-type="pmid">15805158</pub-id>
</element-citation>
</ref>
<ref id="b51-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buxbaum</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Silverman</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Kilifarski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Reichert</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>EH</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Fang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Vitale</surname>
<given-names>R</given-names>
</name>
</person-group>
<year>2002</year>
<article-title>Association between a GABRB3 polymorphism and autism</article-title>
<source/>Mol. Psychiatry
          <volume>7</volume>
<fpage>311</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="doi">10.1038/sj.mp.4001011</pub-id>
<pub-id pub-id-type="pmid">11920158</pub-id>
</element-citation>
</ref>
<ref id="b52-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caldwell</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Wersinger</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>WS</given-names>
<suffix>3rd</suffix>
</name>
</person-group>
<year>2008</year>
<article-title>The role of the vasopressin 1b receptor in aggression and other social behaviours</article-title>
<source/>Prog Brain Res
          <volume>170</volume>
<fpage>65</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1016/S0079-6123(08)00406-8</pub-id>
<pub-id pub-id-type="pmid">18655872</pub-id>
</element-citation>
</ref>
<ref id="b53-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carper</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Courchesne</surname>
<given-names>E</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Localized enlargement of the frontal cortex in early autism</article-title>
<source/>Biol. Psychiatry
          <volume>57</volume>
<fpage>126</fpage>
<lpage>133</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2004.11.005</pub-id>
<pub-id pub-id-type="pmid">15652870</pub-id>
</element-citation>
</ref>
<ref id="b54-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carson</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Van Nielen</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Winzenburger</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Ess</surname>
<given-names>KC</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin</article-title>
<source/>Neurobiol Dis
          <volume>45</volume>
<fpage>369</fpage>
<lpage>380</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2011.08.024</pub-id>
<pub-id pub-id-type="pmid">21907282</pub-id>
</element-citation>
</ref>
<ref id="b55-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casanova</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Buxhoeveden</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>2003</year>
<article-title>Disruption in the inhibitory architecture of the cell minicolumn: implications for autisim</article-title>
<source/>Neuroscientist
          <volume>9</volume>
<fpage>496</fpage>
<lpage>507</lpage>
<pub-id pub-id-type="doi">10.1177/1073858403253552</pub-id>
<pub-id pub-id-type="pmid">14678582</pub-id>
</element-citation>
</ref>
<ref id="b56-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casanova</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Buxhoeveden</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>C</given-names>
</name>
</person-group>
<year>2002</year>
<article-title>Clinical and macroscopic correlates of minicolumnar pathology in autism</article-title>
<source/>J Child Neurol
          <volume>17</volume>
<fpage>692</fpage>
<lpage>695</lpage>
<pub-id pub-id-type="doi">10.1177/088307380201700908</pub-id>
<pub-id pub-id-type="pmid">12503647</pub-id>
</element-citation>
</ref>
<ref id="b57-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casanova</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>van Kooten</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Switala</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>van Engeland</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Heinsen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Steinbusch</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Hof</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Trippe</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schmitz</surname>
<given-names>C</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Minicolumnar abnormalities in autism</article-title>
<source/>Acta Neuropathol
          <volume>112</volume>
<fpage>287</fpage>
<lpage>303</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-006-0085-5</pub-id>
<pub-id pub-id-type="pmid">16819561</pub-id>
</element-citation>
</ref>
<ref id="b58-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cases</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Seif</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Grimsby</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gaspar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Pournin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Aguet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Babinet</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Shih</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>De Maeyer</surname>
<given-names>E</given-names>
</name>
</person-group>
<year>1995</year>
<article-title>Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA</article-title>
<source/>Science
          <volume>268</volume>
<fpage>1763</fpage>
<lpage>1766</lpage>
<pub-id pub-id-type="doi">10.1126/science.7792602</pub-id>
<!--<pub-id pub-id-type="pmcid">2844866</pub-id>-->
<pub-id pub-id-type="pmid">7792602</pub-id>
</element-citation>
</ref>
<ref id="b59-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chadman</surname>
<given-names>KK</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism</article-title>
<source/>Pharmacol Biochem Behav
          <volume>97</volume>
<fpage>586</fpage>
<lpage>594</lpage>
<pub-id pub-id-type="doi">10.1016/j.pbb.2010.09.012</pub-id>
<pub-id pub-id-type="pmid">20863848</pub-id>
</element-citation>
</ref>
<ref id="b60-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chahrour</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>MeCP2, a key contributor to neurological disease, activates and represses transcription</article-title>
<source/>Science
          <volume>320</volume>
<fpage>1224</fpage>
<lpage>1229</lpage>
<pub-id pub-id-type="doi">10.1126/science.1153252</pub-id>
<!--<pub-id pub-id-type="pmcid">2443785</pub-id>-->
<pub-id pub-id-type="pmid">18511691</pub-id>
</element-citation>
</ref>
<ref id="b61-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chahrour</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>The story of Rett syndrome: from clinic to neurobiology</article-title>
<source/>Neuron
          <volume>56</volume>
<fpage>422</fpage>
<lpage>437</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2007.10.001</pub-id>
<pub-id pub-id-type="pmid">17988628</pub-id>
</element-citation>
</ref>
<ref id="b62-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakrabarti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fombonne</surname>
<given-names>E</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Pervasive developmental disorders in preschool children: confirmation of high prevalence</article-title>
<source/>Am. J. Psychiatry
          <volume>162</volume>
<fpage>1133</fpage>
<lpage>1141</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.162.6.1133</pub-id>
<pub-id pub-id-type="pmid">15930062</pub-id>
</element-citation>
</ref>
<ref id="b63-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Unger</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Byrnes</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rios</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Examination of behavioral deficits triggered by targeting Bdnf in fetal or postnatal brains of mice</article-title>
<source/>Neuroscience
          <volume>142</volume>
<fpage>49</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2006.06.002</pub-id>
<pub-id pub-id-type="pmid">16844311</pub-id>
</element-citation>
</ref>
<ref id="b64-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chao</surname>
<given-names>HT</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Samaco</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chahrour</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Neul</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Heintz</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ekker</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rubenstein</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Noebels</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Rosenmund</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes</article-title>
<source/>Nature
          <volume>468</volume>
<fpage>263</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1038/nature09582</pub-id>
<!--<pub-id pub-id-type="pmcid">3057962</pub-id>-->
<pub-id pub-id-type="pmid">21068835</pub-id>
</element-citation>
</ref>
<ref id="b65-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheh</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Millonig</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Roselli</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Ming</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kamdar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>GC</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>En2 knockout mice display neurobehavioral and neurochemical alterations relevant to autism spectrum disorder</article-title>
<source/>Brain Res
          <volume>1116</volume>
<fpage>166</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2006.07.086</pub-id>
<pub-id pub-id-type="pmid">16935268</pub-id>
</element-citation>
</ref>
<ref id="b66-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Beffert</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Ertunc</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Kavalali</surname>
<given-names>ET</given-names>
</name>
<name>
<surname>Bezprozvanny</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Herz</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Reelin modulates NMDA receptor activity in cortical neurons</article-title>
<source/>J Neurosci
          <volume>25</volume>
<fpage>8209</fpage>
<lpage>8216</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1951-05.2005</pub-id>
<pub-id pub-id-type="pmid">16148228</pub-id>
</element-citation>
</ref>
<ref id="b67-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chess</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Korn</surname>
<given-names>S</given-names>
</name>
</person-group>
<year>1978</year>
<article-title>Behavioral consequences of congenital rubella</article-title>
<source/>J Pediatr
          <volume>93</volume>
<fpage>699</fpage>
<lpage>703</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-3476(78)80921-4</pub-id>
<pub-id pub-id-type="pmid">702254</pub-id>
</element-citation>
</ref>
<ref id="b68-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chevere-Torres</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Maki</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Santini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Klann</surname>
<given-names>E</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Impaired social interactions and motor learning skills in tuberous sclerosis complex model mice expressing a dominant/negative form of tuberin</article-title>
<source/>Neurobiol Dis
          <volume>45</volume>
<fpage>156</fpage>
<lpage>164</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2011.07.018</pub-id>
<pub-id pub-id-type="pmid">21827857</pub-id>
</element-citation>
</ref>
<ref id="b69-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ching</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Jeste</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Morrow</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Mukaddes</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hundley</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Austin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Berry</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Driscoll</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Engle</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gusella</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Hisama</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Irons</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Lafiosca</surname>
<given-names>T</given-names>
</name>
<name>
<surname>LeClair</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Neessen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Picker</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Rappaport</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rooney</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Sarco</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Stoler</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Wolff</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nasir</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>BL</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet
          <volume>153B</volume>
<fpage>937</fpage>
<lpage>947</lpage>
<!--<pub-id pub-id-type="pmcid">3001124</pub-id>-->
<pub-id pub-id-type="pmid">20468056</pub-id>
</element-citation>
</ref>
<ref id="b70-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Cheong</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Ryu</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>CY</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Valproic acid induces astrocyte-dependent neu-rite outgrowth from cultured rat primary cortical neuron via modulation of tPA/PAI-1 activity</article-title>
<source/>Glia
          <volume>61</volume>
<fpage>694</fpage>
<lpage>709</lpage>
<pub-id pub-id-type="doi">10.1002/glia.22463</pub-id>
<pub-id pub-id-type="pmid">23378038</pub-id>
</element-citation>
</ref>
<ref id="b71-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christianson</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Chesler</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kromberg</surname>
<given-names>JG</given-names>
</name>
</person-group>
<year>1994</year>
<article-title>Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs</article-title>
<source/>Dev Med Child Neurol
          <volume>36</volume>
<fpage>361</fpage>
<lpage>369</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-8749.1994.tb11858.x</pub-id>
<pub-id pub-id-type="pmid">7512516</pub-id>
</element-citation>
</ref>
<ref id="b72-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chu</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Tarnawski</surname>
<given-names>AS</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>PTEN regulatory functions in tumor suppression and cell biology</article-title>
<source/>Med Sci Monit
          <volume>10</volume>
<fpage>RA235</fpage>
<lpage>RA241</lpage>
<pub-id pub-id-type="pmid">15448614</pub-id>
</element-citation>
</ref>
<ref id="b73-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cichowski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Jacks</surname>
<given-names>T</given-names>
</name>
</person-group>
<year>2001</year>
<article-title>NF1 tumor suppressor gene function: narrowing the GAP</article-title>
<source/>Cell
          <volume>104</volume>
<fpage>593</fpage>
<lpage>604</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(01)00245-8</pub-id>
<pub-id pub-id-type="pmid">11239415</pub-id>
</element-citation>
</ref>
<ref id="b74-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chudley</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Forster-Gibson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Holden</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Autism severity is associated with child and maternal MAOA genotypes</article-title>
<source/>Clin Genet
          <volume>79</volume>
<fpage>355</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0004.2010.01471.x</pub-id>
<pub-id pub-id-type="pmid">20573161</pub-id>
</element-citation>
</ref>
<ref id="b75-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>IL</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Schutz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>White</surname>
<given-names>BN</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Holden</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<year>2003</year>
<article-title>Association of autism severity with a monoamine oxidase A functional polymorphism</article-title>
<source/>Clin Genet
          <volume>64</volume>
<fpage>190</fpage>
<lpage>197</lpage>
<pub-id pub-id-type="doi">10.1034/j.1399-0004.2003.00115.x</pub-id>
<pub-id pub-id-type="pmid">12919132</pub-id>
</element-citation>
</ref>
<ref id="b76-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Comoletti</surname>
<given-names>D</given-names>
</name>
<name>
<surname>De Jaco</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jennings</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Flynn</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Gaietta</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tsigelny</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ellisman</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>P</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>The Arg451Cysneuroligin-3 mutation associated with autism reveals a defect in protein processing</article-title>
<source/>J Neurosci
          <volume>24</volume>
<fpage>4889</fpage>
<lpage>4893</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0468-04.2004</pub-id>
<pub-id pub-id-type="pmid">15152050</pub-id>
</element-citation>
</ref>
<ref id="b77-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Correa-Cerro</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Wassif</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Kratz</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>GF</given-names>
</name>
<name>
<surname>Munasinghe</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Grinberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fliesler</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Porter</surname>
<given-names>FD</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Development and characterization of a hypomorphic Smith-Lemli-Opitz syndrome mouse model and efficacy of simvastatin therapy</article-title>
<source/>Hum Mol Genet
          <volume>15</volume>
<fpage>839</fpage>
<lpage>851</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddl003</pub-id>
<pub-id pub-id-type="pmid">16446309</pub-id>
</element-citation>
</ref>
<ref id="b78-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costa</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Federov</surname>
<given-names>NB</given-names>
</name>
<name>
<surname>Kogan</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Stern</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ohno</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kucherlapati</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jacks</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<year>2002</year>
<article-title>Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1</article-title>
<source/>Nature
          <volume>415</volume>
<fpage>526</fpage>
<lpage>530</lpage>
<pub-id pub-id-type="doi">10.1038/nature711</pub-id>
<pub-id pub-id-type="pmid">11793011</pub-id>
</element-citation>
</ref>
<ref id="b79-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costa</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Huynh</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Pulst</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Viskochil</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Brannan</surname>
<given-names>CI</given-names>
</name>
</person-group>
<year>2001</year>
<article-title>Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1</article-title>
<source/>Nat Genet
          <volume>27</volume>
<fpage>399</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="doi">10.1038/86898</pub-id>
<pub-id pub-id-type="pmid">11279521</pub-id>
</element-citation>
</ref>
<ref id="b80-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Courchesne</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Saitoh</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Yeung-Courchesne</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Press</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Lincoln</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Schreibman</surname>
<given-names>L</given-names>
</name>
</person-group>
<year>1994</year>
<article-title>Abnormality of cerebellar vermian lobules VI and VII in patients with infantile autism: identification of hypoplastic and hyperplastic subgroups with MR imaging</article-title>
<source/>AJR Am J Roentgenol
          <volume>162</volume>
<fpage>123</fpage>
<lpage>130</lpage>
<pub-id pub-id-type="doi">10.2214/ajr.162.1.8273650</pub-id>
<pub-id pub-id-type="pmid">8273650</pub-id>
</element-citation>
</ref>
<ref id="b81-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Croen</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Grether</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Odouli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Van de Water</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study</article-title>
<source/>Arch Pediatr Adolesc Med
          <volume>159</volume>
<fpage>151</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="doi">10.1001/archpedi.159.2.151</pub-id>
<pub-id pub-id-type="pmid">15699309</pub-id>
</element-citation>
</ref>
<ref id="b82-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Curatolo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Porfirio</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Manzi</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Seri</surname>
<given-names>S</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>Autism in tuberous sclerosis</article-title>
<source/>Eur J Paediatr Neurol
          <volume>8</volume>
<fpage>327</fpage>
<lpage>332</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejpn.2004.08.005</pub-id>
<pub-id pub-id-type="pmid">15542389</pub-id>
</element-citation>
</ref>
<ref id="b83-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D’Arcangelo</surname>
<given-names>G</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>The reeler mouse: anatomy of a mutant</article-title>
<source/>Int Rev Neurobiol
          <volume>71</volume>
<fpage>383</fpage>
<lpage>417</lpage>
<pub-id pub-id-type="doi">10.1016/S0074-7742(05)71016-3</pub-id>
<pub-id pub-id-type="pmid">16512359</pub-id>
</element-citation>
</ref>
<ref id="b84-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dani</surname>
<given-names>VS</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Maffei</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Turrigiano</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Jaenisch</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>SB</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>102</volume>
<fpage>12560</fpage>
<lpage>12565</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0506071102</pub-id>
<!--<pub-id pub-id-type="pmcid">1194957</pub-id>-->
<pub-id pub-id-type="pmid">16116096</pub-id>
</element-citation>
</ref>
<ref id="b85-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daniels</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Forssen</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Hultman</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Cnattingius</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Savitz</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Feychting</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sparen</surname>
<given-names>P</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Parental psychiatric disorders associated with autism spectrum disorders in the offspring</article-title>
<source/>Pediatrics
          <volume>121</volume>
<fpage>e1357</fpage>
<lpage>e1362</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2007-2296</pub-id>
<pub-id pub-id-type="pmid">18450879</pub-id>
</element-citation>
</ref>
<ref id="b86-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Hazlett</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Librant</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Nopoulos</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sheffield</surname>
<given-names>VC</given-names>
</name>
<name>
<surname>Piven</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wassink</surname>
<given-names>TH</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet
          <volume>147B</volume>
<fpage>1145</fpage>
<lpage>1151</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30738</pub-id>
<!--<pub-id pub-id-type="pmcid">2752707</pub-id>-->
<pub-id pub-id-type="pmid">18361446</pub-id>
</element-citation>
</ref>
<ref id="b87-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daws</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Munn</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Valdez</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Frosto-Burke</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hensler</surname>
<given-names>JG</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>Serotonin transporter function, but not expression, is dependent on brain-derived neurotrophic factor (BDNF): in vivo studies in BDNF-deficient mice</article-title>
<source/>J Neurochem
          <volume>101</volume>
<fpage>641</fpage>
<lpage>651</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2006.04392.x</pub-id>
<pub-id pub-id-type="pmid">17254018</pub-id>
</element-citation>
</ref>
<ref id="b88-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeLorey</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Handforth</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Anagnostaras</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Homanics</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Minassian</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Asatourian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fanselow</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Delgado-Escueta</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ellison</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Olsen</surname>
<given-names>RW</given-names>
</name>
</person-group>
<year>1998</year>
<article-title>Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome</article-title>
<source/>J Neurosci
          <volume>18</volume>
<fpage>8505</fpage>
<lpage>8514</lpage>
<pub-id pub-id-type="pmid">9763493</pub-id>
</element-citation>
</ref>
<ref id="b89-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeLorey</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Sahbaie</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hashemi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Homanics</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>JD</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder</article-title>
<source/>Behav Brain Res
          <volume>187</volume>
<fpage>207</fpage>
<lpage>220</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2007.09.009</pub-id>
<pub-id pub-id-type="pmid">17983671</pub-id>
</element-citation>
</ref>
<ref id="b90-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Cristofano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pesce</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cordon-Cardo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pandolfi</surname>
<given-names>PP</given-names>
</name>
</person-group>
<year>1998</year>
<article-title>Pten is essential for embryonic development and tumour suppression</article-title>
<source/>Nat Genet
          <volume>19</volume>
<fpage>348</fpage>
<lpage>355</lpage>
<pub-id pub-id-type="doi">10.1038/1235</pub-id>
<pub-id pub-id-type="pmid">9697695</pub-id>
</element-citation>
</ref>
<ref id="b91-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diergaarde</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gerrits</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Brouwers</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>van Ree</surname>
<given-names>JM</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Early amygdala damage disrupts performance on medial prefrontal cortex-related tasks but spares spatial learning and memory in the rat</article-title>
<source/>Neuroscience
          <volume>130</volume>
<fpage>581</fpage>
<lpage>590</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2004.09.022</pub-id>
<pub-id pub-id-type="pmid">15590142</pub-id>
</element-citation>
</ref>
<ref id="b92-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DiMario</surname>
<given-names>FJ</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<year>2004</year>
<article-title>Brain abnormalities in tuberous sclerosis complex</article-title>
<source/>J Child Neurol
          <volume>19</volume>
<fpage>650</fpage>
<lpage>657</lpage>
<pub-id pub-id-type="pmid">15563010</pub-id>
</element-citation>
</ref>
<ref id="b93-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dufour-Rainfray</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Vourc’h</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Le Guisquet</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Garreau</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ternant</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bodard</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jaumain</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gulhan</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Belzung</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Andres</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Chalon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Guilloteau</surname>
<given-names>D</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism</article-title>
<source/>Neurosci Lett
          <volume>470</volume>
<fpage>55</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2009.12.054</pub-id>
<pub-id pub-id-type="pmid">20036713</pub-id>
</element-citation>
</ref>
<ref id="b94-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Durand</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Betancur</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Boeckers</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Bockmann</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chaste</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fauchereau</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Nygren</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rastam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>IC</given-names>
</name>
<name>
<surname>Anckarsater</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sponheim</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Goubran-Botros</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Delorme</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Chabane</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mouren-Simeoni</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>de Mas</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bieth</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Roge</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Heron</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Burglen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Leboyer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bourgeron</surname>
<given-names>T</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders</article-title>
<source/>Nat Genet
          <volume>39</volume>
<fpage>25</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.1038/ng1933</pub-id>
<!--<pub-id pub-id-type="pmcid">2082049</pub-id>-->
<pub-id pub-id-type="pmid">17173049</pub-id>
</element-citation>
</ref>
<ref id="b95-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dykens</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Roof</surname>
<given-names>E</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Prader-Willi syndrome and autism spectrum disorders: an evolving story</article-title>
<source/>J Neurodev Disord
          <volume>3</volume>
<fpage>225</fpage>
<lpage>237</lpage>
<pub-id pub-id-type="doi">10.1007/s11689-011-9092-5</pub-id>
<!--<pub-id pub-id-type="pmcid">3261277</pub-id>-->
<pub-id pub-id-type="pmid">21858456</pub-id>
</element-citation>
</ref>
<ref id="b96-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ehninger</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sano</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Dies</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Franz</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Kaur</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lowe</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Sahin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Whittemore</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice</article-title>
<source/>Mol. Psychiatry
          <volume>17</volume>
<fpage>62</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2010.115</pub-id>
<pub-id pub-id-type="pmid">21079609</pub-id>
</element-citation>
</ref>
<ref id="b97-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engelmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Landgraf</surname>
<given-names>R</given-names>
</name>
</person-group>
<year>1994</year>
<article-title>Microdialysis administration of vasopressin into the septum improves social recognition in Brattleboro rats</article-title>
<source/>Physiol Behav
          <volume>55</volume>
<fpage>145</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="doi">10.1016/0031-9384(94)90022-1</pub-id>
<pub-id pub-id-type="pmid">8140159</pub-id>
</element-citation>
</ref>
<ref id="b98-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eslinger</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Flaherty-Craig</surname>
<given-names>CV</given-names>
</name>
<name>
<surname>Benton</surname>
<given-names>AL</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>Developmental outcomes after early prefrontal cortex damage</article-title>
<source/>Brain Cogn
          <volume>55</volume>
<fpage>84</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1016/S0278-2626(03)00281-1</pub-id>
<pub-id pub-id-type="pmid">15134845</pub-id>
</element-citation>
</ref>
<ref id="b99-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Etherton</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Foldy</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tabuchi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Shamloo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Malenka</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Sudhof</surname>
<given-names>TC</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>108</volume>
<fpage>13764</fpage>
<lpage>13769</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1111093108</pub-id>
<!--<pub-id pub-id-type="pmcid">3158170</pub-id>-->
<pub-id pub-id-type="pmid">21808020</pub-id>
</element-citation>
</ref>
<ref id="b100-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Etherton</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Blaiss</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Sudhof</surname>
<given-names>TC</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>106</volume>
<fpage>17998</fpage>
<lpage>18003</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0910297106</pub-id>
<!--<pub-id pub-id-type="pmcid">2764944</pub-id>-->
<pub-id pub-id-type="pmid">19822762</pub-id>
</element-citation>
</ref>
<ref id="b101-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fatemi</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Aldinger</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Ashwood</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bauman</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Blaha</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Blatt</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Chauhan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chauhan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Dager</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Dickson</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Estes</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Goldowitz</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Heck</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Kemper</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>King</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Millen</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Mittleman</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mosconi</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Persico</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Sweeney</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Webb</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Welsh</surname>
<given-names>JP</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Consensus paper: pathological role of the cerebellum in autism</article-title>
<source/>Cerebellum
          <volume>11</volume>
<fpage>777</fpage>
<lpage>807</lpage>
<pub-id pub-id-type="doi">10.1007/s12311-012-0355-9</pub-id>
<!--<pub-id pub-id-type="pmcid">3677555</pub-id>-->
<pub-id pub-id-type="pmid">22370873</pub-id>
</element-citation>
</ref>
<ref id="b102-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fatemi</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Halt</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Stary</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Kanodia</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schulz</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Realmuto</surname>
<given-names>GR</given-names>
</name>
</person-group>
<year>2002</year>
<article-title>Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices</article-title>
<source/>Biol. Psychiatry
          <volume>52</volume>
<fpage>805</fpage>
<lpage>810</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-3223(02)01430-0</pub-id>
<pub-id pub-id-type="pmid">12372652</pub-id>
</element-citation>
</ref>
<ref id="b103-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fatemi</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Reutiman</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Folsom</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Thuras</surname>
<given-names>PD</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>GABA(A) receptor downregulation in brains of subjects with autism</article-title>
<source/>J Autism Dev Disord
          <volume>39</volume>
<fpage>223</fpage>
<lpage>230</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-008-0646-7</pub-id>
<!--<pub-id pub-id-type="pmcid">2697059</pub-id>-->
<pub-id pub-id-type="pmid">18821008</pub-id>
</element-citation>
</ref>
<ref id="b104-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferguson</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Aldag</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Insel</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>LJ</given-names>
</name>
</person-group>
<year>2001</year>
<article-title>Oxytocin in the medial amygdala is essential for social recognition in the mouse</article-title>
<source/>J Neurosci
          <volume>21</volume>
<fpage>8278</fpage>
<lpage>8285</lpage>
<pub-id pub-id-type="pmid">11588199</pub-id>
</element-citation>
</ref>
<ref id="b105-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fidler</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Smalley</surname>
<given-names>SL</given-names>
</name>
</person-group>
<year>2000</year>
<article-title>Macrocephaly in autism and other pervasive developmental disorders</article-title>
<source/>Dev Med Child Neurol
          <volume>42</volume>
<fpage>737</fpage>
<lpage>740</lpage>
<pub-id pub-id-type="doi">10.1017/S0012162200001365</pub-id>
<pub-id pub-id-type="pmid">11104344</pub-id>
</element-citation>
</ref>
<ref id="b106-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fisher</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Scharff</surname>
<given-names>C</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>FOXP2 as a molecular window into speech and language</article-title>
<source/>Trends Genet
          <volume>25</volume>
<fpage>166</fpage>
<lpage>177</lpage>
<pub-id pub-id-type="doi">10.1016/j.tig.2009.03.002</pub-id>
<pub-id pub-id-type="pmid">19304338</pub-id>
</element-citation>
</ref>
<ref id="b107-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fitzky</surname>
<given-names>BU</given-names>
</name>
<name>
<surname>Moebius</surname>
<given-names>FF</given-names>
</name>
<name>
<surname>Asaoka</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Waage-Baudet</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kluckman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hiller</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Batta</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Shefer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Salen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sulik</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Simoni</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Ness</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Glossmann</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Tint</surname>
<given-names>GS</given-names>
</name>
</person-group>
<year>2001</year>
<article-title>7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome</article-title>
<source/>J Clin Invest
          <volume>108</volume>
<fpage>905</fpage>
<lpage>915</lpage>
<pub-id pub-id-type="doi">10.1172/JCI200112103</pub-id>
<!--<pub-id pub-id-type="pmcid">200927</pub-id>-->
<pub-id pub-id-type="pmid">11560960</pub-id>
</element-citation>
</ref>
<ref id="b108-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fombonne</surname>
<given-names>E</given-names>
</name>
</person-group>
<year>1999</year>
<article-title>The epidemiology of autism: a review</article-title>
<source/>Psychol Med
          <volume>29</volume>
<fpage>769</fpage>
<lpage>786</lpage>
<pub-id pub-id-type="doi">10.1017/S0033291799008508</pub-id>
<pub-id pub-id-type="pmid">10473304</pub-id>
</element-citation>
</ref>
<ref id="b109-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frye</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Llaneza</surname>
<given-names>DC</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Corticosteroid and neurosteroid dysregulation in an animal model of autism, BTBR mice</article-title>
<source/>Physiol Behav
          <volume>100</volume>
<fpage>264</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1016/j.physbeh.2010.03.005</pub-id>
<!--<pub-id pub-id-type="pmcid">2860004</pub-id>-->
<pub-id pub-id-type="pmid">20298706</pub-id>
</element-citation>
</ref>
<ref id="b110-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukuchi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nii</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ishimaru</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Minamino</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hara</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Takasaki</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Tabuchi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tsuda</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions</article-title>
<source/>Neurosci Res
          <volume>65</volume>
<fpage>35</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.1016/j.neures.2009.05.002</pub-id>
<pub-id pub-id-type="pmid">19463867</pub-id>
</element-citation>
</ref>
<ref id="b111-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garber</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Visootsak</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>ST</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Fragile X syndrome</article-title>
<source/>Eur J Hum Genet
          <volume>16</volume>
<fpage>666</fpage>
<lpage>672</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2008.61</pub-id>
<!--<pub-id pub-id-type="pmcid">4369150</pub-id>-->
<pub-id pub-id-type="pmid">18398441</pub-id>
</element-citation>
</ref>
<ref id="b112-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gardiner</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>T</given-names>
</name>
</person-group>
<year>1983</year>
<article-title>The cardiovascular and renal responses to short-term isolation in Brattleboro rats</article-title>
<source/>Clin Sci
          <volume>64</volume>
<fpage>377</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="doi">10.1042/cs0640377</pub-id>
<pub-id pub-id-type="pmid">6825408</pub-id>
</element-citation>
</ref>
<ref id="b113-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gauthier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bonnel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>St-Onge</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Karemera</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Laurent</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mottron</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fombonne</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Joober</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rouleau</surname>
<given-names>GA</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet
          <volume>132B</volume>
<fpage>74</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30066</pub-id>
<pub-id pub-id-type="pmid">15389766</pub-id>
</element-citation>
</ref>
<ref id="b114-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gauthier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Champagne</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lafrenière</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Spiegelman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Brustein</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lapointe</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Côté</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Noreau</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hamdan</surname>
<given-names>FF</given-names>
</name>
<name>
<surname>Addington</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Rapoport</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Delisi</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Krebs</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Joober</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fathalli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mouaffak</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Haghighi</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Néri</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dubé</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Samuels</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Marineau</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Awadalla</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Barker</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Carbonetto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Drapeau</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rouleau</surname>
<given-names>GA</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>107</volume>
<fpage>7863</fpage>
<lpage>7868</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0906232107</pub-id>
<!--<pub-id pub-id-type="pmcid">2867875</pub-id>-->
<pub-id pub-id-type="pmid">20385823</pub-id>
</element-citation>
</ref>
<ref id="b115-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gepner</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Feron</surname>
<given-names>F</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Autism: a world changing too fast for a mis-wired brain?</article-title>
<source/>Neurosci Biobehav Rev
          <volume>33</volume>
<fpage>1227</fpage>
<lpage>1242</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2009.06.006</pub-id>
<pub-id pub-id-type="pmid">19559043</pub-id>
</element-citation>
</ref>
<ref id="b116-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Genetics of autism spectrum disorders</article-title>
<source/>Trends Cogn Sci
          <volume>15</volume>
<fpage>409</fpage>
<lpage>416</lpage>
<pub-id pub-id-type="doi">10.1016/j.tics.2011.07.003</pub-id>
<!--<pub-id pub-id-type="pmcid">3691066</pub-id>-->
<pub-id pub-id-type="pmid">21855394</pub-id>
</element-citation>
</ref>
<ref id="b117-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Levitt</surname>
<given-names>P</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>Autism spectrum disorders: developmental disconnection syndromes</article-title>
<source/>Curr Opin Neurobiol
          <volume>17</volume>
<fpage>103</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2007.01.009</pub-id>
<pub-id pub-id-type="pmid">17275283</pub-id>
</element-citation>
</ref>
<ref id="b118-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gillberg</surname>
<given-names>C</given-names>
</name>
</person-group>
<year>1998</year>
<article-title>Chromosomal disorders and autism</article-title>
<source/>J Autism Dev Disord
          <volume>28</volume>
<fpage>415</fpage>
<lpage>425</lpage>
<pub-id pub-id-type="doi">10.1023/A:1026004505764</pub-id>
<pub-id pub-id-type="pmid">9813777</pub-id>
</element-citation>
</ref>
<ref id="b119-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gillberg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>de Souza</surname>
<given-names>L</given-names>
</name>
</person-group>
<year>2002</year>
<article-title>Head circumference in autism, Asperger syndrome, and ADHD: a comparative study</article-title>
<source/>Dev Med Child Neurol
          <volume>44</volume>
<fpage>296</fpage>
<lpage>300</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-8749.2002.tb00814.x</pub-id>
<pub-id pub-id-type="pmid">12033714</pub-id>
</element-citation>
</ref>
<ref id="b120-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gkogkas</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Khoutorsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ran</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Rampakakis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nevarko</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Weatherill</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Vasuta</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Truitt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dallaire</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Major</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lasko</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ruggero</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nader</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lacaille</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Sonenberg</surname>
<given-names>N</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Autism-related deficits via dysregulated eIF4E-dependent translational control</article-title>
<source/>Nature
          <volume>493</volume>
<fpage>371</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="doi">10.1038/nature11628</pub-id>
<pub-id pub-id-type="pmid">23172145</pub-id>
</element-citation>
</ref>
<ref id="b121-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Go</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>S.-H</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cheong</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Ryu</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>C.-H</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>CY</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3β/β-catenin pathway</article-title>
<source/>Neuropharmacology
          <volume>63</volume>
<fpage>1028</fpage>
<lpage>1041</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2012.07.028</pub-id>
<pub-id pub-id-type="pmid">22841957</pub-id>
</element-citation>
</ref>
<ref id="b122-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goffinet</surname>
<given-names>AM</given-names>
</name>
</person-group>
<year>1983</year>
<article-title>The embryonic development of the inferior olivary complex in normal and reeler (rlORL) mutant mice</article-title>
<source/>J Comp Neurol
          <volume>219</volume>
<fpage>10</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1002/cne.902190103</pub-id>
<pub-id pub-id-type="pmid">6619327</pub-id>
</element-citation>
</ref>
<ref id="b123-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Golan</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Lev</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Hallak</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sorokin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Huleihel</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy</article-title>
<source/>Neuropharmacology
          <volume>48</volume>
<fpage>903</fpage>
<lpage>917</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2004.12.023</pub-id>
<pub-id pub-id-type="pmid">15829260</pub-id>
</element-citation>
</ref>
<ref id="b124-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goorden</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>van Woerden</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>van der Weerd</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cheadle</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Elgersma</surname>
<given-names>Y</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>Cognitive deficits in Tsc1+/− mice in the absence of cerebral lesions and seizures</article-title>
<source/>Ann Neurol
          <volume>62</volume>
<fpage>648</fpage>
<lpage>655</lpage>
<pub-id pub-id-type="doi">10.1002/ana.21317</pub-id>
<pub-id pub-id-type="pmid">18067135</pub-id>
</element-citation>
</ref>
<ref id="b125-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greer</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Hanayama</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bloodgood</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Mardinly</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Lipton</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Flavell</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Griffith</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Waldon</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Maehr</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ploegh</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Chowdhury</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Worley</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Steen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>ME</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc</article-title>
<source/>Cell
          <volume>140</volume>
<fpage>704</fpage>
<lpage>716</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2010.01.026</pub-id>
<!--<pub-id pub-id-type="pmcid">2843143</pub-id>-->
<pub-id pub-id-type="pmid">20211139</pub-id>
</element-citation>
</ref>
<ref id="b126-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregorian</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Le Belle</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ohab</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Groszer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Sofroniew</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Carmichael</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Kornblum</surname>
<given-names>HI</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Pten deletion in adult neural stem/progenitor cells enhances constitutive neurogenesis</article-title>
<source/>J Neurosci
          <volume>29</volume>
<fpage>1874</fpage>
<lpage>1886</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3095-08.2009</pub-id>
<!--<pub-id pub-id-type="pmcid">2754186</pub-id>-->
<pub-id pub-id-type="pmid">19211894</pub-id>
</element-citation>
</ref>
<ref id="b127-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregory</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Connelly</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Towers</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Biscocho</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Markunas</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Lintas</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Abramson</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Langford</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Worley</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Delong</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Cuccaro</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Persico</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pericak-Vance</surname>
<given-names>MA</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Genomic and epigenetic evidence for oxytocin receptor deficiency in autism</article-title>
<source/>BMC Med
          <volume>7</volume>
<fpage>62</fpage>
<pub-id pub-id-type="doi">10.1186/1741-7015-7-62</pub-id>
<!--<pub-id pub-id-type="pmcid">2774338</pub-id>-->
<pub-id pub-id-type="pmid">19845972</pub-id>
</element-citation>
</ref>
<ref id="b128-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Groc</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Choquet</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Stephenson</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Verrier</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Manzoni</surname>
<given-names>OJ</given-names>
</name>
<name>
<surname>Chavis</surname>
<given-names>P</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>NMDA receptor surface trafficking and synaptic subunit composition are developmentally regulated by the extracellular matrix protein Reelin</article-title>
<source/>J Neurosci
          <volume>27</volume>
<fpage>10165</fpage>
<lpage>10175</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1772-07.2007</pub-id>
<pub-id pub-id-type="pmid">17881522</pub-id>
</element-citation>
</ref>
<ref id="b129-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guastella</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Einfeld</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Rinehart</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Tonge</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Hickie</surname>
<given-names>IB</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders</article-title>
<source/>Biol. Psychiatry
          <volume>67</volume>
<fpage>692</fpage>
<lpage>694</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2009.09.020</pub-id>
<pub-id pub-id-type="pmid">19897177</pub-id>
</element-citation>
</ref>
<ref id="b130-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guastella</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Dadds</surname>
<given-names>MR</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Oxytocin increases gaze to the eye region of human faces</article-title>
<source/>Biol. Psychiatry
          <volume>63</volume>
<fpage>3</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2007.06.026</pub-id>
<pub-id pub-id-type="pmid">17888410</pub-id>
</element-citation>
</ref>
<ref id="b131-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guffanti</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lievers</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Bonati</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Marchi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Geronazzo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Nardocci</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Estienne</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Larizza</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Macciardi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>S</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Role of UBE3A and ATP10A genes in autism susceptibility region 15q11-q13 in an Italian population: A positive replication for UBE3A</article-title>
<source/>Psychiatry Res
          <volume>185</volume>
<fpage>33</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1016/j.psychres.2010.04.057</pub-id>
<pub-id pub-id-type="pmid">20609483</pub-id>
</element-citation>
</ref>
<ref id="b132-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cheval</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Selfridge</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>A</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>The Role of MeCP2 in the Brain</article-title>
<source/>Annu Rev Cell Dev Biol
          <volume>27</volume>
<fpage>631</fpage>
<lpage>652</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-cellbio-092910-154121</pub-id>
<pub-id pub-id-type="pmid">21721946</pub-id>
</element-citation>
</ref>
<ref id="b133-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hendrich</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>A</given-names>
</name>
</person-group>
<year>2001</year>
<article-title>A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome</article-title>
<source/>Nat Genet
          <volume>27</volume>
<fpage>322</fpage>
<lpage>326</lpage>
<pub-id pub-id-type="doi">10.1038/85899</pub-id>
<pub-id pub-id-type="pmid">11242117</pub-id>
</element-citation>
</ref>
<ref id="b134-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hallmayer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cleveland</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Torres</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Torigoe</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fedele</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lotspeich</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Croen</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Ozonoff</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lajonchere</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Grether</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Risch</surname>
<given-names>N</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Genetic Heritability and Shared Environmental Factors Among Twin Pairs With Autism</article-title>
<source/>Arch. Gen. Psychiatry
          <volume>68</volume>
<fpage>1095</fpage>
<lpage>1102</lpage>
<pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2011.76</pub-id>
<!--<pub-id pub-id-type="pmcid">4440679</pub-id>-->
<pub-id pub-id-type="pmid">21727249</pub-id>
</element-citation>
</ref>
<ref id="b135-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hardan</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Minshew</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Mallikarjuhn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Keshavan</surname>
<given-names>MS</given-names>
</name>
</person-group>
<year>2001</year>
<article-title>Brain volume in autism</article-title>
<source/>J Child Neurol
          <volume>16</volume>
<fpage>421</fpage>
<lpage>424</lpage>
<pub-id pub-id-type="doi">10.1177/088307380101600607</pub-id>
<pub-id pub-id-type="pmid">11417608</pub-id>
</element-citation>
</ref>
<ref id="b136-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hatton</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Sideris</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Skinner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mankowski</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>DB</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Roberts</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mirrett</surname>
<given-names>P</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Autistic behavior in children with fragile X syndrome: prevalence, stability, and the impact of FMRP</article-title>
<source/>Am. J. Med. Genet. A
          <volume>140A</volume>
<fpage>1804</fpage>
<lpage>1813</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.31286</pub-id>
<pub-id pub-id-type="pmid">16700053</pub-id>
</element-citation>
</ref>
<ref id="b137-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hava</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Vered</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yael</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mordechai</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mahoud</surname>
<given-names>H</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Alterations in behavior in adult offspring mice following maternal inflammation during pregnancy</article-title>
<source/>Dev Psychobiol
          <volume>48</volume>
<fpage>162</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="doi">10.1002/dev.20116</pub-id>
<pub-id pub-id-type="pmid">16489598</pub-id>
</element-citation>
</ref>
<ref id="b138-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hazlett</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Poe</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gerig</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Provenzale</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gilmore</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Piven</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Magnetic resonance imaging and head circumference study of brain size in autism: birth through age 2 years</article-title>
<source/>Arch. Gen. Psychiatry
          <volume>62</volume>
<fpage>1366</fpage>
<lpage>1376</lpage>
<pub-id pub-id-type="doi">10.1001/archpsyc.62.12.1366</pub-id>
<pub-id pub-id-type="pmid">16330725</pub-id>
</element-citation>
</ref>
<ref id="b139-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hertz-Picciotto</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Croen</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>van de Water</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pessah</surname>
<given-names>IN</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism</article-title>
<source/>Environ Health Perspect
          <volume>114</volume>
<fpage>1119</fpage>
<lpage>1125</lpage>
<pub-id pub-id-type="doi">10.1289/ehp.8483</pub-id>
<!--<pub-id pub-id-type="pmcid">1513329</pub-id>-->
<pub-id pub-id-type="pmid">16835068</pub-id>
</element-citation>
</ref>
<ref id="b140-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoeffer</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Santini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Whelan</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pierre</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Pelletier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Klann</surname>
<given-names>E</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Multiple components of eIF4F are required for protein synthesis-dependent hippocampal long-term potentiation</article-title>
<source/>J Neurophysiol
          <volume>109</volume>
<fpage>68</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="doi">10.1152/jn.00342.2012</pub-id>
<!--<pub-id pub-id-type="pmcid">3545154</pub-id>-->
<pub-id pub-id-type="pmid">23054596</pub-id>
</element-citation>
</ref>
<ref id="b141-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hollander</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Novotny</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hanratty</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yaffe</surname>
<given-names>R</given-names>
</name>
<name>
<surname>DeCaria</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Aronowitz</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Mosovich</surname>
<given-names>S</given-names>
</name>
</person-group>
<year>2003</year>
<article-title>Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger’s disorders</article-title>
<source/>Neuropsychopharmacology
          <volume>28</volume>
<fpage>193</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="doi">10.1038/sj.npp.1300021</pub-id>
<pub-id pub-id-type="pmid">12496956</pub-id>
</element-citation>
</ref>
<ref id="b142-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holmes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Lesch</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Crawley</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>DL</given-names>
</name>
</person-group>
<year>2003</year>
<article-title>Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior</article-title>
<source/>Neuropsychopharmacology
          <volume>28</volume>
<fpage>2077</fpage>
<lpage>2088</lpage>
<pub-id pub-id-type="pmid">12968128</pub-id>
</element-citation>
</ref>
<ref id="b143-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Homanics</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>DeLorey</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Firestone</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Quinlan</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Handforth</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>NL</given-names>
</name>
<name>
<surname>Krasowski</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Rick</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Korpi</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Makela</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Brilliant</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Hagiwara</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ferguson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Snyder</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Olsen</surname>
<given-names>RW</given-names>
</name>
</person-group>
<year>1997</year>
<article-title>Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>94</volume>
<fpage>4143</fpage>
<lpage>4148</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.94.8.4143</pub-id>
<!--<pub-id pub-id-type="pmcid">20582</pub-id>-->
<pub-id pub-id-type="pmid">9108119</pub-id>
</element-citation>
</ref>
<ref id="b144-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hornig</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Weissenbock</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Horscroft</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lipkin</surname>
<given-names>WI</given-names>
</name>
</person-group>
<year>1999</year>
<article-title>An infection-based model of neurodevelopmental damage</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>96</volume>
<fpage>12102</fpage>
<lpage>12107</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.96.21.12102</pub-id>
<!--<pub-id pub-id-type="pmcid">18419</pub-id>-->
<pub-id pub-id-type="pmid">10518583</pub-id>
</element-citation>
</ref>
<ref id="b145-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hranilovic</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Novak</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Babic</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Novokmet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bujas-Petkovic</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Jernej</surname>
<given-names>B</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Hyperserotonemia in autism: the potential role of 5HT-related gene variants</article-title>
<source/>Coll. Antropol
          <volume>32</volume>
<issue>Suppl 1</issue>
<fpage>75</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="pmid">18405062</pub-id>
</element-citation>
</ref>
<ref id="b146-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsiao</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>McBride</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Chow</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mazmanian</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>PH</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Modeling an autism risk factor in mice leads to permanent immune dysregulation</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>109</volume>
<fpage>12776</fpage>
<lpage>12781</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1202556109</pub-id>
<!--<pub-id pub-id-type="pmcid">3411999</pub-id>-->
<pub-id pub-id-type="pmid">22802640</pub-id>
</element-citation>
</ref>
<ref id="b147-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Santangelo</surname>
<given-names>SL</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Autism and serotonin transporter gene polymorphisms: A systematic review and meta-analysis</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet
          <volume>147B</volume>
<fpage>903</fpage>
<lpage>913</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30720</pub-id>
<pub-id pub-id-type="pmid">18286633</pub-id>
</element-citation>
</ref>
<ref id="b148-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Reichardt</surname>
<given-names>LF</given-names>
</name>
</person-group>
<year>2001</year>
<article-title>Neurotrophins: roles in neuronal development and function</article-title>
<source/>Annu Rev Neurosci
          <volume>24</volume>
<fpage>677</fpage>
<lpage>736</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.neuro.24.1.677</pub-id>
<!--<pub-id pub-id-type="pmcid">2758233</pub-id>-->
<pub-id pub-id-type="pmid">11520916</pub-id>
</element-citation>
</ref>
<ref id="b149-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hung</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Futai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sala</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Valtschanoff</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Ryu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Woodworth</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Kidd</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bear</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Weinberg</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1</article-title>
<source/>J Neurosci
          <volume>28</volume>
<fpage>1697</fpage>
<lpage>1708</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3032-07.2008</pub-id>
<!--<pub-id pub-id-type="pmcid">2633411</pub-id>-->
<pub-id pub-id-type="pmid">18272690</pub-id>
</element-citation>
</ref>
<ref id="b150-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hunter</surname>
<given-names>P</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>The psycho gene</article-title>
<source/>EMBO Rep
          <volume>11</volume>
<fpage>667</fpage>
<lpage>669</lpage>
<pub-id pub-id-type="doi">10.1038/embor.2010.122</pub-id>
<!--<pub-id pub-id-type="pmcid">2933872</pub-id>-->
<pub-id pub-id-type="pmid">20805840</pub-id>
</element-citation>
</ref>
<ref id="b151-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Husi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Choudhary</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Blackstock</surname>
<given-names>WP</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>SG</given-names>
</name>
</person-group>
<year>2000</year>
<article-title>Proteomic analysis of NMDA receptor-adhesion protein signaling complexes</article-title>
<source/>Nat Neurosci
          <volume>3</volume>
<fpage>661</fpage>
<lpage>669</lpage>
<pub-id pub-id-type="doi">10.1038/76615</pub-id>
<pub-id pub-id-type="pmid">10862698</pub-id>
</element-citation>
</ref>
<ref id="b152-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hutsler</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders</article-title>
<source/>Brain Res
          <volume>1309</volume>
<fpage>83</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2009.09.120</pub-id>
<pub-id pub-id-type="pmid">19896929</pub-id>
</element-citation>
</ref>
<ref id="b153-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iafrati</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Orejarena</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lassalle</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Bouamrane</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gonzalez-Campo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chavis</surname>
<given-names>P</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex via GluN2B-NMDARs and the mTOR pathway</article-title>
<source/>Mol. Psychiatry
          <volume>19</volume>
<fpage>417</fpage>
<lpage>426</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2013.66</pub-id>
<!--<pub-id pub-id-type="pmcid">3965840</pub-id>-->
<pub-id pub-id-type="pmid">23752244</pub-id>
</element-citation>
</ref>
<ref id="b154-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Insel</surname>
<given-names>TR</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior</article-title>
<source/>Neuron
          <volume>65</volume>
<fpage>768</fpage>
<lpage>779</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2010.03.005</pub-id>
<!--<pub-id pub-id-type="pmcid">2847497</pub-id>-->
<pub-id pub-id-type="pmid">20346754</pub-id>
</element-citation>
</ref>
<ref id="b155-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Irons</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Elias</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Salen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tint</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Batta</surname>
<given-names>AK</given-names>
</name>
</person-group>
<year>1993</year>
<article-title>Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome</article-title>
<source/>Lancet
          <volume>341</volume>
<fpage>1414</fpage>
<pub-id pub-id-type="doi">10.1016/0140-6736(93)90983-N</pub-id>
<pub-id pub-id-type="pmid">7684480</pub-id>
</element-citation>
</ref>
<ref id="b156-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Irwin</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Galvez</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Greenough</surname>
<given-names>WT</given-names>
</name>
</person-group>
<year>2000</year>
<article-title>Dendritic spine structural anomalies in fragile-X mental retardation syndrome</article-title>
<source/>Cereb. Cortex
          <volume>10</volume>
<fpage>1038</fpage>
<lpage>1044</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/10.10.1038</pub-id>
<pub-id pub-id-type="pmid">11007554</pub-id>
</element-citation>
</ref>
<ref id="b157-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacob</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brune</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Leventhal</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Lord</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>EH</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<year>2007</year>
<article-title>Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism</article-title>
<source/>Neurosci Lett
          <volume>417</volume>
<fpage>6</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2007.02.001</pub-id>
<!--<pub-id pub-id-type="pmcid">2705963</pub-id>-->
<pub-id pub-id-type="pmid">17383819</pub-id>
</element-citation>
</ref>
<ref id="b158-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jamain</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Quach</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Betancur</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rastam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Colineaux</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>IC</given-names>
</name>
<name>
<surname>Soderstrom</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Giros</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Leboyer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bourgeron</surname>
<given-names>T</given-names>
</name>
</person-group>
<year>2003</year>
<article-title>Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism</article-title>
<source/>Nat Genet
          <volume>34</volume>
<fpage>27</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1038/ng1136</pub-id>
<!--<pub-id pub-id-type="pmcid">1925054</pub-id>-->
<pub-id pub-id-type="pmid">12669065</pub-id>
</element-citation>
</ref>
<ref id="b159-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jamain</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Radyushkin</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hammerschmidt</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Granon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Boretius</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Varoqueaux</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ramanantsoa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gallego</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ronnenberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Winter</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Frahm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bourgeron</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ehrenreich</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Brose</surname>
<given-names>N</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>105</volume>
<fpage>1710</fpage>
<lpage>1715</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0711555105</pub-id>
<!--<pub-id pub-id-type="pmcid">2234209</pub-id>-->
<pub-id pub-id-type="pmid">18227507</pub-id>
</element-citation>
</ref>
<ref id="b160-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Impaired hypothalamic-pituitary-adrenal axis and its feedback regulation in serotonin transporter knockout mice</article-title>
<source/>Psychoneuroendocrinology
          <volume>34</volume>
<fpage>317</fpage>
<lpage>331</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2008.09.011</pub-id>
<!--<pub-id pub-id-type="pmcid">2700011</pub-id>-->
<pub-id pub-id-type="pmid">18980809</pub-id>
</element-citation>
</ref>
<ref id="b161-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Ehlers</surname>
<given-names>MD</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Modeling Autism by SHANK Gene Mutations in Mice</article-title>
<source/>Neuron
          <volume>78</volume>
<fpage>8</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2013.03.016</pub-id>
<!--<pub-id pub-id-type="pmcid">3659167</pub-id>-->
<pub-id pub-id-type="pmid">23583105</pub-id>
</element-citation>
</ref>
<ref id="b162-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Landa</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lorenzo</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Brilliant</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Noebels</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Beaudet</surname>
<given-names>AL</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3</article-title>
<source/>PLoS One
          <volume>5</volume>
<fpage>e12278</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0012278</pub-id>
<!--<pub-id pub-id-type="pmcid">2924885</pub-id>-->
<pub-id pub-id-type="pmid">20808828</pub-id>
</element-citation>
</ref>
<ref id="b163-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Sahoo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Michaelis</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Bercovich</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bressler</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kashork</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Shaffer</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Schroer</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Stockton</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Spielman</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Stevenson</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Beaudet</surname>
<given-names>AL</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A</article-title>
<source/>Am. J. Med. Genet. A
          <volume>131</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.30297</pub-id>
<pub-id pub-id-type="pmid">15389703</pub-id>
</element-citation>
</ref>
<ref id="b164-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joyal</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jacquart</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mahler</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Caston</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lalonde</surname>
<given-names>R</given-names>
</name>
</person-group>
<year>1996</year>
<article-title>Effects of midline and lateral cerebellar lesions on motor coordination and spatial orientation</article-title>
<source/>Brain Res
          <volume>739</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(96)00333-2</pub-id>
<pub-id pub-id-type="pmid">8955918</pub-id>
</element-citation>
</ref>
<ref id="b165-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Bryja</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Arenas</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>KY</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip/WAF1 pathway</article-title>
<source/>BMC Cell Biol
          <volume>9</volume>
<fpage>66</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2121-9-66</pub-id>
<!--<pub-id pub-id-type="pmcid">2639384</pub-id>-->
<pub-id pub-id-type="pmid">19068119</pub-id>
</element-citation>
</ref>
<ref id="b166-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname>
<given-names>K.-M</given-names>
</name>
<name>
<surname>Sepers</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Henstridge</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Lassalle</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Neuhofer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ginger</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Frick</surname>
<given-names>A</given-names>
</name>
<name>
<surname>DiPatrizio</surname>
<given-names>NV</given-names>
</name>
<name>
<surname>Mackie</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Katona</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Piomelli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Manzoni</surname>
<given-names>OJ</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome</article-title>
<source/>Nat Commun
          <volume>3</volume>
<fpage>1080</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms2045</pub-id>
<!--<pub-id pub-id-type="pmcid">3657999</pub-id>-->
<pub-id pub-id-type="pmid">23011134</pub-id>
</element-citation>
</ref>
<ref id="b167-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jyonouchi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Geng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ruby</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zimmerman-Bier</surname>
<given-names>B</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention</article-title>
<source/>Neuropsychobiology
          <volume>51</volume>
<fpage>77</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="doi">10.1159/000084164</pub-id>
<pub-id pub-id-type="pmid">15741748</pub-id>
</element-citation>
</ref>
<ref id="b168-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalueff</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>DL</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice</article-title>
<source/>Genes Brain Behav
          <volume>6</volume>
<fpage>389</fpage>
<lpage>400</lpage>
<pub-id pub-id-type="doi">10.1111/j.1601-183X.2006.00270.x</pub-id>
<pub-id pub-id-type="pmid">16939636</pub-id>
</element-citation>
</ref>
<ref id="b169-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ohno-Shosaku</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hashimotodani</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Uchigashima</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Endocannabinoid-mediated control of synaptic transmission</article-title>
<source/>Physiol Rev
          <volume>89</volume>
<fpage>309</fpage>
<lpage>380</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.00019.2008</pub-id>
<pub-id pub-id-type="pmid">19126760</pub-id>
</element-citation>
</ref>
<ref id="b170-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karvat</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kimchi</surname>
<given-names>T</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Acetylcholine elevation relieves cognitive rigidity and social deficiency in a mouse model of autism</article-title>
<source/>Neuropsychopharmacology
          <volume>39</volume>
<fpage>831</fpage>
<lpage>840</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2013.274</pub-id>
<!--<pub-id pub-id-type="pmcid">3924518</pub-id>-->
<pub-id pub-id-type="pmid">24096295</pub-id>
</element-citation>
</ref>
<ref id="b171-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kataoka</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Takuma</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hara</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ago</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Matsuda</surname>
<given-names>T</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid</article-title>
<source/>Int J Neuropsychopharmacol
          <volume>16</volume>
<fpage>91</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1017/S1461145711001714</pub-id>
<pub-id pub-id-type="pmid">22093185</pub-id>
</element-citation>
</ref>
<ref id="b172-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kavaliers</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Colwell</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Choleris</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Agmo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Muglia</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Ogawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pfaff</surname>
<given-names>DW</given-names>
</name>
</person-group>
<year>2003</year>
<article-title>Impaired discrimination of and aversion to parasitized male odors by female oxytocin knockout mice</article-title>
<source/>Genes Brain Behav
          <volume>2</volume>
<fpage>220</fpage>
<lpage>230</lpage>
<pub-id pub-id-type="doi">10.1034/j.1601-183X.2003.00021.x</pub-id>
<pub-id pub-id-type="pmid">12953788</pub-id>
</element-citation>
</ref>
<ref id="b173-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kemper</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Bauman</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>1998</year>
<article-title>Neuropathology of infantile autism</article-title>
<source/>J Neuropathol Exp Neurol
          <volume>57</volume>
<fpage>645</fpage>
<lpage>652</lpage>
<pub-id pub-id-type="doi">10.1097/00005072-199807000-00001</pub-id>
<pub-id pub-id-type="pmid">9690668</pub-id>
</element-citation>
</ref>
<ref id="b174-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kemper</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Bauman</surname>
<given-names>ML</given-names>
</name>
</person-group>
<year>1993</year>
<article-title>The contribution of neuropathologic studies to the understanding of autism</article-title>
<source/>Neurol Clin
          <volume>11</volume>
<fpage>175</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="pmid">8441369</pub-id>
</element-citation>
</ref>
<ref id="b175-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Thayer</surname>
<given-names>SA</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Lithium increases synapse formation between hippocampal neurons by depleting phosphoinositides</article-title>
<source/>Mol Pharmacol
          <volume>75</volume>
<fpage>1021</fpage>
<lpage>1030</lpage>
<pub-id pub-id-type="doi">10.1124/mol.108.052357</pub-id>
<!--<pub-id pub-id-type="pmcid">2672813</pub-id>-->
<pub-id pub-id-type="pmid">19188338</pub-id>
</element-citation>
</ref>
<ref id="b176-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Seung</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Gonzales</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>You</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Cheong</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Bahn</surname>
<given-names>GH</given-names>
</name>
</person-group>
<year>2014a</year>
<article-title>Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic acid-induced animal model of autism</article-title>
<source/>PLoS One
          <volume>9</volume>
<fpage>e104927</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0104927</pub-id>
<pub-id pub-id-type="pmid">25133713</pub-id>
</element-citation>
</ref>
<ref id="b177-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.-W</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>S.-H</given-names>
</name>
<name>
<surname>Cheong</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Ryu</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>CY</given-names>
</name>
</person-group>
<year>2014b</year>
<article-title>MeCP2 Modulates Sex Differences in the Postsynaptic Development of the Valproate Animal Model of Autism</article-title>
<source/>Mol Neurobiol
          <fpage>1</fpage>
<lpage>17</lpage>
</element-citation>
</ref>
<ref id="b178-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Go</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>SI</given-names>
</name>
<name>
<surname>Cheong</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>KH</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats</article-title>
<source/>Toxicol Lett
          <volume>201</volume>
<fpage>137</fpage>
<lpage>142</lpage>
<pub-id pub-id-type="doi">10.1016/j.toxlet.2010.12.018</pub-id>
<pub-id pub-id-type="pmid">21195144</pub-id>
</element-citation>
</ref>
<ref id="b179-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>D.-K</given-names>
</name>
<name>
<surname>Go</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.-W</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>M.-R</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>CY</given-names>
</name>
</person-group>
<year>2014c</year>
<article-title>Pax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspring</article-title>
<source/>Mol Neurobiol
          <volume>49</volume>
<fpage>512</fpage>
<lpage>528</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-013-8535-2</pub-id>
<pub-id pub-id-type="pmid">24030726</pub-id>
</element-citation>
</ref>
<ref id="b180-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolevzon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Soorya</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Grodberg</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kajiwara</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Willner</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Tryfon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Buxbaum</surname>
<given-names>JD</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Analysis of a purported SHANK3 mutation in a boy with autism: Clinical impact of rare variant research in neurodevelopmental disabilities</article-title>
<source/>Brain Res
          <volume>1380</volume>
<fpage>98</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2010.11.005</pub-id>
<pub-id pub-id-type="pmid">21062623</pub-id>
</element-citation>
</ref>
<ref id="b181-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolevzon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Reichenberg</surname>
<given-names>A</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>Prenatal and perinatal risk factors for autism: a review and integration of findings</article-title>
<source/>Arch Pediatr Adolesc Med
          <volume>161</volume>
<fpage>326</fpage>
<lpage>333</lpage>
<pub-id pub-id-type="doi">10.1001/archpedi.161.4.326</pub-id>
<pub-id pub-id-type="pmid">17404128</pub-id>
</element-citation>
</ref>
<ref id="b182-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korade</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Folkes</surname>
<given-names>OM</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>FE</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Behavioral and serotonergic response changes in the Dhcr7-HET mouse model of Smith-Lemli-Opitz syndrome</article-title>
<source/>Pharmacol Biochem Behav
          <volume>106</volume>
<fpage>101</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="doi">10.1016/j.pbb.2013.03.007</pub-id>
<pub-id pub-id-type="pmid">23541496</pub-id>
</element-citation>
</ref>
<ref id="b183-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuemerle</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gulden</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cherosky</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Herrup</surname>
<given-names>K</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>The mouse Engrailed genes: a window into autism</article-title>
<source/>Behav Brain Res
          <volume>176</volume>
<fpage>121</fpage>
<lpage>132</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2006.09.009</pub-id>
<pub-id pub-id-type="pmid">17055592</pub-id>
</element-citation>
</ref>
<ref id="b184-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuemerle</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zanjani</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Joyner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Herrup</surname>
<given-names>K</given-names>
</name>
</person-group>
<year>1997</year>
<article-title>Pattern deformities and cell loss in Engrailed-2 mutant mice suggest two separate patterning events during cerebellar development</article-title>
<source/>J Neurosci
          <volume>17</volume>
<fpage>7881</fpage>
<lpage>7889</lpage>
<pub-id pub-id-type="pmid">9315908</pub-id>
</element-citation>
</ref>
<ref id="b185-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumamaru</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Egashira</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Takenaka</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Takamori</surname>
<given-names>S</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Valproic acid selectively suppresses the formation of inhibitory synapses in cultured cortical neurons</article-title>
<source/>Neurosci Lett
          <volume>569</volume>
<fpage>142</fpage>
<lpage>147</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2014.03.066</pub-id>
<pub-id pub-id-type="pmid">24708928</pub-id>
</element-citation>
</ref>
<ref id="b186-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuwagata</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ogawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shioda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nagata</surname>
<given-names>T</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Observation of fetal brain in a rat valproate-induced autism model: a developmental neurotoxicity study</article-title>
<source/>Int J Dev Neurosci
          <volume>27</volume>
<fpage>399</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijdevneu.2009.01.006</pub-id>
<pub-id pub-id-type="pmid">19460635</pub-id>
</element-citation>
</ref>
<ref id="b187-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Luikart</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Matheny</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Parada</surname>
<given-names>LF</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Pten regulates neuronal arborization and social interaction in mice</article-title>
<source/>Neuron
          <volume>50</volume>
<fpage>377</fpage>
<lpage>388</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2006.03.023</pub-id>
<!--<pub-id pub-id-type="pmcid">3902853</pub-id>-->
<pub-id pub-id-type="pmid">16675393</pub-id>
</element-citation>
</ref>
<ref id="b188-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lante</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Meunier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Guiramand</surname>
<given-names>J</given-names>
</name>
<name>
<surname>De Jesus Ferreira</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Cambonie</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Aimar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cohen-Solal</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Maurice</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Vignes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Barbanel</surname>
<given-names>G</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation</article-title>
<source/>Hippocampus
          <volume>18</volume>
<fpage>602</fpage>
<lpage>609</lpage>
<pub-id pub-id-type="doi">10.1002/hipo.20421</pub-id>
<pub-id pub-id-type="pmid">18306297</pub-id>
</element-citation>
</ref>
<ref id="b189-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Larimore</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Chapleau</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Kudo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Theibert</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Percy</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Pozzo-Miller</surname>
<given-names>L</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations</article-title>
<source/>Neurobiol Dis
          <volume>34</volume>
<fpage>199</fpage>
<lpage>211</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2008.12.011</pub-id>
<!--<pub-id pub-id-type="pmcid">2726722</pub-id>-->
<pub-id pub-id-type="pmid">19217433</pub-id>
</element-citation>
</ref>
<ref id="b190-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leblond</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Heinrich</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Delorme</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Proepper</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Betancur</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Huguet</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Konyukh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chaste</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ey</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rastam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Anckars?ter</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nygren</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>IC</given-names>
</name>
<name>
<surname>Melke</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Toro</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Regnault</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fauchereau</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mercati</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Lemi?re</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Skuse</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Poot</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Holt</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Monaco</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Järvelä</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kantojärvi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Vanhala</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Curran</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Collier</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Bolton</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chiocchetti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Klauck</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Poustka</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Freitag</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Waltes</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kopp</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Duketis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bacchelli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Minopoli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ruta</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Battaglia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mazzone</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Maestrini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sequeira</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Vicente</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Zelenika</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Delepine</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lathrop</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bonneau</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Guinchat</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Devillard</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Assouline</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Mouren</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Leboyer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Boeckers</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Bourgeron</surname>
<given-names>T</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders</article-title>
<source/>PLoS Genet
          <volume>8</volume>
<fpage>e1002521</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1002521</pub-id>
<!--<pub-id pub-id-type="pmcid">3276563</pub-id>-->
<pub-id pub-id-type="pmid">22346768</pub-id>
</element-citation>
</ref>
<ref id="b191-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>McGrath</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Advancing parental age and autism: multifactorial pathways</article-title>
<source/>Trends Mol Med
          <volume>21</volume>
<fpage>118</fpage>
<lpage>125</lpage>
<pub-id pub-id-type="doi">10.1016/j.molmed.2014.11.005</pub-id>
<pub-id pub-id-type="pmid">25662027</pub-id>
</element-citation>
</ref>
<ref id="b192-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Caldwell</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Macbeth</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>WS</given-names>
<suffix>3rd</suffix>
</name>
</person-group>
<year>2008</year>
<article-title>Behavioural studies using temporal and spatial inactivation of the oxytocin receptor</article-title>
<source/>Prog Brain Res
          <volume>170</volume>
<fpage>73</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1016/S0079-6123(08)00407-X</pub-id>
<pub-id pub-id-type="pmid">18655873</pub-id>
</element-citation>
</ref>
<ref id="b193-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leyfer</surname>
<given-names>OT</given-names>
</name>
<name>
<surname>Folstein</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Bacalman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>NO</given-names>
</name>
<name>
<surname>Dinh</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tager-Flusberg</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lainhart</surname>
<given-names>JE</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Comorbid psychiatric disorders in children with autism: Interview development and rates of disorders</article-title>
<source/>J Autism Dev Disord
          <volume>36</volume>
<fpage>849</fpage>
<lpage>861</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-006-0123-0</pub-id>
<pub-id pub-id-type="pmid">16845581</pub-id>
</element-citation>
</ref>
<ref id="b194-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xun</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mo</surname>
<given-names>X</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Association analysis of CNTNAP2 polymorphisms with autism in the Chinese Han population</article-title>
<source/>Psychiatr Genet
          <volume>20</volume>
<fpage>113</fpage>
<lpage>117</lpage>
<pub-id pub-id-type="pmid">20414140</pub-id>
</element-citation>
</ref>
<ref id="b195-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Solution structure of GOPC PDZ domain and its interaction with the C-terminal motif of neuroligin</article-title>
<source/>Protein Sci
          <volume>15</volume>
<fpage>2149</fpage>
<lpage>2158</lpage>
<pub-id pub-id-type="doi">10.1110/ps.062087506</pub-id>
<!--<pub-id pub-id-type="pmcid">2242614</pub-id>-->
<pub-id pub-id-type="pmid">16882988</pub-id>
</element-citation>
</ref>
<ref id="b196-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Pesold</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Carboni</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Auta</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lacor</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Larson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Condie</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Guidotti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>E</given-names>
</name>
</person-group>
<year>2001</year>
<article-title>Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>98</volume>
<fpage>3477</fpage>
<lpage>3482</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.051614698</pub-id>
<!--<pub-id pub-id-type="pmcid">30678</pub-id>-->
<pub-id pub-id-type="pmid">11248103</pub-id>
</element-citation>
</ref>
<ref id="b197-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Kawamura</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shimada</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Otowa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Koishi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sugiyama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nishida</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Nakagami</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tochigi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Umekage</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kano</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Miyagawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tokunaga</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>T</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Association of the oxytocin receptor (OXTR) gene polymorphisms with autism spectrum disorder (ASD) in the Japanese population</article-title>
<source/>J Hum Genet
          <volume>55</volume>
<fpage>137</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="doi">10.1038/jhg.2009.140</pub-id>
<pub-id pub-id-type="pmid">20094064</pub-id>
</element-citation>
</ref>
<ref id="b198-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>ZH</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>CB</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Dissociation of social and nonsocial anxiety in a mouse model of fragile X syndrome</article-title>
<source/>Neurosci Lett
          <volume>454</volume>
<fpage>62</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2009.02.066</pub-id>
<!--<pub-id pub-id-type="pmcid">3092374</pub-id>-->
<pub-id pub-id-type="pmid">19429055</pub-id>
</element-citation>
</ref>
<ref id="b199-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>LoParo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Waldman</surname>
<given-names>ID</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: a meta-analysis</article-title>
<source/>Mol. Psychiatry
          <volume>20</volume>
<fpage>640</fpage>
<lpage>646</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2014.77</pub-id>
<pub-id pub-id-type="pmid">25092245</pub-id>
</element-citation>
</ref>
<ref id="b200-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lozovaya</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gataullina</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tsintsadze</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tsintsadze</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Pallesi-Pocachard</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Minlebaev</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Goriounova</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Buhler</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Watrin</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Shityakov</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Bordey</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Milh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Scavarda</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bulteau</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dorfmuller</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Delalande</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Represa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cardoso</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dulac</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Ben-Ari</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Burnashev</surname>
<given-names>N</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model</article-title>
<source/>Nat Commun
          <volume>5</volume>
<fpage>4563</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms5563</pub-id>
<!--<pub-id pub-id-type="pmcid">4143949</pub-id>-->
<pub-id pub-id-type="pmid">25081057</pub-id>
</element-citation>
</ref>
<ref id="b201-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luikart</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Schnell</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Washburn</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Bensen</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Tovar</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Westbrook</surname>
<given-names>GL</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Pten knockdown in vivo increases excitatory drive onto dentate granule cells</article-title>
<source/>J Neurosci
          <volume>31</volume>
<fpage>4345</fpage>
<lpage>4354</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0061-11.2011</pub-id>
<!--<pub-id pub-id-type="pmcid">3113533</pub-id>-->
<pub-id pub-id-type="pmid">21411674</pub-id>
</element-citation>
</ref>
<ref id="b202-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lush</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Parada</surname>
<given-names>LF</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Neurofibromin is required for barrel formation in the mouse somatosensory cortex</article-title>
<source/>J Neurosci
          <volume>28</volume>
<fpage>1580</fpage>
<lpage>1587</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5236-07.2008</pub-id>
<!--<pub-id pub-id-type="pmcid">2760344</pub-id>-->
<pub-id pub-id-type="pmid">18272679</pub-id>
</element-citation>
</ref>
<ref id="b203-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maccarrone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bari</surname>
<given-names>M</given-names>
</name>
<name>
<surname>De Chiara</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Rapino</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Musella</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bernardi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bagni</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Centonze</surname>
<given-names>D</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA</article-title>
<source/>Neuropsychopharmacology
          <volume>35</volume>
<fpage>1500</fpage>
<lpage>1509</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2010.19</pub-id>
<!--<pub-id pub-id-type="pmcid">3055456</pub-id>-->
<pub-id pub-id-type="pmid">20393458</pub-id>
</element-citation>
</ref>
<ref id="b204-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacQueen</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Ramakrishnan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Croll</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Siuciak</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>LT</given-names>
</name>
<name>
<surname>Fahnestock</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2001</year>
<article-title>Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression</article-title>
<source/>Behav Neurosci
          <volume>115</volume>
<fpage>1145</fpage>
<lpage>1153</lpage>
<pub-id pub-id-type="doi">10.1037/0735-7044.115.5.1145</pub-id>
<pub-id pub-id-type="pmid">11584927</pub-id>
</element-citation>
</ref>
<ref id="b205-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maezawa</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>LW</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate</article-title>
<source/>J Neurosci
          <volume>30</volume>
<fpage>5346</fpage>
<lpage>5356</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5966-09.2010</pub-id>
<pub-id pub-id-type="pmid">20392956</pub-id>
</element-citation>
</ref>
<ref id="b206-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manning</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Cassidy</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Clericuzio</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cherry</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hudgins</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Enns</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Hoyme</surname>
<given-names>HE</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum</article-title>
<source/>Pediatrics
          <volume>114</volume>
<fpage>451</fpage>
<lpage>457</lpage>
<pub-id pub-id-type="doi">10.1542/peds.114.2.451</pub-id>
<pub-id pub-id-type="pmid">15286229</pub-id>
</element-citation>
</ref>
<ref id="b207-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marrone</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Marinelli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Biamonte</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sgobio</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Ammassari-Teule</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bernardi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mercuri</surname>
<given-names>NB</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Altered cortico-striatal synaptic plasticity and related behavioural impairments in reeler mice</article-title>
<source/>Eur J Neurosci
          <volume>24</volume>
<fpage>2061</fpage>
<lpage>2070</lpage>
<pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.05083.x</pub-id>
<pub-id pub-id-type="pmid">17067303</pub-id>
</element-citation>
</ref>
<ref id="b208-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Manzoni</surname>
<given-names>OJ</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Late onset deficits in synaptic plasticity in the valproic acid rat model of autism</article-title>
<source/>Front Cell Neurosci
          <volume>8</volume>
<fpage>23</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2014.00023</pub-id>
<!--<pub-id pub-id-type="pmcid">3907704</pub-id>-->
<pub-id pub-id-type="pmid">24550781</pub-id>
</element-citation>
</ref>
<ref id="b209-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Escher</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Goldowitz</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mittleman</surname>
<given-names>G</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>A relationship between cerebellar Purkinje cells and spatial working memory demonstrated in a lurcher/chimera mouse model system</article-title>
<source/>Genes Brain Behav
          <volume>3</volume>
<fpage>158</fpage>
<lpage>166</lpage>
<pub-id pub-id-type="doi">10.1111/j.1601-183x.2004.00067.x</pub-id>
<pub-id pub-id-type="pmid">15140011</pub-id>
</element-citation>
</ref>
<ref id="b210-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Goldowitz</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mittleman</surname>
<given-names>G</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Repetitive behavior and increased activity in mice with Purkinje cell loss: a model for understanding the role of cerebellar pathology in autism</article-title>
<source/>Eur J Neurosci
          <volume>31</volume>
<fpage>544</fpage>
<lpage>555</lpage>
<pub-id pub-id-type="doi">10.1111/j.1460-9568.2009.07073.x</pub-id>
<!--<pub-id pub-id-type="pmcid">2846709</pub-id>-->
<pub-id pub-id-type="pmid">20105240</pub-id>
</element-citation>
</ref>
<ref id="b211-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>MR</given-names>
</name>
</person-group>
<year>1981</year>
<article-title>Morphology of the cochlear nucleus of the normal and reeler mutant mouse</article-title>
<source/>J Comp Neurol
          <volume>197</volume>
<fpage>141</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="doi">10.1002/cne.901970111</pub-id>
<pub-id pub-id-type="pmid">6164700</pub-id>
</element-citation>
</ref>
<ref id="b212-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martins</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Robson</surname>
<given-names>DC</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Feeding and eating behaviors in children with autism and typically developing children</article-title>
<source/>J Autism Dev Disord
          <volume>38</volume>
<fpage>1878</fpage>
<lpage>1887</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-008-0583-5</pub-id>
<pub-id pub-id-type="pmid">18483843</pub-id>
</element-citation>
</ref>
<ref id="b213-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marui</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Nanba</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tochigi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Umekage</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ishijima</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kohda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>T</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>Association between the neurofibromatosis-1 (NF1) locus and autism in the Japanese population</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet
          <volume>131B</volume>
<fpage>43</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.20119</pub-id>
<pub-id pub-id-type="pmid">15389774</pub-id>
</element-citation>
</ref>
<ref id="b214-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mazina</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Gerdts</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Trinh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ankenman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Dennis</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Bernier</surname>
<given-names>R</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Epigenetics of autism-related impairment: copy number variation and maternal infection</article-title>
<source/>J Dev Behav Pediatr
          <volume>36</volume>
<fpage>61</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="doi">10.1097/DBP.0000000000000126</pub-id>
<!--<pub-id pub-id-type="pmcid">4318761</pub-id>-->
<pub-id pub-id-type="pmid">25629966</pub-id>
</element-citation>
</ref>
<ref id="b215-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mbarek</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Marouillat</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Martineau</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Barthelemy</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Muh</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Andres</surname>
<given-names>C</given-names>
</name>
</person-group>
<year>1999</year>
<article-title>Association study of the NF1 gene and autistic disorder</article-title>
<source/>Am J Med Genet
          <volume>88</volume>
<fpage>729</fpage>
<lpage>732</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19991215)88:6&lt;729::AID-AJMG26&gt;3.0.CO;2-Q</pub-id>
<pub-id pub-id-type="pmid">10581497</pub-id>
</element-citation>
</ref>
<ref id="b216-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McFarlane</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Kusek</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Phoenix</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Bolivar</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Crawley</surname>
<given-names>JN</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Autism-like behavioral phenotypes in BTBR T+tf/J mice</article-title>
<source/>Genes Brain Behav
          <volume>7</volume>
<fpage>152</fpage>
<lpage>163</lpage>
<pub-id pub-id-type="doi">10.1111/j.1601-183X.2007.00330.x</pub-id>
<pub-id pub-id-type="pmid">17559418</pub-id>
</element-citation>
</ref>
<ref id="b217-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McNaughton</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Strawderman</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Maclean</surname>
<given-names>KN</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Strupp</surname>
<given-names>BJ</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome</article-title>
<source/>Behav Neurosci
          <volume>122</volume>
<fpage>293</fpage>
<lpage>300</lpage>
<pub-id pub-id-type="doi">10.1037/0735-7044.122.2.293</pub-id>
<pub-id pub-id-type="pmid">18410169</pub-id>
</element-citation>
</ref>
<ref id="b218-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meikle</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Talos</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Onda</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pollizzi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rotenberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sahin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>FE</given-names>
</name>
<name>
<surname>Kwiatkowski</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival</article-title>
<source/>J Neurosci
          <volume>27</volume>
<fpage>5546</fpage>
<lpage>5558</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5540-06.2007</pub-id>
<pub-id pub-id-type="pmid">17522300</pub-id>
</element-citation>
</ref>
<ref id="b219-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meyer</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Feldon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dammann</surname>
<given-names>O</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?</article-title>
<source/>Pediatr Res
          <volume>69</volume>
<fpage>26R</fpage>
<lpage>33R</lpage>
<pub-id pub-id-type="doi">10.1203/PDR.0b013e318212c196</pub-id>
<!--<pub-id pub-id-type="pmcid">3086802</pub-id>-->
<pub-id pub-id-type="pmid">21289540</pub-id>
</element-citation>
</ref>
<ref id="b220-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meziane</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Schaller</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Villard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Matarazzo</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Riet</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Guillon</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lafitte</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Desarmenien</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Tauber</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Muscatelli</surname>
<given-names>F</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>An Early Postnatal Oxytocin Treatment Prevents Social and Learning Deficits in Adult Mice Deficient for Magel2, a Gene Involved in Prader-Willi Syndrome and Autism</article-title>
<source/>Biol. Psychiatry
          <volume>78</volume>
<fpage>85</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2014.11.010</pub-id>
<pub-id pub-id-type="pmid">25599930</pub-id>
</element-citation>
</ref>
<ref id="b221-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mineur</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Huynh</surname>
<given-names>LX</given-names>
</name>
<name>
<surname>Crusio</surname>
<given-names>WE</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Social behavior deficits in the Fmr1 mutant mouse</article-title>
<source/>Behav Brain Res
          <volume>168</volume>
<fpage>172</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2005.11.004</pub-id>
<pub-id pub-id-type="pmid">16343653</pub-id>
</element-citation>
</ref>
<ref id="b222-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kishino</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Webber</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dikkes</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Wagstaff</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>2002</year>
<article-title>Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice</article-title>
<source/>Neurobiol Dis
          <volume>9</volume>
<fpage>149</fpage>
<lpage>159</lpage>
<pub-id pub-id-type="doi">10.1006/nbdi.2001.0463</pub-id>
<pub-id pub-id-type="pmid">11895368</pub-id>
</element-citation>
</ref>
<ref id="b223-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monteggia</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Luikart</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Barrot</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Theobold</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Malkovska</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Nef</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Parada</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Nestler</surname>
<given-names>EJ</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors</article-title>
<source/>Biol. Psychiatry
          <volume>61</volume>
<fpage>187</fpage>
<lpage>197</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2006.03.021</pub-id>
<pub-id pub-id-type="pmid">16697351</pub-id>
</element-citation>
</ref>
<ref id="b224-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moore</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Turnpenny</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Quinn</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Glover</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lloyd</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Montgomery</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>JC</given-names>
</name>
</person-group>
<year>2000</year>
<article-title>A clinical study of 57 children with fetal anticonvulsant syndromes</article-title>
<source/>J Med Genet
          <volume>37</volume>
<fpage>489</fpage>
<lpage>497</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.37.7.489</pub-id>
<!--<pub-id pub-id-type="pmcid">1734633</pub-id>-->
<pub-id pub-id-type="pmid">10882750</pub-id>
</element-citation>
</ref>
<ref id="b225-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moretti</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Levenson</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Battaglia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Atkinson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Teague</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Antalffy</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Armstrong</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Arancio</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Sweatt</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome</article-title>
<source/>J Neurosci
          <volume>26</volume>
<fpage>319</fpage>
<lpage>327</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2623-05.2006</pub-id>
<pub-id pub-id-type="pmid">16399702</pub-id>
</element-citation>
</ref>
<ref id="b226-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moy</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Nadler</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>NB</given-names>
</name>
<name>
<surname>Nonneman</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Grossman</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>D’Ercole</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Crawley</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Magnuson</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Lauder</surname>
<given-names>JM</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Social approach in genetically engineered mouse lines relevant to autism</article-title>
<source/>Genes Brain Behav
          <volume>8</volume>
<fpage>129</fpage>
<lpage>142</lpage>
<pub-id pub-id-type="doi">10.1111/j.1601-183X.2008.00452.x</pub-id>
<!--<pub-id pub-id-type="pmcid">2659808</pub-id>-->
<pub-id pub-id-type="pmid">19016890</pub-id>
</element-citation>
</ref>
<ref id="b227-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murer</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Raisman-Vozari</surname>
<given-names>R</given-names>
</name>
</person-group>
<year>2001</year>
<article-title>Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease</article-title>
<source/>Prog Neurobiol
          <volume>63</volume>
<fpage>71</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="doi">10.1016/S0301-0082(00)00014-9</pub-id>
<pub-id pub-id-type="pmid">11040419</pub-id>
</element-citation>
</ref>
<ref id="b228-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muroga</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Adachi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Konagaya</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Takayanagi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sobue</surname>
<given-names>I</given-names>
</name>
</person-group>
<year>1982</year>
<article-title>Effects of thyrotropin releasing hormone on cerebellar mutant mice--a kinesiological comparison between rolling mouse Nagoya, weaver and reeler</article-title>
<source/>Jpn J Med
          <volume>21</volume>
<fpage>101</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="doi">10.2169/internalmedicine1962.21.101</pub-id>
<pub-id pub-id-type="pmid">6811784</pub-id>
</element-citation>
</ref>
<ref id="b229-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sutcliffe</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Durtschi</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Mutirangura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ledbetter</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Beaudet</surname>
<given-names>AL</given-names>
</name>
</person-group>
<year>1994</year>
<article-title>Imprinting analysis of three genes in the Prader-Willi/Angelman region: SNRPN, E6-associated protein, and PAR-2 (D15S225E)</article-title>
<source/>Hum Mol Genet
          <volume>3</volume>
<fpage>309</fpage>
<lpage>315</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/3.2.309</pub-id>
<pub-id pub-id-type="pmid">8004100</pub-id>
</element-citation>
</ref>
<ref id="b230-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naviaux</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Zolkipli</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Nakayama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Naviaux</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Schuchbauer</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Rogac</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Dugan</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>SB</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Antipurinergic therapy corrects the autism-like features in the poly(IC) mouse model</article-title>
<source/>PLoS One
          <volume>8</volume>
<fpage>e57380</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0057380</pub-id>
<!--<pub-id pub-id-type="pmcid">3596371</pub-id>-->
<pub-id pub-id-type="pmid">23516405</pub-id>
</element-citation>
</ref>
<ref id="b231-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Need</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Weale</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Maia</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Heinzen</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Shianna</surname>
<given-names>KV</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Kasperaviciute</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gennarelli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Strittmatter</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Bonvicini</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jayathilake</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cola</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>McEvoy</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Keefe</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>St Jean</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Giegling</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hartmann</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Moller</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Ruppert</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Crombie</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Middleton</surname>
<given-names>LT</given-names>
</name>
<name>
<surname>St Clair</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Roses</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Muglia</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Francks</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rujescu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Meltzer</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>DB</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>A genome-wide investigation of SNPs and CNVs in schizophrenia</article-title>
<source/>PLoS Genet
          <volume>5</volume>
<fpage>e1000373</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1000373</pub-id>
<!--<pub-id pub-id-type="pmcid">2631150</pub-id>-->
<pub-id pub-id-type="pmid">19197363</pub-id>
</element-citation>
</ref>
<ref id="b232-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nosyreva</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>KM</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome</article-title>
<source/>J Neurophysiol
          <volume>95</volume>
<fpage>3291</fpage>
<lpage>3295</lpage>
<pub-id pub-id-type="doi">10.1152/jn.01316.2005</pub-id>
<pub-id pub-id-type="pmid">16452252</pub-id>
</element-citation>
</ref>
<ref id="b233-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Numis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Major</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Montenegro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Muzykewicz</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pulsifer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thiele</surname>
<given-names>E</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex</article-title>
<source/>Neurology
          <volume>76</volume>
<fpage>981</fpage>
<lpage>987</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0b013e3182104347</pub-id>
<!--<pub-id pub-id-type="pmcid">3271577</pub-id>-->
<pub-id pub-id-type="pmid">21403110</pub-id>
</element-citation>
</ref>
<ref id="b234-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nussbaum</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Payne</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>JZ</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Gelernter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>MD</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European- and African-American smokers</article-title>
<source/>Hum Mol Genet
          <volume>17</volume>
<fpage>1569</fpage>
<lpage>1577</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddn044</pub-id>
<!--<pub-id pub-id-type="pmcid">2902291</pub-id>-->
<pub-id pub-id-type="pmid">18270208</pub-id>
</element-citation>
</ref>
<ref id="b235-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oblak</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Gibbs</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Blatt</surname>
<given-names>GJ</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Reduced GABAA receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism</article-title>
<source/>Brain Res
          <volume>1380</volume>
<fpage>218</fpage>
<lpage>228</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2010.09.021</pub-id>
<!--<pub-id pub-id-type="pmcid">3020259</pub-id>-->
<pub-id pub-id-type="pmid">20858465</pub-id>
</element-citation>
</ref>
<ref id="b236-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Koovakkattu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Parada</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Sinton</surname>
<given-names>CM</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>A seizure-prone phenotype is associated with altered free-running rhythm in Pten mutant mice</article-title>
<source/>Brain Res
          <volume>1168</volume>
<fpage>112</fpage>
<lpage>123</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2007.06.074</pub-id>
<pub-id pub-id-type="pmid">17706614</pub-id>
</element-citation>
</ref>
<ref id="b237-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ognibene</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Adriani</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Macri</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Laviola</surname>
<given-names>G</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>Neurobehavioural disorders in the infant reeler mouse model: interaction of genetic vulnerability and consequences of maternal separation</article-title>
<source/>Behav Brain Res
          <volume>177</volume>
<fpage>142</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2006.10.027</pub-id>
<pub-id pub-id-type="pmid">17141885</pub-id>
</element-citation>
</ref>
<ref id="b238-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Onda</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Crino</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Murphey</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Rastelli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gould Rothberg</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Kwiatkowski</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<year>2002</year>
<article-title>Tsc2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway</article-title>
<source/>Mol Cell Neurosci
          <volume>21</volume>
<fpage>561</fpage>
<lpage>574</lpage>
<pub-id pub-id-type="doi">10.1006/mcne.2002.1184</pub-id>
<pub-id pub-id-type="pmid">12504590</pub-id>
</element-citation>
</ref>
<ref id="b239-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ornoy</surname>
<given-names>A</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Valproic acid in pregnancy: how much are we endangering the embryo and fetus?</article-title>
<source/>Reprod Toxicol
          <volume>28</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1016/j.reprotox.2009.02.014</pub-id>
<pub-id pub-id-type="pmid">19490988</pub-id>
</element-citation>
</ref>
<ref id="b240-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papaleo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Silverman</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Aney</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Barkan</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Chadman</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Crawley</surname>
<given-names>JN</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice</article-title>
<source/>Learn Mem
          <volume>18</volume>
<fpage>534</fpage>
<lpage>544</lpage>
<pub-id pub-id-type="doi">10.1101/lm.2213711</pub-id>
<!--<pub-id pub-id-type="pmcid">3256571</pub-id>-->
<pub-id pub-id-type="pmid">21791566</pub-id>
</element-citation>
</ref>
<ref id="b241-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pardo</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Eberhart</surname>
<given-names>CG</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>The neurobiology of autism</article-title>
<source/>Brain Pathol
          <volume>17</volume>
<fpage>434</fpage>
<lpage>447</lpage>
<pub-id pub-id-type="doi">10.1111/j.1750-3639.2007.00102.x</pub-id>
<pub-id pub-id-type="pmid">17919129</pub-id>
</element-citation>
</ref>
<ref id="b242-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parker</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Garner</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Libove</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Hyde</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Hornbeak</surname>
<given-names>KB</given-names>
</name>
<name>
<surname>Carson</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Hallmayer</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Hardan</surname>
<given-names>AY</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Plasma oxytocin concentrations and OXTR polymorphisms predict social impairments in children with and without autism spectrum disorder</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>111</volume>
<fpage>12258</fpage>
<lpage>12263</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1402236111</pub-id>
<!--<pub-id pub-id-type="pmcid">4143031</pub-id>-->
<pub-id pub-id-type="pmid">25092315</pub-id>
</element-citation>
</ref>
<ref id="b243-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patrylo</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Browning</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Cranick</surname>
<given-names>S</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Reeler homozygous mice exhibit enhanced susceptibility to epileptiform activity</article-title>
<source/>Epilepsia
          <volume>47</volume>
<fpage>257</fpage>
<lpage>266</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1167.2006.00417.x</pub-id>
<pub-id pub-id-type="pmid">16499749</pub-id>
</element-citation>
</ref>
<ref id="b244-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patterson</surname>
<given-names>PH</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Immune involvement in schizophrenia and autism: etiology, pathology and animal models</article-title>
<source/>Behav Brain Res
          <volume>204</volume>
<fpage>313</fpage>
<lpage>321</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2008.12.016</pub-id>
<pub-id pub-id-type="pmid">19136031</pub-id>
</element-citation>
</ref>
<ref id="b245-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patterson</surname>
<given-names>PH</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Maternal infection and immune involvement in autism</article-title>
<source/>Trends Mol Med
          <volume>17</volume>
<fpage>389</fpage>
<lpage>394</lpage>
<pub-id pub-id-type="doi">10.1016/j.molmed.2011.03.001</pub-id>
<!--<pub-id pub-id-type="pmcid">3135697</pub-id>-->
<pub-id pub-id-type="pmid">21482187</pub-id>
</element-citation>
</ref>
<ref id="b246-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peca</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Feliciano</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ting</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Venkatraman</surname>
<given-names>TN</given-names>
</name>
<name>
<surname>Lascola</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>G</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Shank3 mutant mice display autistic-like behaviours and striatal dysfunction</article-title>
<source/>Nature
          <volume>472</volume>
<fpage>437</fpage>
<lpage>442</lpage>
<pub-id pub-id-type="doi">10.1038/nature09965</pub-id>
<!--<pub-id pub-id-type="pmcid">3090611</pub-id>-->
<pub-id pub-id-type="pmid">21423165</pub-id>
</element-citation>
</ref>
<ref id="b247-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peñagarikano</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Abrahams</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Herman</surname>
<given-names>EI</given-names>
</name>
<name>
<surname>Winden</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Gdalyahu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sonnenblick</surname>
<given-names>LI</given-names>
</name>
<name>
<surname>Gruver</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Almajano</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bragin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Golshani</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Trachtenberg</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Peles</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Absence of CNTNAP2 Leads to Epilepsy, Neuronal Migration Abnormalities, and Core Autism-Related Deficits</article-title>
<source/>Cell
          <volume>147</volume>
<fpage>235</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2011.08.040</pub-id>
<!--<pub-id pub-id-type="pmcid">3390029</pub-id>-->
<pub-id pub-id-type="pmid">21962519</pub-id>
</element-citation>
</ref>
<ref id="b248-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peñagarikano</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Lazaro</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>XH</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Peles</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Maidment</surname>
<given-names>NT</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>XW</given-names>
</name>
<name>
<surname>Golshani</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism</article-title>
<source/>Sci Transl Med
          <volume>7</volume>
<fpage>271ra8</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3010257</pub-id>
<!--<pub-id pub-id-type="pmcid">4498455</pub-id>-->
<pub-id pub-id-type="pmid">25609168</pub-id>
</element-citation>
</ref>
<ref id="b249-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perry</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Martin-Ruiz</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Court</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Volsen</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Merrit</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Folly</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Iversen</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Bauman</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Perry</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Wenk</surname>
<given-names>GL</given-names>
</name>
</person-group>
<year>2001</year>
<article-title>Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain</article-title>
<source/>Am. J. Psychiatry
          <volume>158</volume>
<fpage>1058</fpage>
<lpage>1066</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.158.7.1058</pub-id>
<pub-id pub-id-type="pmid">11431227</pub-id>
</element-citation>
</ref>
<ref id="b250-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peters</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Beaudet</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Madduri</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bacino</surname>
<given-names>C</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>Autism in Angelman syndrome: implications for autism research</article-title>
<source/>Clin Genet
          <volume>66</volume>
<fpage>530</fpage>
<lpage>536</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0004.2004.00362.x</pub-id>
<pub-id pub-id-type="pmid">15521981</pub-id>
</element-citation>
</ref>
<ref id="b251-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pierce</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Courchesne</surname>
<given-names>E</given-names>
</name>
</person-group>
<year>2001</year>
<article-title>Evidence for a cerebellar role in reduced exploration and stereotyped behavior in autism</article-title>
<source/>Biol. Psychiatry
          <volume>49</volume>
<fpage>655</fpage>
<lpage>664</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-3223(00)01008-8</pub-id>
<pub-id pub-id-type="pmid">11313033</pub-id>
</element-citation>
</ref>
<ref id="b252-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pletnikov</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Moran</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Carbone</surname>
<given-names>KM</given-names>
</name>
</person-group>
<year>2002</year>
<article-title>Borna disease virus infection of the neonatal rat: developmental brain injury model of autism spectrum disorders</article-title>
<source/>Front Biosci
          <volume>7</volume>
<fpage>d593</fpage>
<lpage>d607</lpage>
<pub-id pub-id-type="doi">10.2741/pletnik</pub-id>
<pub-id pub-id-type="pmid">11861216</pub-id>
</element-citation>
</ref>
<ref id="b253-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pletnikov</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Vasudevan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Moran</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Carbone</surname>
<given-names>KM</given-names>
</name>
</person-group>
<year>1999</year>
<article-title>Developmental brain injury associated with abnormal play behavior in neonatally Borna disease virus-infected Lewis rats: a model of autism</article-title>
<source/>Behav Brain Res
          <volume>100</volume>
<fpage>43</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1016/S0166-4328(98)00111-9</pub-id>
<pub-id pub-id-type="pmid">10212052</pub-id>
</element-citation>
</ref>
<ref id="b254-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pobbe</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Pearson</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Defensor</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Bolivar</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>WS</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Lee</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Blanchard</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Blanchard</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Oxytocin receptor knockout mice display deficits in the expression of autism-related behaviors</article-title>
<source/>Horm Behav
          <volume>61</volume>
<fpage>436</fpage>
<lpage>444</lpage>
<pub-id pub-id-type="doi">10.1016/j.yhbeh.2011.10.010</pub-id>
<!--<pub-id pub-id-type="pmcid">3373312</pub-id>-->
<pub-id pub-id-type="pmid">22100185</pub-id>
</element-citation>
</ref>
<ref id="b255-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Podhorna</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Didriksen</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>The heterozygous reeler mouse: behavioural phenotype</article-title>
<source/>Behav Brain Res
          <volume>153</volume>
<fpage>43</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2003.10.033</pub-id>
<pub-id pub-id-type="pmid">15219705</pub-id>
</element-citation>
</ref>
<ref id="b256-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poliak</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gollan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Custer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Einheber</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Salzer</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Trimmer</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Shrager</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Peles</surname>
<given-names>E</given-names>
</name>
</person-group>
<year>1999</year>
<article-title>Caspr2, a New Member of the Neurexin Superfamily, Is Localized at the Juxtaparanodes of Myelinated Axons and Associates with K+ Channels</article-title>
<source/>Neuron
          <volume>24</volume>
<fpage>1037</fpage>
<lpage>1047</lpage>
<pub-id pub-id-type="doi">10.1016/S0896-6273(00)81049-1</pub-id>
<pub-id pub-id-type="pmid">10624965</pub-id>
</element-citation>
</ref>
<ref id="b257-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Popova</surname>
<given-names>NK</given-names>
</name>
<name>
<surname>Vishnivetskaya</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Ivanova</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Skrinskaya</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Seif</surname>
<given-names>I</given-names>
</name>
</person-group>
<year>2000</year>
<article-title>Altered behavior and alcohol tolerance in transgenic mice lacking MAO A: a comparison with effects of MAO A inhibitor clorgyline</article-title>
<source/>Pharmacol Biochem Behav
          <volume>67</volume>
<fpage>719</fpage>
<lpage>727</lpage>
<pub-id pub-id-type="doi">10.1016/S0091-3057(00)00417-2</pub-id>
<pub-id pub-id-type="pmid">11166062</pub-id>
</element-citation>
</ref>
<ref id="b258-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prasad</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Steiner</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Sutcliffe</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Blakely</surname>
<given-names>RD</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Enhanced activity of human serotonin transporter variants associated with autism</article-title>
<source/>Philos Trans R Soc Lond, B, Biol Sci
          <volume>364</volume>
<fpage>163</fpage>
<lpage>173</lpage>
<pub-id pub-id-type="doi">10.1098/rstb.2008.0143</pub-id>
<!--<pub-id pub-id-type="pmcid">2674096</pub-id>-->
<pub-id pub-id-type="pmid">18957375</pub-id>
</element-citation>
</ref>
<ref id="b259-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Radyushkin</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hammerschmidt</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Boretius</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Varoqueaux</surname>
<given-names>F</given-names>
</name>
<name>
<surname>El-Kordi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ronnenberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Winter</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Frahm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Brose</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ehrenreich</surname>
<given-names>H</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit</article-title>
<source/>Genes Brain Behav
          <volume>8</volume>
<fpage>416</fpage>
<lpage>425</lpage>
<pub-id pub-id-type="doi">10.1111/j.1601-183X.2009.00487.x</pub-id>
<pub-id pub-id-type="pmid">19243448</pub-id>
</element-citation>
</ref>
<ref id="b260-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rasmussen</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>JM</given-names>
</name>
</person-group>
<year>2000</year>
<article-title>NF1 gene and neurofibromatosis 1</article-title>
<source/>Am J Epidemiol
          <volume>151</volume>
<fpage>33</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a010118</pub-id>
<pub-id pub-id-type="pmid">10625171</pub-id>
</element-citation>
</ref>
<ref id="b261-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reith</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Way</surname>
<given-names>S</given-names>
</name>
<name>
<surname>McKenna</surname>
<given-names>J</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Haines</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gambello</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Loss of the tuberous sclerosis complex protein tuberin causes Purkinje cell degeneration</article-title>
<source/>Neurobiol Dis
          <volume>43</volume>
<fpage>113</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2011.02.014</pub-id>
<!--<pub-id pub-id-type="pmcid">3096682</pub-id>-->
<pub-id pub-id-type="pmid">21419848</pub-id>
</element-citation>
</ref>
<ref id="b262-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rett</surname>
<given-names>A</given-names>
</name>
</person-group>
<year>1966</year>
<article-title>[On a unusual brain atrophy syndrome in hyperammonemia in childhood]</article-title>
<source/>Wien Med Wochenschr
          <volume>116</volume>
<fpage>723</fpage>
<lpage>726</lpage>
<pub-id pub-id-type="pmid">5300597</pub-id>
</element-citation>
</ref>
<ref id="b263-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richt</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Pfeuffer</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Christ</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Frese</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bechter</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Herzog</surname>
<given-names>S</given-names>
</name>
</person-group>
<year>1997</year>
<article-title>Borna disease virus infection in animals and humans</article-title>
<source/>Emerging Infect Dis
          <volume>3</volume>
<fpage>343</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="doi">10.3201/eid0303.970311</pub-id>
<!--<pub-id pub-id-type="pmcid">2627631</pub-id>-->
<pub-id pub-id-type="pmid">9284379</pub-id>
</element-citation>
</ref>
<ref id="b264-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rinaldi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kulangara</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Antoniello</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Markram</surname>
<given-names>H</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>104</volume>
<fpage>13501</fpage>
<lpage>13506</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0704391104</pub-id>
<!--<pub-id pub-id-type="pmcid">1948920</pub-id>-->
<pub-id pub-id-type="pmid">17675408</pub-id>
</element-citation>
</ref>
<ref id="b265-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rinaldi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Perrodin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Markram</surname>
<given-names>H</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic Acid animal model of autism</article-title>
<source/>Front. Neural Circuits
          <volume>2</volume>
<fpage>4</fpage>
<pub-id pub-id-type="doi">10.3389/neuro.04.004.2008</pub-id>
<!--<pub-id pub-id-type="pmcid">2580056</pub-id>-->
<pub-id pub-id-type="pmid">18989389</pub-id>
</element-citation>
</ref>
<ref id="b266-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rios</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lambe</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Teillon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Akbarian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Roffler-Tarlov</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jaenisch</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Aghajanian</surname>
<given-names>GK</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Severe deficits in 5-HT2A -mediated neurotransmission in BDNF conditional mutant mice</article-title>
<source/>J Neurobiol
          <volume>66</volume>
<fpage>408</fpage>
<lpage>420</lpage>
<pub-id pub-id-type="doi">10.1002/neu.20233</pub-id>
<pub-id pub-id-type="pmid">16408297</pub-id>
</element-citation>
</ref>
<ref id="b267-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rogers</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Rusiana</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Trotter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Donaldson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pak</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Babus</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Banko</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Chavis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rebeck</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Hoe</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Weeber</surname>
<given-names>EJ</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Reelin supplementation enhances cognitive ability, synaptic plasticity, and dendritic spine density</article-title>
<source/>Learn Mem
          <volume>18</volume>
<fpage>558</fpage>
<lpage>564</lpage>
<pub-id pub-id-type="doi">10.1101/lm.2153511</pub-id>
<!--<pub-id pub-id-type="pmcid">3166788</pub-id>-->
<pub-id pub-id-type="pmid">21852430</pub-id>
</element-citation>
</ref>
<ref id="b268-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rogers</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Hepburn</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wehner</surname>
<given-names>E</given-names>
</name>
</person-group>
<year>2003</year>
<article-title>Parent reports of sensory symptoms in toddlers with autism and those with other developmental disorders</article-title>
<source/>J Autism Dev Disord
          <volume>33</volume>
<fpage>631</fpage>
<lpage>642</lpage>
<pub-id pub-id-type="doi">10.1023/B:JADD.0000006000.38991.a7</pub-id>
<pub-id pub-id-type="pmid">14714932</pub-id>
</element-citation>
</ref>
<ref id="b269-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romero</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Molina-Holgado</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Castellano</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Guaza</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Borrell</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>Neurobehavioral and immunological consequences of prenatal immune activation in rats. Influence of antipsychotics</article-title>
<source/>Neuropsychopharmacology
          <volume>32</volume>
<fpage>1791</fpage>
<lpage>1804</lpage>
<pub-id pub-id-type="doi">10.1038/sj.npp.1301292</pub-id>
<pub-id pub-id-type="pmid">17180123</pub-id>
</element-citation>
</ref>
<ref id="b270-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rout</surname>
<given-names>UK</given-names>
</name>
<name>
<surname>Dhossche</surname>
<given-names>DM</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>A pathogenetic model of autism involving Purkinje cell loss through anti-GAD antibodies</article-title>
<source/>Med. Hypotheses
          <volume>71</volume>
<fpage>218</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1016/j.mehy.2007.11.012</pub-id>
<pub-id pub-id-type="pmid">18514431</pub-id>
</element-citation>
</ref>
<ref id="b271-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rutter</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Caspi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Moffitt</surname>
<given-names>TE</given-names>
</name>
</person-group>
<year>2003</year>
<article-title>Using sex differences in psychopathology to study causal mechanisms: unifying issues and research strategies</article-title>
<source/>J. Child Psychol. Psychiatry
          <volume>44</volume>
<fpage>1092</fpage>
<lpage>1115</lpage>
<pub-id pub-id-type="doi">10.1111/1469-7610.00194</pub-id>
<pub-id pub-id-type="pmid">14626453</pub-id>
</element-citation>
</ref>
<ref id="b272-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sala</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Braida</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lentini</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Busnelli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bulgheroni</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Capurro</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Finardi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Donzelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pattini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rubino</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Parolaro</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nishimori</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Parenti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chini</surname>
<given-names>B</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism</article-title>
<source/>Biol. Psychiatry
          <volume>69</volume>
<fpage>875</fpage>
<lpage>882</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2010.12.022</pub-id>
<pub-id pub-id-type="pmid">21306704</pub-id>
</element-citation>
</ref>
<ref id="b273-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salinger</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Ladrow</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wheeler</surname>
<given-names>C</given-names>
</name>
</person-group>
<year>2003</year>
<article-title>Behavioral phenotype of the reeler mutant mouse: effects of RELN gene dosage and social isolation</article-title>
<source/>Behav Neurosci
          <volume>117</volume>
<fpage>1257</fpage>
<lpage>1275</lpage>
<pub-id pub-id-type="doi">10.1037/0735-7044.117.6.1257</pub-id>
<pub-id pub-id-type="pmid">14674845</pub-id>
</element-citation>
</ref>
<ref id="b274-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samaco</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Hogart</surname>
<given-names>A</given-names>
</name>
<name>
<surname>LaSalle</surname>
<given-names>JM</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3</article-title>
<source/>Hum Mol Genet
          <volume>14</volume>
<fpage>483</fpage>
<lpage>492</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddi045</pub-id>
<!--<pub-id pub-id-type="pmcid">1224722</pub-id>-->
<pub-id pub-id-type="pmid">15615769</pub-id>
</element-citation>
</ref>
<ref id="b275-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sampath</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bhat</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>O’Connor</surname>
<given-names>A</given-names>
</name>
<name>
<surname>West</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Arking</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Chakravarti</surname>
<given-names>A</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Defining the Contribution of CNTNAP2 to Autism Susceptibility</article-title>
<source/>PLoS One
          <volume>8</volume>
<fpage>e77906</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0077906</pub-id>
<!--<pub-id pub-id-type="pmcid">3798378</pub-id>-->
<pub-id pub-id-type="pmid">24147096</pub-id>
</element-citation>
</ref>
<ref id="b276-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Huynh</surname>
<given-names>TN</given-names>
</name>
<name>
<surname>MacAskill</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Pierre</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ruggero</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kaphzan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Klann</surname>
<given-names>E</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Exaggerated translation causes synaptic and behavioural aberrations associated with autism</article-title>
<source/>Nature
          <volume>493</volume>
<fpage>411</fpage>
<lpage>415</lpage>
<pub-id pub-id-type="doi">10.1038/nature11782</pub-id>
<!--<pub-id pub-id-type="pmcid">3548017</pub-id>-->
<pub-id pub-id-type="pmid">23263185</pub-id>
</element-citation>
</ref>
<ref id="b277-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sato</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lionel</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Leblond</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>S</given-names>
</name>
<name>
<surname>O’Connor</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Drmic</surname>
<given-names>IE</given-names>
</name>
<name>
<surname>Hamdan</surname>
<given-names>FF</given-names>
</name>
<name>
<surname>Michaud</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Endris</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Roeth</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Delorme</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Huguet</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Leboyer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rastam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lathrop</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stavropoulos</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Anagnostou</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Weksberg</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fombonne</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zwaigenbaum</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Rappold</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Bourgeron</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Szatmari</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>SHANK1 Deletions in Males with Autism Spectrum Disorder</article-title>
<source/>Am J Hum Genet
          <volume>90</volume>
<fpage>879</fpage>
<lpage>887</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2012.03.017</pub-id>
<!--<pub-id pub-id-type="pmcid">3376495</pub-id>-->
<pub-id pub-id-type="pmid">22503632</pub-id>
</element-citation>
</ref>
<ref id="b278-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Savaskan</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ehrhardt</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schulz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schachinger</surname>
<given-names>H</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Post-learning intranasal oxytocin modulates human memory for facial identity</article-title>
<source/>Psychoneuroendocrinology
          <volume>33</volume>
<fpage>368</fpage>
<lpage>374</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2007.12.004</pub-id>
<pub-id pub-id-type="pmid">18221838</pub-id>
</element-citation>
</ref>
<ref id="b279-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scattoni</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>McFarlane</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Zhodzishsky</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Caldwell</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Ricceri</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Crawley</surname>
<given-names>JN</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Reduced ultrasonic vocalizations in vasopressin 1b knockout mice</article-title>
<source/>Behav Brain Res
          <volume>187</volume>
<fpage>371</fpage>
<lpage>378</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2007.09.034</pub-id>
<pub-id pub-id-type="pmid">18005969</pub-id>
</element-citation>
</ref>
<ref id="b280-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaaf</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Gonzalez-Garay</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Potocki</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gripp</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>McElwain</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Drmanac</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Beaudet</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Caskey</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Truncating mutations of MAGEL2 cause Prader-Willi phenotypes and autism</article-title>
<source/>Nat Genet
          <volume>45</volume>
<fpage>1405</fpage>
<lpage>1408</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2776</pub-id>
<!--<pub-id pub-id-type="pmcid">3819162</pub-id>-->
<pub-id pub-id-type="pmid">24076603</pub-id>
</element-citation>
</ref>
<ref id="b281-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaller</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Watrin</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sturny</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Massacrier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Szepetowski</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Muscatelli</surname>
<given-names>F</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene</article-title>
<source/>Hum Mol Genet
          <volume>19</volume>
<fpage>4895</fpage>
<lpage>4905</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddq424</pub-id>
<pub-id pub-id-type="pmid">20876615</pub-id>
</element-citation>
</ref>
<ref id="b282-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmale</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Borowiak</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Holtgreve-Grez</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>D</given-names>
</name>
</person-group>
<year>1989</year>
<article-title>Impact of altered protein structures on the intracellular traffic of a mutated vasopressin precursor from Brattleboro rats</article-title>
<source/>Eur J Biochem
          <volume>182</volume>
<fpage>621</fpage>
<lpage>627</lpage>
<pub-id pub-id-type="doi">10.1111/j.1432-1033.1989.tb14871.x</pub-id>
<pub-id pub-id-type="pmid">2502393</pub-id>
</element-citation>
</ref>
<ref id="b283-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmeisser</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Ey</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wegener</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bockmann</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stempel</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Kuebler</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Janssen</surname>
<given-names>A.-L</given-names>
</name>
<name>
<surname>Udvardi</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Shiban</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Spilker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Balschun</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Skryabin</surname>
<given-names>BV</given-names>
</name>
<name>
<surname>Dieck</surname>
<given-names>S. t</given-names>
</name>
<name>
<surname>Smalla</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Montag</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Leblond</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Faure</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Torquet</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Le Sourd</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Toro</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Grabrucker</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Shoichet</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Schmitz</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kreutz</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Bourgeron</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gundelfinger</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Boeckers</surname>
<given-names>TM</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2</article-title>
<source/>Nature
          <volume>486</volume>
<fpage>256</fpage>
<lpage>260</lpage>
<pub-id pub-id-type="pmid">22699619</pub-id>
</element-citation>
</ref>
<ref id="b284-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schneider</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Deficient social and play behavior in juvenile and adult rats after neonatal cortical lesion: effects of chronic pubertal cannabinoid treatment</article-title>
<source/>Neuropsychopharmacology
          <volume>30</volume>
<fpage>944</fpage>
<lpage>957</lpage>
<pub-id pub-id-type="doi">10.1038/sj.npp.1300634</pub-id>
<pub-id pub-id-type="pmid">15592349</pub-id>
</element-citation>
</ref>
<ref id="b285-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schneider</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Roman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Basta-Kaim</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kubera</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Budziszewska</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Przewlocki</surname>
<given-names>R</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid</article-title>
<source/>Psychoneuroendocrinology
          <volume>33</volume>
<fpage>728</fpage>
<lpage>740</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2008.02.011</pub-id>
<pub-id pub-id-type="pmid">18396377</pub-id>
</element-citation>
</ref>
<ref id="b286-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schreck</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Mulick</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>AF</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>Sleep problems as possible predictors of intensified symptoms of autism</article-title>
<source/>Res Dev Disabil
          <volume>25</volume>
<fpage>57</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1016/j.ridd.2003.04.007</pub-id>
<pub-id pub-id-type="pmid">14733976</pub-id>
</element-citation>
</ref>
<ref id="b287-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schumann</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Hamstra</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Goodlin-Jones</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Lotspeich</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Buonocore</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Lammers</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Reiss</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Amaral</surname>
<given-names>DG</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages</article-title>
<source/>J Neurosci
          <volume>24</volume>
<fpage>6392</fpage>
<lpage>6401</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1297-04.2004</pub-id>
<pub-id pub-id-type="pmid">15254095</pub-id>
</element-citation>
</ref>
<ref id="b288-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scott-Van Zeeland</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Abrahams</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Alvarez-Retuerto</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Sonnenblick</surname>
<given-names>LI</given-names>
</name>
<name>
<surname>Rudie</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Ghahremani</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mumford</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Poldrack</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Dapretto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Bookheimer</surname>
<given-names>SY</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2</article-title>
<source/>Sci Transl Med
          <volume>2</volume>
<fpage>56ra80</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3001344</pub-id>
<!--<pub-id pub-id-type="pmcid">3065863</pub-id>-->
<pub-id pub-id-type="pmid">21048216</pub-id>
</element-citation>
</ref>
<ref id="b289-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shinohe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tsujii</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Iwata</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tsuchiya</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Sekine</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Suda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sugihara</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Matsuzaki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Minabe</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sugiyama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kawai</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Iyo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Takei</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>N</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Increased serum levels of glutamate in adult patients with autism</article-title>
<source/>Prog. Neuropsychopharmacol. Biol. Psychiatry
          <volume>30</volume>
<fpage>1472</fpage>
<lpage>1477</lpage>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2006.06.013</pub-id>
<pub-id pub-id-type="pmid">16863675</pub-id>
</element-citation>
</ref>
<ref id="b290-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Ehninger</surname>
<given-names>D</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Adult reversal of cognitive phenotypes in neurodevelopmental disorders</article-title>
<source/>J Neurodev Disord
          <volume>1</volume>
<fpage>150</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="doi">10.1007/s11689-009-9018-7</pub-id>
<!--<pub-id pub-id-type="pmcid">2755132</pub-id>-->
<pub-id pub-id-type="pmid">19812701</pub-id>
</element-citation>
</ref>
<ref id="b291-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Frankland</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Marowitz</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Laszlo</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Cioffi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jacks</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bourtchuladze</surname>
<given-names>R</given-names>
</name>
</person-group>
<year>1997</year>
<article-title>A mouse model for the learning and memory deficits associated with neurofibromatosis type I</article-title>
<source/>Nat Genet
          <volume>15</volume>
<fpage>281</fpage>
<lpage>284</lpage>
<pub-id pub-id-type="doi">10.1038/ng0397-281</pub-id>
<pub-id pub-id-type="pmid">9054942</pub-id>
</element-citation>
</ref>
<ref id="b292-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silverman</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Tolu</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Barkan</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Crawley</surname>
<given-names>JN</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP</article-title>
<source/>Neuropsychopharmacology
          <volume>35</volume>
<fpage>976</fpage>
<lpage>989</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2009.201</pub-id>
<!--<pub-id pub-id-type="pmcid">2827881</pub-id>-->
<pub-id pub-id-type="pmid">20032969</pub-id>
</element-citation>
</ref>
<ref id="b293-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silverman</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Barkan</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Tolu</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Saxena</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Crawley</surname>
<given-names>JN</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Sociability and motor functions in Shank1 mutant mice</article-title>
<source/>Brain Res
          <volume>1380</volume>
<fpage>120</fpage>
<lpage>137</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2010.09.026</pub-id>
<!--<pub-id pub-id-type="pmcid">3041833</pub-id>-->
<pub-id pub-id-type="pmid">20868654</pub-id>
</element-citation>
</ref>
<ref id="b294-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bortolato</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bali</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Godar</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Shih</surname>
<given-names>JC</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Cognitive abnormalities and hippocampal alterations in monoamine oxidase A and B knockout mice</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>110</volume>
<fpage>12816</fpage>
<lpage>12821</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1308037110</pub-id>
<!--<pub-id pub-id-type="pmcid">3732950</pub-id>-->
<pub-id pub-id-type="pmid">23858446</pub-id>
</element-citation>
</ref>
<ref id="b295-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>NN</given-names>
</name>
<name>
<surname>Lancioni</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Winton</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Wahler</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Mcaleavey</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sabaawi</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Mindful parenting decreases aggression, noncompliance, and self-injury in children with autism</article-title>
<source/>J Emot Behav Disord
          <volume>14</volume>
<fpage>169</fpage>
<lpage>177</lpage>
<pub-id pub-id-type="doi">10.1177/10634266060140030401</pub-id>
</element-citation>
</ref>
<ref id="b296-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinkkonen</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Homanics</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Korpi</surname>
<given-names>ER</given-names>
</name>
</person-group>
<year>2003</year>
<article-title>Mouse models of Angelman syndrome, a neurodevelopmental disorder, display different brain regional GABA(A) receptor alterations</article-title>
<source/>Neurosci Lett
          <volume>340</volume>
<fpage>205</fpage>
<lpage>208</lpage>
<pub-id pub-id-type="doi">10.1016/S0304-3940(03)00123-X</pub-id>
<pub-id pub-id-type="pmid">12672542</pub-id>
</element-citation>
</ref>
<ref id="b297-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skidmore</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Chiller</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Weigle</surname>
<given-names>WO</given-names>
</name>
</person-group>
<year>1975</year>
<article-title>Immunologic properties of bacterial lipopolysaccharide (LPS): correlation between the mitogenic, adjuvant, and immunogenic activities</article-title>
<source/>J Immunol
          <volume>114</volume>
<fpage>770</fpage>
<lpage>775</lpage>
<pub-id pub-id-type="pmid">46249</pub-id>
</element-citation>
</ref>
<ref id="b298-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smalheiser</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Guidotti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Impagnatiello</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Auta</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lacor</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kriho</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Pappas</surname>
<given-names>GD</given-names>
</name>
</person-group>
<year>2000</year>
<article-title>Expression of reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>97</volume>
<fpage>1281</fpage>
<lpage>1286</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.97.3.1281</pub-id>
<!--<pub-id pub-id-type="pmcid">15597</pub-id>-->
<pub-id pub-id-type="pmid">10655522</pub-id>
</element-citation>
</ref>
<ref id="b299-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Garbett</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mirnics</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>PH</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>Maternal immune activation alters fetal brain development through interleukin-6</article-title>
<source/>J Neurosci
          <volume>27</volume>
<fpage>10695</fpage>
<lpage>10702</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2178-07.2007</pub-id>
<!--<pub-id pub-id-type="pmcid">2387067</pub-id>-->
<pub-id pub-id-type="pmid">17913903</pub-id>
</element-citation>
</ref>
<ref id="b300-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>YD</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Stoppel</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>MP</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice</article-title>
<source/>Sci Transl Med
          <volume>3</volume>
<fpage>103ra97</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3002627</pub-id>
<!--<pub-id pub-id-type="pmcid">3356696</pub-id>-->
<pub-id pub-id-type="pmid">21974935</pub-id>
</element-citation>
</ref>
<ref id="b301-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spence</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>MT</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>The role of epilepsy and epileptiform EEGs in autism spectrum disorders</article-title>
<source/>Pediatr Res
          <volume>65</volume>
<fpage>599</fpage>
<lpage>606</lpage>
<pub-id pub-id-type="doi">10.1203/PDR.0b013e31819e7168</pub-id>
<!--<pub-id pub-id-type="pmcid">2692092</pub-id>-->
<pub-id pub-id-type="pmid">19454962</pub-id>
</element-citation>
</ref>
<ref id="b302-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spencer</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Alekseyenko</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Serysheva</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Yuva-Paylor</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Paylor</surname>
<given-names>R</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome</article-title>
<source/>Genes Brain Behav
          <volume>4</volume>
<fpage>420</fpage>
<lpage>430</lpage>
<pub-id pub-id-type="doi">10.1111/j.1601-183X.2005.00123.x</pub-id>
<pub-id pub-id-type="pmid">16176388</pub-id>
</element-citation>
</ref>
<ref id="b303-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stanfield</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Cowan</surname>
<given-names>WM</given-names>
</name>
</person-group>
<year>1979</year>
<article-title>The morphology of the hippocampus and dentate gyrus in normal and reeler mice</article-title>
<source/>J Comp Neurol
          <volume>185</volume>
<fpage>393</fpage>
<lpage>422</lpage>
<pub-id pub-id-type="doi">10.1002/cne.901850302</pub-id>
<pub-id pub-id-type="pmid">438366</pub-id>
</element-citation>
</ref>
<ref id="b304-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steffenburg</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hellgren</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>IC</given-names>
</name>
<name>
<surname>Jakobsson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bohman</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>1989</year>
<article-title>A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden</article-title>
<source/>J. Child Psychol. Psychiatry
          <volume>30</volume>
<fpage>405</fpage>
<lpage>416</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-7610.1989.tb00254.x</pub-id>
<pub-id pub-id-type="pmid">2745591</pub-id>
</element-citation>
</ref>
<ref id="b305-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stephenson</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>O’Neill</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Narayan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tiwari</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Samaroo</surname>
<given-names>HD</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ring</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pletcher</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vaidya</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Morton</surname>
<given-names>D</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis</article-title>
<source/>Mol. Autism
          <volume>2</volume>
<fpage>7</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-2-7</pub-id>
<!--<pub-id pub-id-type="pmcid">3135520</pub-id>-->
<pub-id pub-id-type="pmid">21575186</pub-id>
</element-citation>
</ref>
<ref id="b306-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strang</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Kenworthy</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Daniolos</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Case</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wills</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>GL</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Depression and Anxiety Symptoms in Children and Adolescents with Autism Spectrum Disorders without Intellectual Disability</article-title>
<source/>Res Autism Spectr Disord
          <volume>6</volume>
<fpage>406</fpage>
<lpage>412</lpage>
<pub-id pub-id-type="doi">10.1016/j.rasd.2011.06.015</pub-id>
<!--<pub-id pub-id-type="pmcid">3355529</pub-id>-->
<pub-id pub-id-type="pmid">22615713</pub-id>
</element-citation>
</ref>
<ref id="b307-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strauss</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Puffenberger</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Huentelman</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Gottlieb</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dobrin</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Parod</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Stephan</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Morton</surname>
<given-names>DH</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2</article-title>
<source/>N Engl J Med
          <volume>354</volume>
<fpage>1370</fpage>
<lpage>1377</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa052773</pub-id>
<pub-id pub-id-type="pmid">16571880</pub-id>
</element-citation>
</ref>
<ref id="b308-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stromland</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Philipson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Andersson Gronlund</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2002</year>
<article-title>Off-spring of male and female parents with thalidomide embryopathy: birth defects and functional anomalies</article-title>
<source/>Teratology
          <volume>66</volume>
<fpage>115</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="doi">10.1002/tera.10083</pub-id>
<pub-id pub-id-type="pmid">12210472</pub-id>
</element-citation>
</ref>
<ref id="b309-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sudhof</surname>
<given-names>TC</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Neuroligins and neurexins link synaptic function to cognitive disease</article-title>
<source/>Nature
          <volume>455</volume>
<fpage>903</fpage>
<lpage>911</lpage>
<pub-id pub-id-type="doi">10.1038/nature07456</pub-id>
<!--<pub-id pub-id-type="pmcid">2673233</pub-id>-->
<pub-id pub-id-type="pmid">18923512</pub-id>
</element-citation>
</ref>
<ref id="b310-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szatmari</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Maziade</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zwaigenbaum</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Merette</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Joober</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Palmour</surname>
<given-names>R</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>Informative phenotypes for genetic studies of psychiatric disorders</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet
          <volume>144B</volume>
<fpage>581</fpage>
<lpage>588</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30426</pub-id>
<pub-id pub-id-type="pmid">17219386</pub-id>
</element-citation>
</ref>
<ref id="b311-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taieb</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Baleyte</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Mazet</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fillet</surname>
<given-names>AM</given-names>
</name>
</person-group>
<year>2001</year>
<article-title>Borna disease virus and psychiatry</article-title>
<source/>Eur. Psychiatry
          <volume>16</volume>
<fpage>3</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1016/S0924-9338(00)00529-0</pub-id>
<pub-id pub-id-type="pmid">11246286</pub-id>
</element-citation>
</ref>
<ref id="b312-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gudsnuk</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>S-H</given-names>
</name>
<name>
<surname>Cotrina</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Rosoklija</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sosunov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sonders</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Kanter</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Castagna</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yue</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Arancio</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Champagne</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dwork</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Goldman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sulzer</surname>
<given-names>D</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Loss of mTOR-Dependent Macroautophagy Causes Autistic-like Synaptic Pruning Deficits</article-title>
<source/>Neuron
          <volume>83</volume>
<fpage>1131</fpage>
<lpage>1143</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2014.07.040</pub-id>
<!--<pub-id pub-id-type="pmcid">4159743</pub-id>-->
<pub-id pub-id-type="pmid">25155956</pub-id>
</element-citation>
</ref>
<ref id="b313-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tansey</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Brookes</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Cochrane</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Skuse</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Correia</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vicente</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kent</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Anney</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Oxytocin receptor (OXTR) does not play a major role in the aetiology of autism: genetic and molecular studies</article-title>
<source/>Neurosci Lett
          <volume>474</volume>
<fpage>163</fpage>
<lpage>167</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2010.03.035</pub-id>
<pub-id pub-id-type="pmid">20303388</pub-id>
</element-citation>
</ref>
<ref id="b314-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taurines</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Segura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schecklmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Albantakis</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Grunblatt</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Walitza</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jans</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lyttwin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Haberhausen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Theisen</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Briegel</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Thome</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schwenck</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Romanos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gerlach</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Altered peripheral BDNF mRNA expression and BDNF protein concentrations in blood of children and adolescents with autism spectrum disorder</article-title>
<source/>J. Neural Transm. (Vienna)
          <volume>121</volume>
<fpage>1117</fpage>
<lpage>1128</lpage>
<pub-id pub-id-type="doi">10.1007/s00702-014-1162-x</pub-id>
<pub-id pub-id-type="pmid">24500031</pub-id>
</element-citation>
</ref>
<ref id="b315-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tavassoli</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Auyeung</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Baron-Cohen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chakrabarti</surname>
<given-names>B</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Variation in the autism candidate gene GABRB3 modulates tactile sensitivity in typically developing children</article-title>
<source/>Mol. Autism
          <volume>3</volume>
<fpage>6</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-3-6</pub-id>
<!--<pub-id pub-id-type="pmcid">3434022</pub-id>-->
<pub-id pub-id-type="pmid">22769427</pub-id>
</element-citation>
</ref>
<ref id="b316-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>The International Schizophrenia Consortium</collab>
</person-group>
<year>2008</year>
<article-title>Rare chromosomal deletions and duplications increase risk of schizophrenia</article-title>
<source/>Nature
          <volume>455</volume>
<fpage>237</fpage>
<lpage>241</lpage>
<pub-id pub-id-type="doi">10.1038/nature07239</pub-id>
<!--<pub-id pub-id-type="pmcid">3912847</pub-id>-->
<pub-id pub-id-type="pmid">18668038</pub-id>
</element-citation>
</ref>
<ref id="b317-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tierney</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bukelis</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Aneja</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kratz</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>RI</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Abnormalities of cholesterol metabolism in autism spectrum disorders</article-title>
<source/>Am. J. Med. Genet. B Neuropsychiatr. Genet
          <volume>141B</volume>
<fpage>666</fpage>
<lpage>668</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30368</pub-id>
<!--<pub-id pub-id-type="pmcid">2553243</pub-id>-->
<pub-id pub-id-type="pmid">16874769</pub-id>
</element-citation>
</ref>
<ref id="b318-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tierney</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nwokoro</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>RI</given-names>
</name>
</person-group>
<year>2000</year>
<article-title>Behavioral phenotype of RSH/Smith-Lemli-Opitz syndrome</article-title>
<source/>Ment Retard Dev Disabil Res Rev
          <volume>6</volume>
<fpage>131</fpage>
<lpage>134</lpage>
<pub-id pub-id-type="doi">10.1002/1098-2779(2000)6:2&lt;131::AID-MRDD7&gt;3.0.CO;2-R</pub-id>
<pub-id pub-id-type="pmid">10899806</pub-id>
</element-citation>
</ref>
<ref id="b319-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tottenham</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hertzig</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Gillespie-Lynch</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gilhooly</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Millner</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Casey</surname>
<given-names>B</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Elevated amygdala response to faces and gaze aversion in autism spectrum disorder</article-title>
<source/>Soc Cogn Affect Neurosci
          <volume>9</volume>
<fpage>106</fpage>
<lpage>117</lpage>
<pub-id pub-id-type="doi">10.1093/scan/nst050</pub-id>
<pub-id pub-id-type="pmid">23596190</pub-id>
</element-citation>
</ref>
<ref id="b320-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Truong</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Rendall</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Castelluccio</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Eigsti</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Fitch</surname>
<given-names>RH</given-names>
</name>
</person-group>
<year>2015</year>
<article-title>Auditory processing and morphological anomalies in medial geniculate nucleus of Cntnap2 mutant mice</article-title>
<source/>Behav Neurosci
          <volume>129</volume>
<fpage>731</fpage>
<lpage>743</lpage>
<pub-id pub-id-type="doi">10.1037/bne0000096</pub-id>
<pub-id pub-id-type="pmid">26501174</pub-id>
</element-citation>
</ref>
<ref id="b321-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Greene-Colozzi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sadowski</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Leech</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Crawley</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Regehr</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Sahin</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice</article-title>
<source/>Nature
          <volume>488</volume>
<fpage>647</fpage>
<lpage>651</lpage>
<pub-id pub-id-type="doi">10.1038/nature11310</pub-id>
<!--<pub-id pub-id-type="pmcid">3615424</pub-id>-->
<pub-id pub-id-type="pmid">22763451</pub-id>
</element-citation>
</ref>
<ref id="b322-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Is autism caused by early hyperactivity of brain-derived neurotrophic factor?</article-title>
<source/>Med. Hypotheses
          <volume>65</volume>
<fpage>79</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1016/j.mehy.2005.01.034</pub-id>
<pub-id pub-id-type="pmid">15893122</pub-id>
</element-citation>
</ref>
<ref id="b323-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tueting</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dwivedi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Guidotti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Impagnatiello</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Manev</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pesold</surname>
<given-names>C</given-names>
</name>
</person-group>
<year>1999</year>
<article-title>The phenotypic characteristics of heterozygous reeler mouse</article-title>
<source/>Neuroreport
          <volume>10</volume>
<fpage>1329</fpage>
<lpage>1334</lpage>
<pub-id pub-id-type="doi">10.1097/00001756-199904260-00032</pub-id>
<pub-id pub-id-type="pmid">10363948</pub-id>
</element-citation>
</ref>
<ref id="b324-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turrigiano</surname>
<given-names>G</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Homeostatic synaptic plasticity: local and global mechanisms for stabilizing neuronal function</article-title>
<source/>Cold Spring Harb Perspect Biol
          <volume>4</volume>
<fpage>a005736</fpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a005736</pub-id>
<pub-id pub-id-type="pmid">22086977</pub-id>
</element-citation>
</ref>
<ref id="b325-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tyzio</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Nardou</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ferrari</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Tsintsadze</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shahrokhi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Eftekhari</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Khalilov</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Tsintsadze</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Brouchoud</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chazal</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lemonnier</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lozovaya</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Burnashev</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ben-Ari</surname>
<given-names>Y</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring</article-title>
<source/>Science
          <volume>343</volume>
<fpage>675</fpage>
<lpage>679</lpage>
<pub-id pub-id-type="doi">10.1126/science.1247190</pub-id>
<pub-id pub-id-type="pmid">24503856</pub-id>
</element-citation>
</ref>
<ref id="b326-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uhlmann</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Baldwin</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Bajenaru</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Onda</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kwiatkowski</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gutmann</surname>
<given-names>DH</given-names>
</name>
</person-group>
<year>2002</year>
<article-title>Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures</article-title>
<source/>Ann Neurol
          <volume>52</volume>
<fpage>285</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="doi">10.1002/ana.10283</pub-id>
<pub-id pub-id-type="pmid">12205640</pub-id>
</element-citation>
</ref>
<ref id="b327-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veenstra-Vanderweele</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jessen</surname>
<given-names>TN</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Steiner</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Sutcliffe</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Blakely</surname>
<given-names>RD</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Modeling rare gene variation to gain insight into the oldest biomarker in autism: construction of the serotonin transporter Gly56Ala knock-in mouse</article-title>
<source/>J Neurodev Disord
          <volume>1</volume>
<fpage>158</fpage>
<lpage>171</lpage>
<pub-id pub-id-type="doi">10.1007/s11689-009-9020-0</pub-id>
<!--<pub-id pub-id-type="pmcid">2786076</pub-id>-->
<pub-id pub-id-type="pmid">19960097</pub-id>
</element-citation>
</ref>
<ref id="b328-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verheij</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bakker</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>de Graaff</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Keulemans</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Willemsen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Verkerk</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Galjaard</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Reuser</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Hoogeveen</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Oostra</surname>
<given-names>BA</given-names>
</name>
</person-group>
<year>1993</year>
<article-title>Characterization and localization of the FMR-1 gene product associated with fragile X syndrome</article-title>
<source/>Nature
          <volume>363</volume>
<fpage>722</fpage>
<lpage>724</lpage>
<pub-id pub-id-type="doi">10.1038/363722a0</pub-id>
<pub-id pub-id-type="pmid">8515814</pub-id>
</element-citation>
</ref>
<ref id="b329-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verpelli</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dvoretskova</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Vicidomini</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Chiappalone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schoen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Di Stefano</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Mantegazza</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Broccoli</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bockers</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Dityatev</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sala</surname>
<given-names>C</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses</article-title>
<source/>J Biol Chem
          <volume>286</volume>
<fpage>34839</fpage>
<lpage>34850</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M111.258384</pub-id>
<!--<pub-id pub-id-type="pmcid">3186429</pub-id>-->
<pub-id pub-id-type="pmid">21795692</pub-id>
</element-citation>
</ref>
<ref id="b330-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volkmar</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>DS</given-names>
</name>
</person-group>
<year>1990</year>
<article-title>Seizure Disorders in Autism</article-title>
<source/>J. Am. Acad. Child Adolesc Psychiatry
          <volume>29</volume>
<fpage>127</fpage>
<lpage>129</lpage>
<pub-id pub-id-type="doi">10.1097/00004583-199001000-00020</pub-id>
<pub-id pub-id-type="pmid">2295565</pub-id>
</element-citation>
</ref>
<ref id="b331-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waage-Baudet</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lauder</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Dehart</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Kluckman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hiller</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tint</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Sulik</surname>
<given-names>KK</given-names>
</name>
</person-group>
<year>2003</year>
<article-title>Abnormal serotonergic development in a mouse model for the Smith-Lemli-Opitz syndrome: implications for autism</article-title>
<source/>Int J Dev Neurosci
          <volume>21</volume>
<fpage>451</fpage>
<lpage>459</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijdevneu.2003.09.002</pub-id>
<pub-id pub-id-type="pmid">14659996</pub-id>
</element-citation>
</ref>
<ref id="b332-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wagstaff</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Knoll</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Fleming</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kirkness</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Martin-Gallardo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>JM</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Menninger</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Venter</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Lalande</surname>
<given-names>M</given-names>
</name>
</person-group>
<year>1991</year>
<article-title>Localization of the gene encoding the GABAA receptor beta 3 subunit to the Angelman/Prader-Willi region of human chromosome 15</article-title>
<source/>Am J Hum Genet
          <volume>49</volume>
<fpage>330</fpage>
<lpage>337</lpage>
<!--<pub-id pub-id-type="pmcid">1683305</pub-id>-->
<pub-id pub-id-type="pmid">1714232</pub-id>
</element-citation>
</ref>
<ref id="b333-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wahlsten</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Metten</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Crabbe</surname>
<given-names>JC</given-names>
</name>
</person-group>
<year>2003</year>
<article-title>Survey of 21 inbred mouse strains in two laboratories reveals that BTBR T/+ tf/tf has severely reduced hippocampal commissure and absent corpus callosum</article-title>
<source/>Brain Res
          <volume>971</volume>
<fpage>47</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(03)02354-0</pub-id>
<pub-id pub-id-type="pmid">12691836</pub-id>
</element-citation>
</ref>
<ref id="b334-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walcott</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Higgins</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Desai</surname>
<given-names>NS</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>Synaptic and intrinsic balancing during postnatal development in rat pups exposed to valproic acid in utero</article-title>
<source/>J Neurosci
          <volume>31</volume>
<fpage>13097</fpage>
<lpage>13109</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1341-11.2011</pub-id>
<pub-id pub-id-type="pmid">21917793</pub-id>
</element-citation>
</ref>
<ref id="b335-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walsh</surname>
<given-names>T</given-names>
</name>
<name>
<surname>McClellan</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Addington</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Pierce</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Nord</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Kusenda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Malhotra</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bhandari</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stray</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Rippey</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Roccanova</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Makarov</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lakshmi</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Findling</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Sikich</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Stromberg</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Merriman</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gogtay</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Eckstrand</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Noory</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gochman</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Meltzer</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Singleton</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Rapoport</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>King</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Sebat</surname>
<given-names>J</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia</article-title>
<source/>Science
          <volume>320</volume>
<fpage>539</fpage>
<lpage>543</lpage>
<pub-id pub-id-type="doi">10.1126/science.1155174</pub-id>
<pub-id pub-id-type="pmid">18369103</pub-id>
</element-citation>
</ref>
<ref id="b336-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>XH</given-names>
</name>
<name>
<surname>Ning</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>XF</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>GH</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>DX</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Age- and gender-dependent impairments of neurobehaviors in mice whose mothers were exposed to lipopolysaccharide during pregnancy</article-title>
<source/>Toxicol Lett
          <volume>192</volume>
<fpage>245</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="doi">10.1016/j.toxlet.2009.10.030</pub-id>
<pub-id pub-id-type="pmid">19896524</pub-id>
</element-citation>
</ref>
<ref id="b337-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Kloth</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Badura</surname>
<given-names>A</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>The Cerebellum, Sensitive Periods, and Autism</article-title>
<source/>Neuron
          <volume>83</volume>
<fpage>518</fpage>
<lpage>532</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2014.07.016</pub-id>
<!--<pub-id pub-id-type="pmcid">4135479</pub-id>-->
<pub-id pub-id-type="pmid">25102558</pub-id>
</element-citation>
</ref>
<ref id="b338-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warrier</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Baron-Cohen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chakrabarti</surname>
<given-names>B</given-names>
</name>
</person-group>
<year>2013</year>
<article-title>Genetic variation in GABRB3 is associated with Asperger syndrome and multiple endophenotypes relevant to autism</article-title>
<source/>Mol. Autism
          <volume>4</volume>
<fpage>48</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-4-48</pub-id>
<!--<pub-id pub-id-type="pmcid">3903107</pub-id>-->
<pub-id pub-id-type="pmid">24321478</pub-id>
</element-citation>
</ref>
<ref id="b339-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wassink</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Piven</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vieland</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Pietila</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Goedken</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Folstein</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Sheffield</surname>
<given-names>VC</given-names>
</name>
</person-group>
<year>2004</year>
<article-title>Examination of AVPR1a as an autism susceptibility gene</article-title>
<source/>Mol. Psychiatry
          <volume>9</volume>
<fpage>968</fpage>
<lpage>972</lpage>
<pub-id pub-id-type="doi">10.1038/sj.mp.4001503</pub-id>
<pub-id pub-id-type="pmid">15098001</pub-id>
</element-citation>
</ref>
<ref id="b340-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weidner</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Buenaventura</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Chadman</surname>
<given-names>KK</given-names>
</name>
</person-group>
<year>2014</year>
<article-title>Mice over-expressing BDNF in forebrain neurons develop an altered behavioral phenotype with age</article-title>
<source/>Behav Brain Res
          <volume>268</volume>
<fpage>222</fpage>
<lpage>228</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2014.04.025</pub-id>
<pub-id pub-id-type="pmid">24768643</pub-id>
</element-citation>
</ref>
<ref id="b341-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiler</surname>
<given-names>IJ</given-names>
</name>
<name>
<surname>Irwin</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Klintsova</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Brazelton</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Miyashiro</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Comery</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Eberwine</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Greenough</surname>
<given-names>WT</given-names>
</name>
</person-group>
<year>1997</year>
<article-title>Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>94</volume>
<fpage>5395</fpage>
<lpage>5400</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.94.10.5395</pub-id>
<!--<pub-id pub-id-type="pmcid">24689</pub-id>-->
<pub-id pub-id-type="pmid">9144248</pub-id>
</element-citation>
</ref>
<ref id="b342-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wersinger</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Kelliher</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Zufall</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lolait</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>O’Carroll</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>WS</given-names>
<suffix>3rd</suffix>
</name>
</person-group>
<year>2004</year>
<article-title>Social motivation is reduced in vasopressin 1b receptor null mice despite normal performance in an olfactory discrimination task</article-title>
<source/>Horm Behav
          <volume>46</volume>
<fpage>638</fpage>
<lpage>645</lpage>
<pub-id pub-id-type="doi">10.1016/j.yhbeh.2004.07.004</pub-id>
<pub-id pub-id-type="pmid">15555506</pub-id>
</element-citation>
</ref>
<ref id="b343-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whitehouse</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Bishop</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Ang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Pennell</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>SE</given-names>
</name>
</person-group>
<year>2011</year>
<article-title>CNTNAP2 variants affect early language development in the general population</article-title>
<source/>Genes Brain and Behav
          <volume>10</volume>
<fpage>451</fpage>
<lpage>456</lpage>
<pub-id pub-id-type="doi">10.1111/j.1601-183X.2011.00684.x</pub-id>
</element-citation>
</ref>
<ref id="b344-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winslow</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Insel</surname>
<given-names>TR</given-names>
</name>
</person-group>
<year>2002</year>
<article-title>The social deficits of the oxytocin knockout mouse</article-title>
<source/>Neuropeptides
          <volume>36</volume>
<fpage>221</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="doi">10.1054/npep.2002.0909</pub-id>
<pub-id pub-id-type="pmid">12359512</pub-id>
</element-citation>
</ref>
<ref id="b345-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wohr</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Roullet</surname>
<given-names>FI</given-names>
</name>
<name>
<surname>Crawley</surname>
<given-names>JN</given-names>
</name>
</person-group>
<year>2011a</year>
<article-title>Reduced scent marking and ultrasonic vocalizations in the BTBR T+tf/J mouse model of autism</article-title>
<source/>Genes Brain Behav
          <volume>10</volume>
<fpage>35</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.1111/j.1601-183X.2010.00582.x</pub-id>
<pub-id pub-id-type="pmid">20345893</pub-id>
</element-citation>
</ref>
<ref id="b346-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wohr</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Roullet</surname>
<given-names>FI</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Crawley</surname>
<given-names>JN</given-names>
</name>
</person-group>
<year>2011b</year>
<article-title>Communication impairments in mice lacking Shank1: reduced levels of ultrasonic vocalizations and scent marking behavior</article-title>
<source/>PLoS One
          <volume>6</volume>
<fpage>e20631</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0020631</pub-id>
<pub-id pub-id-type="pmid">21695253</pub-id>
</element-citation>
</ref>
<ref id="b347-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolterink</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Daenen</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Dubbeldam</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gerrits</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>van Rijn</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kruse</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Van Der Heijden</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Van Ree</surname>
<given-names>JM</given-names>
</name>
</person-group>
<year>2001</year>
<article-title>Early amygdala damage in the rat as a model for neurodevelopmental psychopathological disorders</article-title>
<source/>Eur Neuropsychopharmacol
          <volume>11</volume>
<fpage>51</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="doi">10.1016/S0924-977X(00)00138-3</pub-id>
<pub-id pub-id-type="pmid">11226812</pub-id>
</element-citation>
</ref>
<ref id="b348-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Won</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Gee</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Mah</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ha</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Kaang</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>E</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function</article-title>
<source/>Nature
          <volume>486</volume>
<fpage>261</fpage>
<lpage>265</lpage>
<pub-id pub-id-type="doi">10.1038/nature11208</pub-id>
<pub-id pub-id-type="pmid">22699620</pub-id>
</element-citation>
</ref>
<ref id="b349-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shuang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population</article-title>
<source/>Biol. Psychiatry
          <volume>58</volume>
<fpage>74</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2005.03.013</pub-id>
<pub-id pub-id-type="pmid">15992526</pub-id>
</element-citation>
</ref>
<ref id="b350-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamashita</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fujimoto</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nakajima</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Isagai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Matsuishi</surname>
<given-names>T</given-names>
</name>
</person-group>
<year>2003</year>
<article-title>Possible association between congenital cytomegalovirus infection and autistic disorder</article-title>
<source/>J Autism Dev Disord
          <volume>33</volume>
<fpage>455</fpage>
<lpage>459</lpage>
<pub-id pub-id-type="doi">10.1023/A:1025023131029</pub-id>
<pub-id pub-id-type="pmid">12959425</pub-id>
</element-citation>
</ref>
<ref id="b351-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamauchi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Miyamoto</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kusakawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Torii</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mizutani</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sanbe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nakajima</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kiyokawa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tanoue</surname>
<given-names>A</given-names>
</name>
</person-group>
<year>2008</year>
<article-title>Neurofibromatosis 2 tumor suppressor, the gene induced by valproic acid, mediates neurite outgrowth through interaction with paxillin</article-title>
<source/>Exp Cell Res
          <volume>314</volume>
<fpage>2279</fpage>
<lpage>2288</lpage>
<pub-id pub-id-type="doi">10.1016/j.yexcr.2008.03.019</pub-id>
<pub-id pub-id-type="pmid">18486129</pub-id>
</element-citation>
</ref>
<ref id="b352-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>XY</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Nicolson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yap</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Krasnewich</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Kumra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lenane</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Gochman</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Damschroder-Williams</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Esterling</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Sidransky</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rapoport</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Ginns</surname>
<given-names>EI</given-names>
</name>
</person-group>
<year>2000</year>
<article-title>Childhood-onset schizophrenia/autistic disorder and t(1;7) reciprocal translocation: identification of a BAC contig spanning the translocation breakpoint at 7q21</article-title>
<source/>Am J Med Genet
          <volume>96</volume>
<fpage>749</fpage>
<lpage>753</lpage>
<pub-id pub-id-type="doi">10.1002/1096-8628(20001204)96:6&lt;749::AID-AJMG10&gt;3.0.CO;2-K</pub-id>
<pub-id pub-id-type="pmid">11121174</pub-id>
</element-citation>
</ref>
<ref id="b353-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bozdagi</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Scattoni</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Wöhr</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Roullet</surname>
<given-names>FI</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Abrams</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Kalikhman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Woldeyohannes</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Saxena</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Silverman</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Buxbaum</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Crawley</surname>
<given-names>JN</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice</article-title>
<source/>J Neurosci
          <volume>32</volume>
<fpage>6525</fpage>
<lpage>6541</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.6107-11.2012</pub-id>
<!--<pub-id pub-id-type="pmcid">3362928</pub-id>-->
<pub-id pub-id-type="pmid">22573675</pub-id>
</element-citation>
</ref>
<ref id="b354-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yasui</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Peddada</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bieda</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Vallero</surname>
<given-names>RO</given-names>
</name>
<name>
<surname>Hogart</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nagarajan</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Thatcher</surname>
<given-names>KN</given-names>
</name>
<name>
<surname>Farnham</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Lasalle</surname>
<given-names>JM</given-names>
</name>
</person-group>
<year>2007</year>
<article-title>Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>104</volume>
<fpage>19416</fpage>
<lpage>19421</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0707442104</pub-id>
<!--<pub-id pub-id-type="pmcid">2148304</pub-id>-->
<pub-id pub-id-type="pmid">18042715</pub-id>
</element-citation>
</ref>
<ref id="b355-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yip</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Yip</surname>
<given-names>YP</given-names>
</name>
<name>
<surname>Nakajima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Capriotti</surname>
<given-names>C</given-names>
</name>
</person-group>
<year>2000</year>
<article-title>Reelin controls position of autonomic neurons in the spinal cord</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>97</volume>
<fpage>8612</fpage>
<lpage>8616</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.150040497</pub-id>
<!--<pub-id pub-id-type="pmcid">26996</pub-id>-->
<pub-id pub-id-type="pmid">10880573</pub-id>
</element-citation>
</ref>
<ref id="b356-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yirmiya</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rosenberg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Levi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Salomon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shulman</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nemanov</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dina</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ebstein</surname>
<given-names>RP</given-names>
</name>
</person-group>
<year>2006</year>
<article-title>Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: mediation by socialization skills</article-title>
<source/>Mol. Psychiatry
          <volume>11</volume>
<fpage>488</fpage>
<lpage>494</lpage>
<pub-id pub-id-type="doi">10.1038/sj.mp.4001812</pub-id>
<pub-id pub-id-type="pmid">16520824</pub-id>
</element-citation>
</ref>
<ref id="b357-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ylisaukko-oja</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rehnström</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Auranen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vanhala</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Alen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kempas</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ellonen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Turunen</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Makkonen</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Riikonen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Nieminen-von Wendt</surname>
<given-names>T</given-names>
</name>
<name>
<surname>von Wendt</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Peltonen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Järvelä</surname>
<given-names>I</given-names>
</name>
</person-group>
<year>2005</year>
<article-title>Analysis of four neuroligin genes as candidates for autism</article-title>
<source/>Eur J Hum Genet
          <volume>13</volume>
<fpage>1285</fpage>
<lpage>1292</lpage>
<pub-id pub-id-type="doi">10.1038/sj.ejhg.5201474</pub-id>
<pub-id pub-id-type="pmid">16077734</pub-id>
</element-citation>
</ref>
<ref id="b358-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Schenk</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Jan</surname>
<given-names>YN</given-names>
</name>
<name>
<surname>Jan</surname>
<given-names>LY</given-names>
</name>
</person-group>
<year>2010</year>
<article-title>Altered ultrasonic vocalizations in a tuberous sclerosis mouse model of autism</article-title>
<source/>Proc Natl Acad Sci USA
          <volume>107</volume>
<fpage>11074</fpage>
<lpage>11079</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1005620107</pub-id>
<!--<pub-id pub-id-type="pmcid">2890736</pub-id>-->
<pub-id pub-id-type="pmid">20534473</pub-id>
</element-citation>
</ref>
<ref id="b359-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zec</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rowitch</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Bitgood</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Kinney</surname>
<given-names>HC</given-names>
</name>
</person-group>
<year>1997</year>
<article-title>Expression of the homeobox-containing genes EN1 and EN2 in human fetal midgestational medulla and cerebellum</article-title>
<source/>J Neuropathol Exp Neurol
          <volume>56</volume>
<fpage>236</fpage>
<lpage>242</lpage>
<pub-id pub-id-type="doi">10.1097/00005072-199703000-00002</pub-id>
<pub-id pub-id-type="pmid">9056537</pub-id>
</element-citation>
</ref>
<ref id="b360-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Klann</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>DL</given-names>
</name>
</person-group>
<year>2009</year>
<article-title>Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models</article-title>
<source/>J Neurophysiol
          <volume>101</volume>
<fpage>2572</fpage>
<lpage>2580</lpage>
<pub-id pub-id-type="doi">10.1152/jn.90558.2008</pub-id>
<!--<pub-id pub-id-type="pmcid">2681424</pub-id>-->
<pub-id pub-id-type="pmid">19244359</pub-id>
</element-citation>
</ref>
<ref id="b361-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Serajee</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Nabi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Huq</surname>
<given-names>AH</given-names>
</name>
</person-group>
<year>2003</year>
<article-title>No association between the EN2 gene and autistic disorder</article-title>
<source/>J Med Genet
          <volume>40</volume>
<fpage>e4</fpage>
<pub-id pub-id-type="doi">10.1136/jmg.40.1.e4</pub-id>
<!--<pub-id pub-id-type="pmcid">1735256</pub-id>-->
<pub-id pub-id-type="pmid">12525552</pub-id>
</element-citation>
</ref>
<ref id="b362-bt-24-207">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Parada</surname>
<given-names>LF</given-names>
</name>
</person-group>
<year>2012</year>
<article-title>PTEN signaling in autism spectrum disorders</article-title>
<source/>Curr Opin Neurobiol
          <volume>22</volume>
<fpage>873</fpage>
<lpage>879</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2012.05.004</pub-id>
<pub-id pub-id-type="pmid">22664040</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-bt-24-207" orientation="portrait" position="float">
<label>Fig. 1.</label>
<caption>
<p>Excitatory/Inhibitory Imbalance in ASD. (A) Normal/optimum condition (balanced excitation, inhibition and synaptic regulation). (B) Hyper-excitatory condition due to increased excitation from a variety of genetic and/or environmental factors (B-1, i.e. FMR1, MeCP2, NLGN3, PTEN, SAHNK2 and PTEN genetic knockout/mutations; LPS and VPA prenatal exposures) or decreased-inhibitory regulators (B-2, i.e. CNTNAP2, GABRB3, MeCP2, RELN genetic knockout/mutations; prenatal VPA exposure) affecting synaptic strength; synaptic regulators could be normal. (C) Hyper-inhibitory condition due to increased inhibition from genetic or environmental factors (C-1, for example, NLGN3 mutation) and decreased excitation inducers (C-2, i.e. SHANK2 &amp; UBE3A genetic knockout/mutations).</p>
</caption>
<graphic xlink:href="bt-24-207f1"></graphic>
</fig>
<fig id="f2-bt-24-207" orientation="portrait" position="float">
<label>Fig. 2.</label>
<caption>
<p>Altered synaptic regulators in ASD leading to E-I imbalance. (A) Normal/optimum condition (balanced excitation, inhibition, and synaptic regulation). (B) Hyper-excitatory condition due to altered synaptic regulators. Even with the normal synaptic structure and numbers, dysregulation of synaptic modulators such as altered intracellular calcium level either by genetic or environmental factors may render the brain to more excitable states. (C) Hyper-inhibitory condition due to altered synaptic regulators, for example, reduced intracellular calcium level. With the altered synaptic regulators function, otherwise harmless weak stimuli (either genetic or environmental) may contribute to the manifestation of autistic phenotypes, which explains various types of gene (environmental) x gene (environmental) interaction. Alternatively, innate differences in the synaptic modulator functions between male and female may explain the gender-skewed prevalence of ASD.</p>
</caption>
<graphic xlink:href="bt-24-207f2"></graphic>
</fig>
<table-wrap id="t1-bt-24-207" orientation="portrait" position="float">
<label>Table 1.</label>
<caption>
<p>Neurobiological and behavioral features of ASD animal models in relation to their clinical relevance</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="3" valign="middle">Animal model of ASD</th>
<th align="center" colspan="3" rowspan="1" valign="middle">Features of animal model</th>
<th align="center" colspan="1" rowspan="3" valign="middle">Clinical behavioral and neurobiological findings</th>
<th align="center" colspan="1" rowspan="3" valign="middle">Citations</th>
</tr>
<tr>
<th align="center" colspan="3" rowspan="1" valign="middle">
<hr/></th>
</tr>
<tr>
<th align="center" colspan="1" rowspan="1" valign="middle">Core symptoms of ASD</th>
<th align="center" colspan="1" rowspan="1" valign="middle">Other symptoms</th>
<th align="center" colspan="1" rowspan="1" valign="middle">Neurobiological defects</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">A. Lesion Models</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Amygdala lesion</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Stereotyped walking<sup>g</sup> Decreased social play and social exploration<sup>g,h</sup></p></list-item><list-item><p>Decreased social interaction<sup>i</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Decreased spontaneous alteration (spatial learning and memory)<sup>i</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Amygdala lesion</p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Enlarged amygdala in young children<sup>a</sup></p></list-item><list-item><p>Increased cell density and small neuronal cell size<sup>b,c</sup></p></list-item><list-item><p>Initiating eye-contact and gaze manipulation<sup>d,e</sup></p></list-item><list-item><p>Impaired fear and anxiety processing<sup>f</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b287-bt-24-207">Schumann <italic>et al</italic>., 2004</xref><break></break><sup>b</sup><xref ref-type="bibr" rid="b22-bt-24-207">Bauman and Kemper, 1985</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b173-bt-24-207">Kemper and Bauman, 1998</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b20-bt-24-207">Barnea-Goraly <italic>et al</italic>., 2014</xref><break></break><sup>e</sup><xref ref-type="bibr" rid="b319-bt-24-207">Tottenham <italic>et al</italic>., 2014</xref><break></break><sup>f</sup><xref ref-type="bibr" rid="b6-bt-24-207">Amaral <italic>et al</italic>., 2003</xref><break></break><sup>g</sup><xref ref-type="bibr" rid="b347-bt-24-207">Wolterink <italic>et al</italic>., 2001</xref><break></break><sup>h</sup>Daenen <italic>et al</italic>., 2002<break></break><sup>i</sup><xref ref-type="bibr" rid="b91-bt-24-207">Diergaarde <italic>et al</italic>., 2005</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Cerebellum lesion</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Impaired social discrimination<sup>e</sup></p></list-item><list-item><p>Repetitive behavior<sup>f</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Impaired visuomotor ability but not spatial memory<sup>d</sup></p></list-item><list-item><p>Hyperlocomotor activity<sup>e</sup></p></list-item><list-item><p>Decreased anxiety<sup>e</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Cerebellar lesions</p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased repetitive behaviors and decreased exploratory behavior<sup>a</sup></p></list-item><list-item><p>Hypoplasia of cerebellar vermal lobules VI and VII<sup>b</sup></p></list-item><list-item><p>Loss of Purkinje cells<sup>c</sup></p></list-item><list-item><p>Cerebellar injury causes high risk ratio for ASD in children<sup>g</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>a</sup>
<xref ref-type="bibr" rid="b251-bt-24-207">Pierce and Courchesne, 2001</xref>
<break></break>
<sup>b</sup>
<xref ref-type="bibr" rid="b80-bt-24-207">Courchesne <italic>et al</italic>., 1994</xref>
<break></break>
<sup>c</sup>
<xref ref-type="bibr" rid="b3-bt-24-207">Allen and Courchesne, 2003</xref>
<break></break>
<sup>d</sup>
<xref ref-type="bibr" rid="b164-bt-24-207">Joyal <italic>et al</italic>., 1996</xref>
<break></break>
<sup>e</sup>
<xref ref-type="bibr" rid="b39-bt-24-207">Bobee <italic>et al</italic>., 2000</xref>
<break></break>
<sup>f</sup>
<xref ref-type="bibr" rid="b210-bt-24-207">Martin <italic>et al</italic>., 2010</xref>
<break></break>
<sup>g</sup>
<xref ref-type="bibr" rid="b337-bt-24-207">Wang <italic>et al</italic>., 2014</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  mPFC lesion</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Decreased social play, conditioned place preference (social contact related) and social grooming<sup>c</sup></p></list-item><list-item><p><italic>Normal social interaction in adult rats</italic><sup>c</sup></p></list-item></list></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>ND</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>mPFC lesions</p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Brain overgrowth in mPFC<sup>a</sup></p></list-item><list-item><p>Early PFC damage can impair social interaction and cognition<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b53-bt-24-207">Carper and Courchesne, 2005</xref>; <xref ref-type="bibr" rid="b138-bt-24-207">Hazlett et al., 2005</xref><break></break><sup>b</sup><xref ref-type="bibr" rid="b98-bt-24-207">Eslinger et al., 2004</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b284-bt-24-207">Schneider and Koch, 2005</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Maternal BDV infection</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increase stereotyped scale<sup>b</sup></p></list-item><list-item><p>Impaired social play &amp; social interaction<sup>c</sup></p></list-item></list></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>ND</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Abnormalities in postnatal development of hippocampus and cerebellum<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p><italic>MIA</italic><sup>a</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b214-bt-24-207">Mazina <italic>et al</italic>., 2015</xref><break></break><sup>b</sup><xref ref-type="bibr" rid="b144-bt-24-207">Hornig <italic>et al</italic>., 1999</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b253-bt-24-207">Pletnikov <italic>et al</italic>., 1999</xref>, <xref ref-type="bibr" rid="b252-bt-24-207">2002</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b311-bt-24-207">Taieb <italic>et al</italic>., 2001</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Prenatal LPS exposure</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Deficits in social interaction<sup>c</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased anxiety<sup>c,d</sup></p></list-item><list-item><p>Impaired learning and memory<sup>e</sup></p></list-item><list-item><p>Decreased PPI<sup>f</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased cell density<sup>g</sup></p></list-item><list-item><p>Increased excitability of pyramidal neurons and postsynaptic glutamatergic responses<sup>h</sup></p></list-item><list-item><p>Decreased NMDA-induced synaptic plasticity<sup>i</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p><italic>MIA</italic><sup>a</sup></p></list-item><list-item><p>Increased TNF-α, IL-1β and IL-6 in peripheral blood mononuclear cells of ASD patients after LPS stimulation<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b214-bt-24-207">Mazina <italic>et al</italic>., 2015</xref><break></break><sup>b</sup><xref ref-type="bibr" rid="b167-bt-24-207">Jyonouchi <italic>et al</italic>., 2005</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b137-bt-24-207">Hava <italic>et al</italic>., 2006</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b336-bt-24-207">Wang <italic>et al</italic>., 2010</xref><break></break><sup>e</sup><xref ref-type="bibr" rid="b123-bt-24-207">Golan <italic>et al</italic>., 2005</xref><break></break><sup>f</sup><xref ref-type="bibr" rid="b269-bt-24-207">Romero <italic>et al</italic>., 2007</xref><break></break><sup>g</sup><xref ref-type="bibr" rid="b244-bt-24-207">Patterson, 2009</xref><break></break><sup>h</sup>Lowe <italic>et al</italic>., 2008<break></break><sup>i</sup><xref ref-type="bibr" rid="b188-bt-24-207">Lante <italic>et al</italic>., 2008</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Prenatal Poly (I:C) exposure</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Stereotypic repetitive behavior<sup>b,c</sup></p></list-item><list-item><p>Deficits in social interaction and communication<sup>d</sup></p></list-item><list-item><p>Impaired social preference<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased anxiety<sup>b,c</sup></p></list-item><list-item><p>Impaired sensorimotor coordination<sup>d</sup></p></list-item><list-item><p>Decreased PPI<sup>b,c</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Spatially localized deficit in Purkinje cells<sup>d,e</sup></p></list-item><list-item><p>PSD malformation, purinergic receptors downregulation and reduced phosphorylation of ERK1/2 and CAMKII<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p><italic>MIA</italic><sup>a</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b214-bt-24-207">Mazina <italic>et al</italic>., 2015</xref><break></break><sup>b</sup><xref ref-type="bibr" rid="b219-bt-24-207">Meyer <italic>et al</italic>., 2011</xref>;<break></break><sup>c</sup><xref ref-type="bibr" rid="b244-bt-24-207">Patterson, 2009</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b230-bt-24-207">Naviaux <italic>et al</italic>., 2013</xref><break></break><sup>e</sup>Shi <italic>et al</italic>., 2009</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Prenatal VPA exposure</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Stereotypic repetitive behavior<sup>f</sup></p></list-item><list-item><p>Impaired social interaction<sup>e,f,g,h</sup></p></list-item><list-item><p>Decreased social preference for social novelty<sup>e,h</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Macrocephaly</p></list-item><list-item><p>Increased anxiety<sup>e,f</sup></p></list-item><list-item><p>Impaired reversal learning and fear memory processing<sup>e,f</sup></p></list-item><list-item><p>Abnormal nest seeking behaviors<sup>e,f</sup></p></list-item><list-item><p>Decreased PPI<sup>f</sup></p></list-item><list-item><p>Seizure susceptibility<sup>h</sup></p></list-item><list-item><p>Male preponderance</p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Neural tube defects &amp; smaller brain mass at birth<sup>e</sup></p></list-item><list-item><p>Hyper-connectivity and hyper-plasticity in the mPFC region<sup>j</sup></p></list-item><list-item><p>Increased ratio between NMDA and AMPA receptor function<sup>k</sup></p></list-item><list-item><p>Reduced synaptic function of LTP and NMDAR-mediated currents<sup>l</sup></p></list-item><list-item><p>Abnormal neuronal migration<sup>m</sup></p></list-item><list-item><p>Reduced GAD and GABA<sub>A</sub> receptor subunit expression and dysfunction of benzodiazepine bin induced extensive neurogenesis ding site<sup>n</sup></p></list-item><list-item><p>Increased GABA<sub>A</sub> receptor driving force (DF<sub>GABA</sub>)<sup>o</sup></p></list-item><list-item><p>Induced extensive neurogenesis <italic>in vitro</italic><sup>p</sup></p></list-item><list-item><p>Reduced natural apoptosis of neural progenitor cells (NPCs) and increased neurogenesis<sup>q</sup></p></list-item><list-item><p>Increased PSD-95, α-CaMKII, vGluT1 and synaptophysin expressions and elevated kinetic profiles of the glutamatergic NMDA, AMPA and mGluR5 pathways in the PFC through attenuation of MeCP2<sup>r</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Gestational VPA treatment can induce ASD in children<sup>a</sup></p></list-item><list-item><p>Neural tube defects<sup>b</sup></p></list-item><list-item><p>Intellectual impairments<sup>c</sup></p></list-item><list-item><p>ASD related neurobehavioral impairments<sup>d</sup></p></list-item><list-item><p>Increased seizure susceptibility<sup>j</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b71-bt-24-207">Christianson <italic>et al</italic>., 1994</xref><break></break><sup>b</sup><xref ref-type="bibr" rid="b239-bt-24-207">Ornoy, 2009</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b224-bt-24-207">Moore <italic>et al</italic>., 2000</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b224-bt-24-207">Moore <italic>et al</italic>., 2000</xref><break></break><sup>e</sup><xref ref-type="bibr" rid="b239-bt-24-207">Ornoy, 2009</xref>; <xref ref-type="bibr" rid="b171-bt-24-207">Kataoka <italic>et al</italic>., 2013</xref>; <xref ref-type="bibr" rid="b179-bt-24-207">Kim <italic>et al</italic>., 2014c</xref><break></break><sup>f</sup><xref ref-type="bibr" rid="b284-bt-24-207">Schneider and Koch, 2005</xref>; <xref ref-type="bibr" rid="b285-bt-24-207">Schneider <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="b244-bt-24-207">Patterson, 2009</xref><break></break><sup>g</sup><xref ref-type="bibr" rid="b93-bt-24-207">Dufour-Rainfray <italic>et al</italic>., 2010</xref>;<break></break><sup>h</sup><xref ref-type="bibr" rid="b178-bt-24-207">Kim <italic>et al</italic>., 2011</xref><break></break><sup>i</sup><xref ref-type="bibr" rid="b301-bt-24-207">Spence and Schneider, 2009</xref><break></break><sup>j</sup><xref ref-type="bibr" rid="b265-bt-24-207">Rinaldi <italic>et al</italic>., 2008</xref><break></break><sup>k</sup><xref ref-type="bibr" rid="b264-bt-24-207">Rinaldi <italic>et al</italic>., 2007</xref><break></break><sup>l</sup><xref ref-type="bibr" rid="b208-bt-24-207">Martin and Manzoni, 2014</xref><break></break><sup>m</sup><xref ref-type="bibr" rid="b186-bt-24-207">Kuwagata <italic>et al</italic>., 2009</xref><break></break><sup>n</sup><xref ref-type="bibr" rid="b110-bt-24-207">Fukuchi <italic>et al</italic>., 2009</xref><break></break><sup>o</sup><xref ref-type="bibr" rid="b325-bt-24-207">Tyzio <italic>et al</italic>., 2014</xref><break></break><sup>p</sup><xref ref-type="bibr" rid="b60-bt-24-207">Jung <italic>et al</italic>., 2008</xref><break></break><sup>q</sup><xref ref-type="bibr" rid="b121-bt-24-207">Go <italic>et al</italic>., 2012</xref><break></break><sup>r</sup><xref ref-type="bibr" rid="b177-bt-24-207">Kim <italic>et al</italic>., 2014b</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  BTBR T+ tf/J mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Low level of social interaction<sup>b</sup></p></list-item><list-item><p>Stereotyped repetitive behaviors such as repetitive grooming<sup>c</sup></p></list-item><list-item><p>Ultrasonic vocalization abnormalities<sup>d</sup></p></list-item></list></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>ND</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Absent corpus callosum and reduction of hippocampal commissure<sup>a</sup></p></list-item><list-item><p>Altered brain connective tissue and reduced level of heparan sulfate<sup>e</sup></p></list-item><list-item><p>Reduction of adult hippocampal neurogenesis<sup>f</sup></p></list-item><list-item><p>No difference in GAD65/67<sup>f</sup></p></list-item></list></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>ND</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b333-bt-24-207">Wahlsten <italic>et al</italic>., 2003</xref><break></break><sup>b</sup><xref ref-type="bibr" rid="b41-bt-24-207">Bolivar <italic>et al</italic>., 2007</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b9-bt-24-207">Amodeo <italic>et al</italic>., 2012</xref>; <xref ref-type="bibr" rid="b216-bt-24-207">McFarlane <italic>et al</italic>., 2008</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b345-bt-24-207">Wohr <italic>et al</italic>., 2011a</xref><break></break><sup>e</sup><xref ref-type="bibr" rid="b35-bt-24-207">Blanchard <italic>et al</italic>., 2012</xref>;<break></break><sup>f</sup><xref ref-type="bibr" rid="b304-bt-24-207">Stephenson <italic>et al</italic>., 2011</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">B. Genetic Models</td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="center" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  BDNF<sup>−/+</sup>mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p><italic>Male BDNF</italic>-<italic>tg mice exhibited less marble burying</italic><sup>f</sup></p></list-item><list-item><p>Female BDNF-tg mice had higher self-grooming<sup>g</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>High seizure susceptibilities<sup>f,g</sup></p></list-item><list-item><p>Male BDNF-tg mice exhibited less anxiety- and depressive-like behaviors-<sup>f</sup></p></list-item><list-item><p>Female BDNF-tg mice had higher anxiety scores and no change in depression-like behaviors<sup>g</sup></p></list-item><list-item><p>Hyperactivity</p></list-item><list-item><p>Increased aggression</p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Serotonergic defects</p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Higher BDNF levels in the blood of children with ASD<sup>a</sup> but decreased serum BDNF levels in other ASD patients<sup>e</sup></p></list-item><list-item><p>Basal forebrain of autistic adults showed increased BDNF levels<sup>b</sup></p></list-item><list-item><p>BDNF mutation may underlie the overgrowth of brain in ASD<sup>c</sup></p></list-item><list-item><p>A candidate gene for ASD susceptibility<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>a</sup>
<xref ref-type="bibr" rid="b48-bt-24-207">Bryn <italic>et al</italic>., 2015</xref>
<break></break>
<sup>b</sup>
<xref ref-type="bibr" rid="b249-bt-24-207">Perry <italic>et al</italic>., 2001</xref>
<break></break>
<sup>c</sup>
<xref ref-type="bibr" rid="b322-bt-24-207">Tsai, 2005</xref>
<break></break>
<sup>d</sup>
<xref ref-type="bibr" rid="b241-bt-24-207">Pardo and Eberhart, 2007</xref>
<break></break>
<sup>e</sup>
<xref ref-type="bibr" rid="b314-bt-24-207">Taurines <italic>et al</italic>., 2014</xref>
<break></break>
<sup>f</sup>
<xref ref-type="bibr" rid="b340-bt-24-207">Weidner <italic>et al</italic>., 2014</xref>
<break></break>
<sup>g</sup>
<xref ref-type="bibr" rid="b240-bt-24-207">Papaleo <italic>et al</italic>., 2011</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>DHCR7</italic> mutant mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Low exploratory activity in the social preference test<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Low exploration in open field test<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased ventricular size<sup>e</sup></p></list-item><list-item><p>Hippocampus abnormalities<sup>f</sup></p></list-item><list-item><p>Serotonergic neurons abnormalities<sup>f,g</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Main cause of SLOS from a defective DHCR7<sup>a</sup></p></list-item><list-item><p>50% of SLOS are relevant to autism<sup>b</sup></p></list-item><list-item><p>Low cholesterol observed in children with ASD<sup>c</sup></p></list-item><list-item><p>SLOS patients have hyperactivity, irritability, aggression, insomnia, self-injurious behavior, repetitive and ritualistic behaviors as well as impaired communication<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>a</sup>
<xref ref-type="bibr" rid="b155-bt-24-207">Irons <italic>et al</italic>., 1993</xref>
<break></break>
<sup>b</sup>
<xref ref-type="bibr" rid="b318-bt-24-207">Tierney <italic>et al</italic>., 2000</xref>
<break></break>
<sup>c</sup>
<xref ref-type="bibr" rid="b317-bt-24-207">Tierney <italic>et al</italic>., 2006</xref>
<break></break>
<sup>d</sup>
<xref ref-type="bibr" rid="b226-bt-24-207">Moy <italic>et al</italic>., 2009</xref>
<break></break>
<sup>e</sup>
<xref ref-type="bibr" rid="b77-bt-24-207">Correa-Cerro <italic>et al</italic>., 2006</xref>
<break></break>
<sup>f</sup>
<xref ref-type="bibr" rid="b331-bt-24-207">Waage-Baudet <italic>et al</italic>., 2003</xref>
<break></break>
<sup>g</sup>
<xref ref-type="bibr" rid="b182-bt-24-207">Korade <italic>et al</italic>., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>EN2</italic><sup>−/−</sup> mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Decreased social play<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased aggression, impaired learning and memory and motor coordination<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Decreased cerebellar size and abnormal foliation patterns<sup>c</sup></p></list-item><list-item><p>Major cell types of the olivocerebellar circuit e.g. Purkinje, were reduced up to 30–40%<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Mutations of this gene were found to have some associations with ASD<sup>a</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b25-bt-24-207">Benayed <italic>et al</italic>., 2005</xref>;<break></break><sup>b</sup><xref ref-type="bibr" rid="b65-bt-24-207">Cheh <italic>et al</italic>., 2006</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b183-bt-24-207">Kuemerle <italic>et al</italic>., 2007</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b184-bt-24-207">Kuemerle <italic>et al</italic>., 1997</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>FMR1</italic> knockout mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Repetitive behaviors<sup>c</sup></p></list-item><list-item><p>Decreased social interaction<sup>c</sup></p></list-item><list-item><p><italic>Controversy in social approach &amp; social anxiety behaviors</italic><sup>f</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased anxiety &amp; hyperactivity<sup>c</sup></p></list-item><list-item><p>High seizure susceptibility<sup>d</sup></p></list-item><list-item><p>Decreased spatial learning ability &amp; impaired object recognition<sup>e</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased dendritic spine length<sup>g</sup></p></list-item><list-item><p>Increased mGluR-dependent LTD<sup>h</sup></p></list-item><list-item><p>50% reduced mGluR5 expression<sup>i</sup></p></list-item><list-item><p>Imbalance between excitation and inhibition in the brain circuitry<sup>d</sup></p></list-item><list-item><p>Increased dendritic spine length</p></list-item><list-item><p>Cortical LTP decrement<sup>j</sup></p></list-item><list-item><p>Delayed GABA polarity developmental switch (i.e. from depolarizing to hyperpolarizing) and dysregulated intracellular chloride levels<sup>k</sup></p></list-item><list-item><p>Dysfunctional endocannabinoid system (ECS), i.e altered CB1 and CB2 receptors<sup>l</sup></p></list-item><list-item><p>Increased excitatory synaptic plasticity and abnormal mGlu5R/2-AG coupling<sup>l</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Main cause of FXS, from <italic>FMR1</italic> mutation, i.e. expanded CGG trinucleotide repeats (55–230) in the 5′ untranslated region (5′UTR) &amp; halts the production of FMRP<sup>a</sup></p></list-item><list-item><p>10–30% of FXS are diagnosed with autism<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b111-bt-24-207">Garber <italic>et al</italic>., 2008</xref>;<break></break><sup>b</sup><xref ref-type="bibr" rid="b136-bt-24-207">Hatton <italic>et al</italic>., 2006</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b136-bt-24-207">Bernardet and Crusio, 2006</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b290-bt-24-207">Silva and Ehninger, 2009</xref><break></break><sup>e</sup><xref ref-type="bibr" rid="b46-bt-24-207">Brennan <italic>et al</italic>., 2006</xref><break></break><sup>f</sup><xref ref-type="bibr" rid="b302-bt-24-207">Spencer <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="b217-bt-24-207">McNaughton <italic>et al</italic>., 2008</xref> vs <xref ref-type="bibr" rid="b221-bt-24-207">Mineur <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="b198-bt-24-207">Liu and Smith, 2009</xref><break></break><sup>g</sup><xref ref-type="bibr" rid="b156-bt-24-207">Irwin <italic>et al</italic>., 2000</xref><break></break><sup>h</sup><xref ref-type="bibr" rid="b232-bt-24-207">Nosyreva and Huber, 2006</xref><break></break><sup>i</sup><xref ref-type="bibr" rid="b23-bt-24-207">Bear <italic>et al</italic>., 2004</xref><break></break><sup>j</sup><xref ref-type="bibr" rid="b360-bt-24-207">Zhang <italic>et al</italic>., 2009</xref><break></break><sup>k</sup>He <italic>et al</italic>., 2014; <xref ref-type="bibr" rid="b325-bt-24-207">Tyzio <italic>et al</italic>., 2014</xref><break></break><sup>l</sup><xref ref-type="bibr" rid="b203-bt-24-207">Maccarrone <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="b166-bt-24-207">Jung <italic>et al</italic>., 2012</xref>; <xref ref-type="bibr" rid="b49-bt-24-207">Busquets-Garcia <italic>et al</italic>., 2013</xref>;</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>GABRB3</italic> knockout mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Stereotyped circling<sup>g</sup></p></list-item><list-item><p>Decreased social interaction<sup>g</sup></p></list-item><list-item><p>Impaired nesting behaviors<sup>g</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased neonatal mortality and seizure susceptibility<sup>f</sup></p></list-item><list-item><p>Hyperactivity<sup>g</sup></p></list-item><list-item><p>Impaired learning and memory with low exploratory behaviors<sup>g</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>50% reduction of the binding capacity to the GABAA receptor sites in newborns and adults<sup>h</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Maternal deletion of 15q11-13 containing <italic>UBE3A</italic> and <italic>GABRB3</italic> causes Angelman syndrome<sup>a</sup></p></list-item><list-item><p><italic>UBE3A</italic> and <italic>GABRB3</italic> downregulations have overlapping genotypes and phenotypes with autism especially those with <italic>MECP2</italic> mutations causing Rett syndrome<sup>b</sup></p></list-item><list-item><p>Reduced GABAergic receptor system<sup>c</sup></p></list-item><list-item><p>Decreased GAD expression<sup>d</sup></p></list-item><list-item><p><italic>GABRB3</italic> polymorphism<sup>e</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b332-bt-24-207">Wagstaff <italic>et al</italic>., 1991</xref>; <xref ref-type="bibr" rid="b229-bt-24-207">Nakao <italic>et al</italic>., 1994</xref>;<break></break><sup>b</sup><xref ref-type="bibr" rid="b274-bt-24-207">Samaco <italic>et al</italic>., 2005</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b37-bt-24-207">Blatt <italic>et al</italic>., 2001</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b102-bt-24-207">Fatemi <italic>et al</italic>., 2002</xref><break></break><sup>e</sup><xref ref-type="bibr" rid="b51-bt-24-207">Buxbaum <italic>et al</italic>., 2002</xref><break></break><sup>f</sup><xref ref-type="bibr" rid="b143-bt-24-207">Homanics <italic>et al</italic>., 1997</xref><break></break><sup>g</sup><xref ref-type="bibr" rid="b89-bt-24-207">DeLorey <italic>et al</italic>., 2008</xref><break></break><sup>h</sup><xref ref-type="bibr" rid="b296-bt-24-207">Sinkkonen <italic>et al</italic>., 2003</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>MeCP2</italic> knockout mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Impaired social interaction and nest building ability<sup>b,d</sup></p></list-item><list-item><p>Impaired long-term social memory<sup>b,d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased anxiety<sup>b</sup></p></list-item><list-item><p>Decreased motor coordination<sup>c</sup></p></list-item><list-item><p>Impaired learning and memory<sup>b,d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased neuronal transcription through enhanced histone acetylation<sup>e</sup></p></list-item><list-item><p>Neurotoxicity due to excessive glutamate release from microglia<sup>f</sup></p></list-item><list-item><p><italic>MeCP2</italic>-null astrocytes cannot support normal dendritic morphology in the wild-type hippocampal neurons<sup>g</sup></p></list-item><list-item><p>Abnormal dendrites and axon development<sup>h</sup></p></list-item><list-item><p>Reduced inhibitory quantal size of GABAergic neurons<sup>i</sup></p></list-item><list-item><p>Decreased GAD expression<sup>i</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Main cause of x-linked, female–prevalent Rett syndrome, an MeCP2 mutation disorder<sup>a</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>a</sup>
<xref ref-type="bibr" rid="b262-bt-24-207">Rett, 1966</xref>
<break></break>
<sup>b</sup>
<xref ref-type="bibr" rid="b61-bt-24-207">Chahrour and Zoghbi, 2007</xref>
<break></break>
<sup>c</sup>
<xref ref-type="bibr" rid="b133-bt-24-207">Guy <italic>et al</italic>., 2001</xref>
<break></break>
<sup>d</sup>
<xref ref-type="bibr" rid="b225-bt-24-207">Moretti <italic>et al</italic>., 2006</xref>
<break></break>
<sup>e</sup>
<xref ref-type="bibr" rid="b132-bt-24-207">Guy <italic>et al</italic>., 2011</xref>
<break></break>
<sup>f</sup>
<xref ref-type="bibr" rid="b205-bt-24-207">Maezawa and Jin, 2010</xref>
<break></break>
<sup>g</sup>
<xref ref-type="bibr" rid="b19-bt-24-207">Ballas <italic>et al</italic>., 2009</xref>
<break></break>
<sup>h</sup>
<xref ref-type="bibr" rid="b189-bt-24-207">Larimore <italic>et al</italic>., 2009</xref>
<break></break>
<sup>i</sup>
<xref ref-type="bibr" rid="b64-bt-24-207">Chao <italic>et al</italic>., 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>MAOA</italic> deficient mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Social and communication impairments<sup>h</sup></p></list-item><list-item><p>Repetitive behavior responses &amp; behavioral rigidity<sup>h</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased aggression<sup>e</sup></p></list-item><list-item><p>Increased fear and eye-blink conditioning<sup>f</sup></p></list-item><list-item><p>Hyper-responsiveness to acoustic stimuli<sup>g</sup></p></list-item><list-item><p>Motor abnormalities<sup>h</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased hippocampal LTP and NMDAR expression<sup>g</sup></p></list-item><list-item><p>Thinning of the corpus callosum<sup>i</sup></p></list-item><list-item><p>Increased pyramidal neurodendrite arborization in the PFC<sup>h</sup></p></list-item><list-item><p>Disrupted microarchitecture of the cerebellum<sup>h</sup></p></list-item><list-item><p>Increased levels of serotonin, dopamine and norepinephrine<sup>e,g,h</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Mutation of MAOA causes Brunner syndrome and is linked to antisocial behaviors<sup>a</sup></p></list-item><list-item><p>The alleles regulating the levels of MAOA were correlated with autism and the severity of autistic symptoms<sup>b</sup></p></list-item><list-item><p>Causative role of MAOA-up stream variable number of tandem repeats (uVNTR) in ASD hyperserotone <italic>MIA</italic><sup>c</sup></p></list-item><list-item><p>Cortical enlargement in autism is associated with a functional variable number tandem repeats in MAOA<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>a</sup>
<xref ref-type="bibr" rid="b150-bt-24-207">Hunter, 2010</xref>
<break></break>
<sup>b</sup>
<xref ref-type="bibr" rid="b75-bt-24-207">Cohen <italic>et al</italic>., 2003</xref>
<break></break>
<sup>c</sup>
<xref ref-type="bibr" rid="b145-bt-24-207">Hranilovic <italic>et al</italic>., 2008</xref>
<break></break>
<sup>d</sup>
<xref ref-type="bibr" rid="b86-bt-24-207">Davis <italic>et al</italic>., 2008</xref>
<break></break>
<sup>e</sup>
<xref ref-type="bibr" rid="b58-bt-24-207">Cases <italic>et al</italic>., 1995</xref>
<break></break>
<sup>f</sup>
<xref ref-type="bibr" rid="b294-bt-24-207">Singh <italic>et al</italic>., 2013</xref>
<break></break>
<sup>g</sup>
<xref ref-type="bibr" rid="b257-bt-24-207">Popova <italic>et al</italic>., 2000</xref>
<break></break>
<sup>h</sup>
<xref ref-type="bibr" rid="b44-bt-24-207">Bortolato <italic>et al</italic>., 2013</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>NF1</italic><sup>+/−</sup> mice</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>ND</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Defects in spatial learning and memory<sup>c,d</sup></p></list-item><list-item><p>Delayed acquisition of motor skills<sup>d</sup></p></list-item><list-item><p>Impaired fear conditioning<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Cortical neurons and astrocytes fail to form cortical barrels in the somatosensory cortex<sup>e</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Mutations of the NF1 gene causes a life-shortening condition known as neurofibromatosis<sup>a</sup></p></list-item><list-item><p>NF1 was suggested to underlie mental retardation and learning deficits<sup>b</sup></p></list-item><list-item><p>Overexpression of <italic>NF1</italic> gene and polymorphisms in some NF1 allele region were correlated with autism<sup>f</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b260-bt-24-207">Rasmussen and Friedman, 2000</xref><break></break><sup>b</sup><xref ref-type="bibr" rid="b151-bt-24-207">Husi <italic>et al</italic>., 2000</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b291-bt-24-207">Silva <italic>et al</italic>., 1997</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b78-bt-24-207">Costa <italic>et al</italic>., 2002</xref><break></break><sup>e</sup><xref ref-type="bibr" rid="b202-bt-24-207">Lush <italic>et al</italic>., 2008</xref><break></break><sup>f</sup><xref ref-type="bibr" rid="b215-bt-24-207">Mbarek <italic>et al</italic>., 1999</xref>; <xref ref-type="bibr" rid="b213-bt-24-207">Marui <italic>et al</italic>., 2004</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>NLGN1</italic> knockout mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Repetitive/stereotype grooming<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Impaired spatial memory<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Decreased NMDA/AMPA ratios in cortico-striatal synapses<sup>b</sup></p></list-item><list-item><p>Decreased hippocampal LTP<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>In-depth molecular genetic analysis concluded that neuroligin mutations may cause autism only in rare occasions and neuroligin allele variations would be unlikely major risk factor for autism<sup>a</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>a</sup>
<xref ref-type="bibr" rid="b357-bt-24-207">Ylisaukko-oja <italic>et al</italic>., 2005</xref>
<break></break>
<sup>b</sup>
<xref ref-type="bibr" rid="b38-bt-24-207">Blundell <italic>et al</italic>., 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>NLGN3</italic> R451C mutant mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Impaired social interaction<sup>c</sup></p></list-item><list-item><p>Deficits in USV and preference for social novelty<sup>d,e</sup></p></list-item><list-item><p><italic>No changes in time spent in social interaction</italic><sup>e</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Enhanced spatial learning ability<sup>c</sup></p></list-item><list-item><p>Olfactory defects<sup>e</sup></p></list-item><list-item><p><italic>No changes in PPI and seizure susceptibility</italic><sup>e</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased inhibitory synaptic transmission with no apparent effect in excitatory synapses in the somatosensory cortex<sup>d</sup></p></list-item><list-item><p>Increased excitatory transmission in the hippocampal region for both AMPAR and NMDAR–mediated currents<sup>c</sup></p></list-item><list-item><p>Enhanced LTP<sup>c</sup></p></list-item><list-item><p>Increased dendritic branching and synaptic structure abnormalities in hippocampus<sup>c</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Mutations of <italic>NLGN3</italic> and <italic>NLGN4</italic> are associated with X-linked intellectual disability, seizures, and autism<sup>a</sup></p></list-item><list-item><p>Arg451Cys (R451C) mutation of <italic>NLGN3</italic> is associated with autism<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b158-bt-24-207">Jamain <italic>et al</italic>., 2003</xref><break></break><sup>b</sup><xref ref-type="bibr" rid="b76-bt-24-207">Comoletti <italic>et al</italic>., 2004</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b99-bt-24-207">Etherton <italic>et al</italic>., 2011</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b159-bt-24-207">Jamain <italic>et al</italic>., 2008</xref>;<break></break><sup>e</sup><xref ref-type="bibr" rid="b259-bt-24-207">Radyushkin <italic>et al</italic>., 2009</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>NLGN4</italic> mutant mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Impaired social interaction and social memory<sup>c,d</sup></p></list-item><list-item><p><italic>No change in repetitive behaviors</italic><sup>c</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p><italic>No change in exploratory activity, anxiety, learning and memory</italic><sup>c</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Reduced brain volume<sup>c</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Mutations of <italic>NLGN3</italic> and <italic>NLGN4</italic> are associated with X-linked intellectual disability, seizures, and autism<sup>a</sup></p></list-item><list-item><p>Attributed to many comorbid neurodevelopmental conditions and may only contribute to ASD at a small fraction<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b158-bt-24-207">Jamain <italic>et al</italic>., 2003</xref>;<break></break><sup>b</sup><xref ref-type="bibr" rid="b113-bt-24-207">Gauthier <italic>et al</italic>., 2005</xref>;<break></break><sup>c</sup><xref ref-type="bibr" rid="b159-bt-24-207">Jamain <italic>et al</italic>., 2008</xref>;<break></break><sup>d</sup><xref ref-type="bibr" rid="b259-bt-24-207">Radyushkin <italic>et al</italic>., 2009</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>NRXN1</italic>α deficient mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Impaired nesting ability<sup>b</sup></p></list-item><list-item><p>Increased grooming activity<sup>b</sup></p></list-item><list-item><p><italic>No obvious social defects</italic><sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Impaired pre-pulse inhibition<sup>b</sup></p></list-item><list-item><p><italic>Enhanced motor learning</italic><sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Defects in excitatory synaptic transmission<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p><italic>NRXN1</italic> deletion was implicated with ASD along with other disorders<sup>a</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>a</sup>
<xref ref-type="bibr" rid="b69-bt-24-207">Ching <italic>et al</italic>., 2010</xref>
<break></break>
<sup>b</sup>
<xref ref-type="bibr" rid="b100-bt-24-207">Etherton <italic>et al</italic>., 2009</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>Oxt</italic> deficient mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Impaired social ecognition<sup>f</sup></p></list-item><list-item><p>Decreased social odor memory in females<sup>g</sup></p></list-item><list-item><p>Normal social approach<sup>h</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p><italic>Reduced aggression</italic><sup>h</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Oxytocin administration into the amygdala region showed enhanced social recognition in Oxt knockout mice<sup>i</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Oxytocin has a key role in the process of social recognition and interactions<sup>a</sup></p></list-item><list-item><p>Reduced plasma levels of oxytocin observed in autistic children<sup>b</sup></p></list-item><list-item><p>Administration of oxytocin in autistic patients resulted to enhanced social interactions<sup>c</sup>, reduced repetitive behaviors<sup>d</sup>, and improved emotional recognition<sup>e</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b130-bt-24-207">Guastella <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="b278-bt-24-207">Savaskan <italic>et al</italic>., 2008</xref><break></break><sup>b</sup><xref ref-type="bibr" rid="b154-bt-24-207">Insel, 2010</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b10-bt-24-207">Andari <italic>et al</italic>., 2010</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b141-bt-24-207">Hollander <italic>et al</italic>., 2003</xref><break></break><sup>e</sup><xref ref-type="bibr" rid="b129-bt-24-207">Guastella <italic>et al</italic>., 2010</xref><break></break><sup>f</sup><xref ref-type="bibr" rid="b104-bt-24-207">Ferguson <italic>et al</italic>., 2001</xref>;<break></break><sup>g</sup><xref ref-type="bibr" rid="b172-bt-24-207">Kavaliers <italic>et al</italic>., 2003</xref><break></break><sup>h</sup><xref ref-type="bibr" rid="b344-bt-24-207">Winslow and Insel, 2002</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>Oxtr</italic>-null mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Reduced social memory<sup>b</sup></p></list-item><list-item><p>Defective USVs<sup>b</sup></p></list-item><list-item><p>Deficits in social behaviors<sup>c,d</sup></p></list-item><list-item><p><italic>No changes in stereotyped behaviors</italic><sup>c</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased aggression<sup>d</sup></p></list-item><list-item><p>High seizure susceptibility<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Decreased ratio of GABAergic presynapses in the hippocampus<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Polymorphisms in <italic>Oxtr</italic> from various ethnic populations revealed an associations to ASD<sup>a</sup></p></list-item><list-item><p>OXTR SNPs as predictors of social impairments in children with or without ASD<sup>e</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b157-bt-24-207">Jacob <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="b127-bt-24-207">Gregory <italic>et al</italic>., 2009</xref>; <xref ref-type="bibr" rid="b349-bt-24-207">Wu <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="b194-bt-24-207">Liu <italic>et al</italic>., 2010</xref>;<break></break><sup>b</sup><xref ref-type="bibr" rid="b192-bt-24-207">Lee <italic>et al</italic>., 2008</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b254-bt-24-207">Pobbe <italic>et al</italic>., 2012</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b272-bt-24-207">Sala <italic>et al</italic>., 2011</xref><break></break><sup>e</sup><xref ref-type="bibr" rid="b242-bt-24-207">Parker <italic>et al</italic>., 2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>MAGEL2</italic>-deficient mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Impaired social recognition and interaction in adulthood<sup>c</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Learning difficulties in adulthood<sup>c</sup></p></list-item><list-item><p>Decreased suckling behavior leading to 50% mortality<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Reduced production of oxytocin in the hypothalamus during neonatal period<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p><italic>MAGEL2</italic> is a paternally imprinted gene located in chromosome 15q11-q13 found to have a genetic role in the development of PWS<sup>a</sup></p></list-item><list-item><p><italic>MAGEL2</italic> has been introduced as a causative gene for the complex ASD and contributes to PWS and ASD comorbidity<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>a</sup>
<xref ref-type="bibr" rid="b40-bt-24-207">Boccaccio <italic>et al</italic>., 1999</xref>
<break></break>
<sup>b</sup>
<xref ref-type="bibr" rid="b280-bt-24-207">Schaaf <italic>et al</italic>., 2013</xref>
<break></break>
<sup>c</sup>
<xref ref-type="bibr" rid="b220-bt-24-207">Meziane <italic>et al</italic>., 2015</xref>
<break></break>
<sup>d</sup>
<xref ref-type="bibr" rid="b281-bt-24-207">Schaller <italic>et al</italic>., 2010</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>PTEN</italic> mutant mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Abnormal social interaction<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Excessive responses to stimuli<sup>b</sup></p></list-item><list-item><p>Hyperactivity<sup>c</sup></p></list-item><list-item><p>Decreased PPI<sup>c</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Macrocephaly and neuronal hypertrophy<sup>b</sup></p></list-item><list-item><p>Increased net excitatory drive onto granule neurons with a preferential increase in excitatory synaptic neurons<sup>d</sup></p></list-item><list-item><p>Increased cell proliferation capacity<sup>e</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>PTEN variations were observed in ASD with macrocephaly phenotypes<sup>a</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b50-bt-24-207">Butler <italic>et al</italic>., 2005</xref><break></break><sup>b</sup><xref ref-type="bibr" rid="b187-bt-24-207">Kwon <italic>et al</italic>., 2006</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b236-bt-24-207">Ogawa <italic>et al</italic>., 2007</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b201-bt-24-207">Luikart <italic>et al</italic>., 2011</xref><break></break><sup>e</sup><xref ref-type="bibr" rid="b126-bt-24-207">Gregorian <italic>et al</italic>., 2009</xref>; <xref ref-type="bibr" rid="b43-bt-24-207">Bonaguidi <italic>et al</italic>., 2011</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>Reeler</italic> (rl/rl) and mutant (+/rl) mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Deficits in USV<sup>a</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased seizure susceptibility<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Disorganizations in the cerebrum, cerebellum, hippocampus, subcortical regions, and spinal cord<sup>c</sup></p></list-item><list-item><p>Decreased density of striatal GABAergic interneurons<sup>e</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Downregulation of Reelin in the cortical GABAergic interneurons has been frequently observed in schizophrenia, bipolar disorders and autism<sup>a</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="2" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b237-bt-24-207">Ognibene <italic>et al</italic>., 2007</xref><break></break><sup>b</sup><xref ref-type="bibr" rid="b118-bt-24-207">Gillberg, 1998</xref>;<break></break><sup>c</sup><xref ref-type="bibr" rid="b211-bt-24-207">Martin, 1981</xref>; <xref ref-type="bibr" rid="b122-bt-24-207">Goffinet, 1983</xref>; <xref ref-type="bibr" rid="b355-bt-24-207">Yip <italic>et al</italic>., 2000</xref>; <xref ref-type="bibr" rid="b83-bt-24-207">D’Arcangelo, 2005</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b243-bt-24-207">Patrylo <italic>et al</italic>., 2006</xref><break></break><sup>e</sup><xref ref-type="bibr" rid="b207-bt-24-207">Marrone <italic>et al</italic>., 2006</xref><break></break><sup>f</sup><xref ref-type="bibr" rid="b323-bt-24-207">Tueting <italic>et al</italic>., 1999</xref><break></break><sup>g</sup><xref ref-type="bibr" rid="b273-bt-24-207">Salinger <italic>et al</italic>., 2003</xref><break></break><sup>h</sup><xref ref-type="bibr" rid="b255-bt-24-207">Podhorna and Didriksen, 2004</xref><break></break><sup>i</sup><xref ref-type="bibr" rid="b153-bt-24-207">Iafrati <italic>et al</italic>., 2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Heterozygous <italic>reeler</italic> (+/rl) mice</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>ND</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Deficits in PPI and decreased exploration in the EPM<sup>f</sup></p></list-item><list-item><p><italic>Normal social aggressive behaviors</italic><sup>g</sup></p></list-item><list-item><p><italic>No behavioral abnormalities</italic><sup>h</sup></p></list-item><list-item><p>Abnormal fear memory<sup>i</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Reduction in dendritic spine density and abnormal LTP in the prefrontal cortex<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Mutation of 7q22-23 resulting to longer triplet repeats in the 5′UTR of <italic>RELN</italic> gene were observed in autistic patients<sup>b</sup></p></list-item></list></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>SERT</italic> knockout mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Reduced social interactions<sup>c</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Decreased exploration<sup>d</sup></p></list-item><list-item><p>Increased anxiety<sup>d</sup></p></list-item><list-item><p>Increased sensitivity to stress<sup>e</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Altered HPA axis signaling<sup>e</sup></p></list-item><list-item><p>Altered cortical thickness and cell density<sup>f</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Hyperserotone <italic>MIA</italic> is a consistent finding ASD<sup>a</sup></p></list-item><list-item><p>Conflicting results regarding the involvement of SERT variants in autism hyperserotone <italic>MIA</italic><sup>b</sup></p></list-item><list-item><p>Variations of SERT including Gly56Ala, Ile425Leu, Ile425Val, Phe465Leu, Leu550Val, and Lys605Asn all increase the serotonin uptake activity of SERT<sup>g</sup></p></list-item><list-item><p>SERT variation may overlap between ASD and OCD<sup>h</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b145-bt-24-207">Hranilovic <italic>et al</italic>., 2008</xref><break></break><sup>b</sup><xref ref-type="bibr" rid="b31-bt-24-207">Betancur <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="b147-bt-24-207">Huang <italic>et al</italic>., 2008</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b168-bt-24-207">Kalueff <italic>et al</italic>., 2007</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b142-bt-24-207">Holmes <italic>et al</italic>., 2003</xref>;<break></break><sup>e</sup><xref ref-type="bibr" rid="b160-bt-24-207">Jiang <italic>et al</italic>., 2009</xref><break></break><sup>f</sup><xref ref-type="bibr" rid="b4-bt-24-207">Altamura <italic>et al</italic>., 2007</xref><break></break><sup>g</sup><xref ref-type="bibr" rid="b258-bt-24-207">Prasad <italic>et al</italic>., 2009</xref><break></break><sup>h</sup><xref ref-type="bibr" rid="b327-bt-24-207">Veenstra-Vanderweele <italic>et al</italic>., 2009</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>SHANK1</italic><sup>−/−</sup> mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p><italic>No defects in social interaction</italic><sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased anxiety<sup>b,d</sup></p></list-item><list-item><p>Impaired contextual fear memory<sup>b</sup></p></list-item><list-item><p><italic>Enhanced spatial learning</italic><sup>b</sup></p></list-item><list-item><p>Deficits in USV and scent marking behaviors<sup>c</sup></p></list-item><list-item><p>Motor disability<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Altered composition of PSD proteins<sup>b</sup></p></list-item><list-item><p>Reduced size of dendritic spines and weaker basal synaptic transmission<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Synaptic dysfunction hypothesis in ASD pathophysiology could be supported by studies of <italic>Shank</italic> mutation neurobiology in mice<sup>a</sup></p></list-item><list-item><p>Male-heritable <italic>SHANK1</italic> locus microdeletions in ASD patients</p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>a</sup>
<xref ref-type="bibr" rid="b161-bt-24-207">Jiang and Ehlers, 2013</xref>
<break></break>
<sup>b</sup>
<xref ref-type="bibr" rid="b149-bt-24-207">Hung <italic>et al</italic>., 2008</xref>
<break></break>
<sup>c</sup>
<xref ref-type="bibr" rid="b346-bt-24-207">Wohr <italic>et al</italic>., 2011b</xref>
<break></break>
<sup>d</sup>
<xref ref-type="bibr" rid="b293-bt-24-207">Silverman <italic>et al</italic>., 2011</xref>
<break></break>
<sup>e</sup>
<xref ref-type="bibr" rid="b277-bt-24-207">Sato <italic>et al</italic>., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>SHANK2</italic><sup>−/−</sup> mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Repetitive grooming and jumping<sup>c,d</sup></p></list-item><list-item><p>Impaired USVs and social interaction behaviors<sup>c,d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Hyperactivity <sup>c</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Fewer dendritic spines and lower basal synaptic transmission with increased excitatory currents by NMDA receptors<sup>c</sup></p></list-item><list-item><p>Decreased NMDA receptor function (another study)<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Mutations in the <italic>SHANK2</italic> gene were reported in ASD patients<sup>a</sup></p></list-item><list-item><p>Spine volume alterations and smaller <italic>SHANK2</italic> cluster sizes (R462X &amp; T1127M <italic>SHANK2</italic> variants)<sup>b</sup></p></list-item><list-item><p>Defective dendritic branching and decreased postsynaptic clustering (R4623X variant)<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b27-bt-24-207">Berkel <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="b190-bt-24-207">Leblond <italic>et al</italic>., 2012</xref><break></break><sup>b</sup><xref ref-type="bibr" rid="b28-bt-24-207">Berkel <italic>et al</italic>., 2012</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b283-bt-24-207">Schmeisser <italic>et al</italic>., 2012</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b348-bt-24-207">Won <italic>et al</italic>., 2012</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>SHANK3</italic> mutant mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Deficits in social interaction<sup>c</sup></p></list-item><list-item><p>Mild social deficits in juvenile but not adults<sup>e</sup></p></list-item><list-item><p>Repetitive grooming (variable)<sup>c,e</sup></p></list-item><list-item><p>Decreased USVs (variable)<sup>e,f</sup></p></list-item><list-item><p>Reduced social sniffing<sup>f</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Decreased reversal learning (variable)<sup>e</sup></p></list-item><list-item><p>Impaired novel object recognition and motor coordination<sup>e</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Cortico-striatal circuit and striatal synaptic defects<sup>c</sup></p></list-item><list-item><p>Decreased EPSCs in the pyramidal neurons of hippocampal CA1<sup>f</sup></p></list-item><list-item><p>Reduced basal neurotransmission in these animals in an AMPAR mediated manner<sup>f</sup></p></list-item><list-item><p>Reduced GluR1-immunoreactive puncta of the stratum radiatum<sup>f</sup></p></list-item><list-item><p>Impaired LTP but not LTD<sup>f</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Mutations of the <italic>SHANK3</italic> genes, such as the microdeletions of 22q13, have been implicated in ASD<sup>a</sup></p></list-item><list-item><p>Heterozygous mutations of <italic>SHANK3</italic> may cause ASD in a gene-dosage-dependent manner<sup>b</sup></p></list-item><list-item><p>Possible link between autism and schizophrenia due to similar findings regarding <italic>SHANK3</italic> mutations<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b206-bt-24-207">Manning <italic>et al</italic>., 2004</xref><break></break><sup>b</sup><xref ref-type="bibr" rid="b94-bt-24-207">Durand <italic>et al</italic>., 2007</xref>;<break></break><sup>c</sup><xref ref-type="bibr" rid="b246-bt-24-207">Peca <italic>et al</italic>., 2011</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b114-bt-24-207">Gauthier <italic>et al</italic>., 2010</xref><break></break><sup>e</sup><xref ref-type="bibr" rid="b353-bt-24-207">Yang <italic>et al</italic>., 2012</xref><break></break><sup>f</sup><xref ref-type="bibr" rid="b45-bt-24-207">Bozdagi <italic>et al</italic>., 2010</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Conditional <italic>TSC1</italic> knockout mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Abnormal social interactions<sup>g</sup></p></list-item><list-item><p>Repetitive behaviors<sup>g</sup></p></list-item><list-item><p>Impaired vocalizations<sup>g</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased seizure susceptibility<sup>c,d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Significant brain pathology<sup>c</sup></p></list-item><list-item><p>Cortical excitability<sup>d</sup></p></list-item><list-item><p>Enhanced AMPAR and NMDAR-mediated EPSCs<sup>e</sup></p></list-item><list-item><p>Increased brain size and elevated mTORC1 signaling but declined mTORC2 signaling<sup>f</sup></p></list-item><list-item><p>Decreased Purkinje cells<sup>g</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="2" valign="top">
<list list-type="bullet"><list-item><p>Mutations of <italic>TSC1</italic> or <italic>TSC2</italic> cause Tuberous sclerosis complex (TSC)<sup>a</sup></p></list-item><list-item><p>20–60% of TSC patients have ASD<sup>a</sup></p></list-item><list-item><p><italic>TSC1</italic>/<italic>TSC2</italic> mutations are associated with neurological deficits including cognitive dysfunction, epilepsy, and autism<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="2" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b42-bt-24-207">Bolton <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="b82-bt-24-207">Curatolo <italic>et al</italic>., 2004</xref><break></break><sup>b</sup><xref ref-type="bibr" rid="b92-bt-24-207">DiMario, 2004</xref>; <xref ref-type="bibr" rid="b124-bt-24-207">Goorden <italic>et al</italic>., 2007</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b326-bt-24-207">Uhlmann <italic>et al</italic>., 2002</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b218-bt-24-207">Meikle <italic>et al</italic>., 2007</xref><break></break><sup>e</sup><xref ref-type="bibr" rid="b21-bt-24-207">Bateup <italic>et al</italic>., 2011</xref><break></break><sup>f</sup><xref ref-type="bibr" rid="b54-bt-24-207">Carson <italic>et al</italic>., 2012</xref><break></break><sup>g</sup><xref ref-type="bibr" rid="b321-bt-24-207">Tsai <italic>et al</italic>., 2012</xref><break></break><sup>h</sup><xref ref-type="bibr" rid="b96-bt-24-207">Ehninger <italic>et al</italic>., 2012</xref><break></break><sup>i</sup><xref ref-type="bibr" rid="b238-bt-24-207">Onda <italic>et al</italic>., 2002</xref><break></break><sup>j</sup><xref ref-type="bibr" rid="b358-bt-24-207">Young <italic>et al</italic>., 2010</xref><break></break><sup>k</sup><xref ref-type="bibr" rid="b68-bt-24-207">Chevere-Torres <italic>et al</italic>., 2012</xref><break></break><sup>l</sup><xref ref-type="bibr" rid="b261-bt-24-207">Reith <italic>et al</italic>., 2011</xref><break></break><sup>m</sup><xref ref-type="bibr" rid="b15-bt-24-207">Auerbach <italic>et al</italic>., 2011</xref><break></break><sup>n</sup><xref ref-type="bibr" rid="b312-bt-24-207">Tang <italic>et al</italic>., 2014</xref><break></break><sup>o</sup><xref ref-type="bibr" rid="b200-bt-24-207">Lozovaya <italic>et al</italic>., 2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Conditional <italic>TSC2</italic> knockout mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>TSC (+/−) mutant mice with MIA by poly I:C induced impaired social interactions<sup>h</sup></p></list-item><list-item><p>Altered USVs<sup>j</sup></p></list-item><list-item><p>Impaired social interaction<sup>k,n</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Seizure behaviors early in life<sup>o</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>No significant brain pathology in <italic>TSC2</italic><sup>w/−</sup>mice<sup>i</sup></p></list-item><list-item><p>Purkinje cell degeneration and apoptosis via ER and oxidative stress<sup>l</sup></p></list-item><list-item><p>Deficient mGluR-LTD in the hippocampus<sup>m</sup></p></list-item><list-item><p>mTOR over activity leading to abnormal postnatal dendritic pruning through normal autophagic inactivation in the brain<sup>n</sup></p></list-item><list-item><p>mTOR-dependent upregulation of NMDARs that contain GluN2C<sup>o</sup></p></list-item></list></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>UBE3A</italic> mutation</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Core symptoms of autism (increased <italic>UBE3A</italic>)<sup>b</sup></p></list-item><list-item><p>Increased emissions of USVs<sup>c</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Increased seizure susceptibility<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Reduced glutamate synaptic transmission (increased <italic>UBE3A</italic>)<sup>b</sup></p></list-item><list-item><p>Weakened synaptic functions through excessive internalization of AMPA receptors<sup>e</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Mutations of 15q11-13 containing <italic>UBE3A</italic> and <italic>GABRB3</italic> results to Angelman syndrome<sup>a</sup></p></list-item><list-item><p>Italian ASD patients have <italic>UBE3A</italic> mutation<sup>f</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b332-bt-24-207">Wagstaff <italic>et al</italic>., 1991</xref>; <xref ref-type="bibr" rid="b229-bt-24-207">Nakao <italic>et al</italic>., 1994</xref>;<break></break><sup>b</sup><xref ref-type="bibr" rid="b300-bt-24-207">Smith <italic>et al</italic>., 2011</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b162-bt-24-207">Jiang <italic>et al</italic>., 2010</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b222-bt-24-207">Miura <italic>et al</italic>., 2002</xref><break></break><sup>e</sup><xref ref-type="bibr" rid="b125-bt-24-207">Greer <italic>et al</italic>., 2010</xref><break></break><sup>f</sup><xref ref-type="bibr" rid="b131-bt-24-207">Guffanti <italic>et al</italic>., 2011</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  Brattleboro rats</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Decreased social recognition<sup>c</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>No cardiovascular response to social isolation<sup>d</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Could not synthesize AVP due to a frameshift mutation of its gene<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="3" valign="top">
<list list-type="bullet"><list-item><p>Autistic individuals and their immediate family members usually have an associated defect in <italic>AVPR1a</italic> gene<sup>a</sup></p></list-item><list-item><p>Transmission disequilibrium in the AVR intronic microsatellite of ASD patients<sup>a</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="3" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b339-bt-24-207">Wassink <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="b356-bt-24-207">Yirmiya <italic>et al</italic>., 2006</xref><break></break><sup>b</sup><xref ref-type="bibr" rid="b282-bt-24-207">Schmale <italic>et al</italic>., 1989</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b97-bt-24-207">Engelmann and Landgraf, 1994</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b112-bt-24-207">Gardiner and Bennett, 1983</xref><break></break><sup>e</sup><xref ref-type="bibr" rid="b32-bt-24-207">Bielsky <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="b154-bt-24-207">Insel, 2010</xref><break></break><sup>f</sup><xref ref-type="bibr" rid="b342-bt-24-207">Wersinger <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="b52-bt-24-207">Caldwell <italic>et al</italic>., 2008</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>V1aR</italic> knockout mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Deficits in social interaction and recognition<sup>e</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Decreased anxiety<sup>e</sup></p></list-item></list></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>ND</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  <italic>V1bR</italic> knockout mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Decreased social aggression, social aggression and social memory<sup>f</sup></p></list-item><list-item><p>Deficits in USV<sup>f</sup></p></list-item></list></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>ND</italic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>ND</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  CNTNAP2<sup>−/−</sup> mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>All core symptoms of ASD<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Hyperactivity and epileptic seizures<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Abnormal neuronal migration and network activity<sup>b</sup></p></list-item><list-item><p>Reduced GABAergic interneuron population<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Variants of CNTNAP2 have been identified in a number of ASD patients<sup>a</sup></p></list-item><list-item><p>CNTNAP2 mutations were found in a certain Australian population and in a boy with autism that have exhibited speech delays; an implication of this gene’s involvement in language development<sup>c</sup></p></list-item><list-item><p>CNTNAP2 mutations impaired the frontal lobe circuitry in ASD<sup>d</sup></p></list-item><list-item><p>Not all variants of the CNTNAP2 gene may relate to ASD<sup>e</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top"><sup>a</sup><xref ref-type="bibr" rid="b2-bt-24-207">Alarcón <italic>et al</italic>., 2008</xref>; <xref ref-type="bibr" rid="b11-bt-24-207">Arking <italic>et al</italic>., 2008</xref><break></break><sup>b</sup><xref ref-type="bibr" rid="b247-bt-24-207">Peñagarikano <italic>et al</italic>., 2011</xref><break></break><sup>c</sup><xref ref-type="bibr" rid="b343-bt-24-207">Whitehouse <italic>et al</italic>., 2011</xref><break></break><sup>d</sup><xref ref-type="bibr" rid="b288-bt-24-207">Scott-Van Zeeland <italic>et al</italic>., 2010</xref><break></break><sup>e</sup><xref ref-type="bibr" rid="b275-bt-24-207">Sampath <italic>et al</italic>., 2013</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">  eIF4E overexpression mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Social interaction deficits<sup>b</sup></p></list-item><list-item><p>Repetitive behaviors<sup>b</sup></p></list-item></list></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<italic>ND</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>mPFC, striatal and hippocampal synaptic abnormalities through increased cap-dependent translation in the brain<sup>b</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<list list-type="bullet"><list-item><p>Variants of the eIF4E gene promoter had been found were found in patients with ASD<sup>a</sup></p></list-item></list></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>a</sup>
<xref ref-type="bibr" rid="b310-bt-24-207">Szatmari <italic>et al</italic>., 2007</xref>
<break></break>
<sup>b</sup>
<xref ref-type="bibr" rid="b276-bt-24-207">Santini <italic>et al</italic>., 2013</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-bt-24-207">
<p>All descriptions with supercript alphabets correspond to their authors in the citation area and these alphabet sets have uniquecitations for each animal model. ND: no data, <italic>MIA</italic>: maternal immune activation, Italicized sentences-negative, controversial or normal findings, USVs: ultrasonic vocalizations.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>